US20070270892A1 - Devices and methods for treatment of obesity - Google Patents
Devices and methods for treatment of obesity Download PDFInfo
- Publication number
- US20070270892A1 US20070270892A1 US11/820,249 US82024907A US2007270892A1 US 20070270892 A1 US20070270892 A1 US 20070270892A1 US 82024907 A US82024907 A US 82024907A US 2007270892 A1 US2007270892 A1 US 2007270892A1
- Authority
- US
- United States
- Prior art keywords
- expandable member
- expandable
- patient
- stomach
- anchoring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07207—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously the staples being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07292—Reinforcements for staple line, e.g. pledgets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B17/115—Staplers for performing anastomosis in a single operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0073—Implantable devices or invasive measures in the abdominal cavity, e.g. not attached to the stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00876—Material properties magnetic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Methods, devices, tools, instruments and systems for treating a patient to induce weight loss. In one method embodiment, a device, including an expandable member in a collapsed configuration, is passed through an opening in the skin of the patient, and into the abdominal cavity of the patient. At least a portion of the expandable member is anchored relative to at least one structure in the abdominal cavity, without piercing the stomach. The expandable member is expanded to an expanded configuration in a space in the abdominal cavity to perform at least one of: prevention of expansion of the stomach of the patient into the space; and compression of a portion of the stomach.
Description
- This application is a continuation-in-part application of co-pending application Ser. No. 11/407,701, filed Apr. 19, 2006, which is incorporated herein by reference thereto, in its entirety, and to which application we claim priority under 35 USC §120.
- This application claims the benefit of U.S. Provisional Application No. 60/833,284, filed Jul. 24, 2006, and U.S. Provisional Application No. 60/877,595, filed Dec. 28, 2006, both of which applications are hereby incorporated herein, in their entireties, by reference thereto.
- This application also hereby incorporates herein by reference thereto, in its entirety, co-pending application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3) filed on even date herewith, and titled “Devices and Methods for Treatment of Obesity”.
- The present invention relates to treatment of obesity, more particularly to implantable devices and methods of implanting the devices in the abdominal cavity to treat an obese patient.
- Obesity has become a major health concern, both nationally and internationally. The National Center for Health Statistics (NCHS) estimates that over 120 million Americans are overweight, including about 56% of the adult population. Of these, about 52 million are considered obese, as measured by a body mass index (BMI) of 30% or greater. In Europe, an estimated 77 million people are obese, as measured by the same standard. This problem is not limited to western nations, as many developing countries are reported to have obesity rates over 75% of the adult population.
- Co-morbidities that are associated with obesity include, but are not limited to type II Diabetes, high blood pressure, sleep apnea, stroke and arthritis, the symptoms of which often tend to be lessened or alleviated upon loss of weight by a person so affected.
- In the U.S., options for treatment of obesity are currently quite limited. Current treatment methodologies typically rely upon surgically introducing a “malabsorptive” environment in the gastro-intestinal tract, a restrictive environment, or a combination of these. One available treatment method is gastric bypass surgery and another is referred to as gastric banding (one of these techniques is referred to as the LAPBAND™ procedure). These procedures are limited to only those patients with a BMI over 40 (or over 35, with co-morbidities present).
- Gastric bypass procedures incur a great deal of morbidity and create a malabsorptive state in the patient by bypassing a large portion of the intestines. Serious side effects, such as liver failure have been associated with this procedure, as well as chronic diarrhea. Another surgical procedure that has a high degree of morbidity associated with it is known as the “Gastric Bypass Roux-en-Y” procedure. This procedure reduces the capacity of the stomach by creating a smaller stomach pouch. The small space holds only about one ounce of fluid. A tiny stomach outlet is also surgically created to slow the speed at which food leaves the stomach. Staples are used to create a small (15 to 20 cc) stomach pouch, with the rest of the stomach being stapled completely shut and divided from the stomach pouch. The small intestine is divided just beyond the duodenum, brought up, and connected to the newly formed stomach pouch. In addition to the considerable morbidity associated with this procedure, other disadvantages include “dumping syndrome”, where stomach contents are literally “dumped” rapidly into the small intestine which may lead to nausea, weakness, sweating, faintness, and diarrhea; hernias resulting from the surgery; gallstones; leakage of the connection between the pouch and the intestine; stretching of the pouch that was formed; nutritional deficiencies; and possible dehiscence of the staples.
- The LAPBAND™ is a band that, when placed, encircles the fundus-cardia junction and is inflatable to constrict the same. It does not reduce the volume of the stomach, but rather restricts passage of food into the stomach, the theory being that the patient will feel satiety with a much smaller volume of food than previously. Although the LAPBAND™ procedure is less invasive than a gastric bypass procedure, it also typically achieves less weight loss. Further, it is not a simple procedure and requires a substantial amount of training by a surgeon to become proficient in performing the procedure. Also, a substantial amount of dissecting and suturing is required because the pathway by which the band is introduced is not an existing pathway, and must be established by dissection. Great care is required to avoid blood vessels and nerves that may be in the intended pathway to be created by the dissection. After placing the band around the fundus-cardia junction, the ends of the band must be connected together and then it must be cinched down into place. Additionally, complications such as erosion at the fundus-cardia junction, slippage of the band from its intended location, nausea/vomiting, gastroesophageal reflux, dysphagia and lack of effectiveness in causing weight loss have been reported.
- Intragastric balloons have also been placed, in an attempt to fill a portion of the volume in the stomach, with the theory being that it will then require less food than previously, to give the patient a sensation of fullness or satiety. This procedure involves delivery of a balloon (typically, transorally) to the interior of the stomach and inflation of the balloon to take up a portion of the volume inside the stomach. However, intragastric balloons may also lead to complications such as obstruction, vomiting and/or mucosal erosion of the inner lining of the stomach. The balloon can break down over extended exposure to the stomach's acids, and in some cases, after breaking down, the balloon translated through the intestines and caused a bowel obstruction.
- Gastrointestinal sleeves have been implanted to line the stomach and/or a portion of the small intestines to reduce the absorptive capabilities of the small intestine and/or to reduce the volume in the stomach, by reducing the available volume to the tubular structure of the graft running therethrough. Although weight loss may be effective while these types of devices are properly functioning, there are complications with anchoring the device within the stomach/GI tract, as the stomach and GI tract function to break down things that enter into them and to move/transport them through. Accordingly, the integrity of the anchoring of the device, as well as the device itself may be compromised over time by the acids and actions of the stomach and GI tract.
- A sleeve gastrectomy is an operation in which the left side of the stomach is surgically removed. This results in a much reduced stomach which is substantially tubular and may take on the shape of a banana. This procedure is associated with a high degree of morbidity, as a large portion of the stomach is surgically removed. Additionally, there are risks of complications such as dehiscence of the staple line where the staples are installed to close the surgical incisions where the portion of the stomach was removed. Further, the procedure is not reversible.
- In the laparoscopic duodenal switch, the size of the stomach is reduced in similar manner to that performed in a sleeve gastrectomy. Additionally, approximately half of the small intestine is bypassed and the stomach is reconnected to the shortened small intestine. This procedure suffers from the same complications as the sleeve gastrectomy, and even greater morbidity is associated with this procedure due to the additional intestinal bypass that needs to be performed. Still further, complications associated with malabsorption may also present themselves.
- An inflatable gastric device is disclosed in U.S. Pat. No. 4,246,893, in which a balloon is inserted anteriorly of the stomach and posteriorly of the left lobe of the liver. The balloon is then inflated to compress the stomach so that it fills with less food that would ordinarily be possible. Not only does this device compress the stomach, but it also compresses the liver, as seen in
FIG. 5 of the patent, which may cause complications with the liver function. Additionally, the balloon is simply placed into this location, and there is no assurance that it will not migrate and lose its effectiveness in compressing the stomach to the degree intended. Still further, the balloon is of a simple spherical design, and, as such, extends pressure outwardly in all directions, 360 degrees, in all planes. Accordingly, the liver is compressed just as much as the stomach is. Also, the compression forces against the stomach are not ideal, as the spherical balloon conformation does not match the conformation of the expanding stomach. The stomach is not spherical when expanded, or concave with a constant radius of curvature, but expands into a designated space that allows the fundus to expand preferentially more than other parts of the stomach. - Brazzini et al. in WO2005/18417 discloses at least two or more expandable devices used to treat obesity, in which the devices are inserted through the abdominal wall and anchored against the external surface of the stomach wall by an anchoring mechanism that extends through the stomach wall and fixes to the internal surface of the stomach wall.
- U.S. Patent Publication No. 2005/0261712 to Balbierz et al. describes capturing a device against the outer surface of the stomach wall to form a restriction that appears to function similarly to the restriction imposed by the LAPBAND™. The anchoring of the devices disclosed relies upon placement of features against the internal wall of the stomach to form an interlock with the device which is placed against the external wall of the stomach.
- U.S. Patent Publication Nos. 2005/0267533 and 2006/0212053 to Gertner disclose devices for treatment of obesity that use one or more anchoring mechanisms that are passed through the wall of the stomach to establish an anchor.
- U.S. Pat. No. 6,981,978 to Gannoe discloses devices for reducing the internal cavity of the stomach to a much smaller volume, which may be used to carry out a bypass procedure. Stapling is employed to isolate the smaller volume in the stomach, and thus the same potential disadvantages are present as with other stapling procedures described herein.
- U.S. Pat. No. 6,186,149 to Pacella et al. describes an occluder device that can be used as a dietary control device (see
FIG. 8C ). The occluder device is placed against the wall of the stomach and inflated to press inwardly on the stomach wall. A frame is wrapped around the stomach wall and is inflated to press against the stomach wall. However, there is no disclosure of how the frame might be adjusted to maintain a position relative to the stomach wall as the size of the stomach varies. - Gastric reduction techniques have been attempted, such as by inserting instruments trans-orally and reducing the volume of the stomach by stapling portions of it together. However, this technique is prone to failure due to the staples pulling through the tissues that they are meant to bind.
- Techniques referred to as gastric pacing endeavor to use electrical stimulation to simulate the normal feedback mechanisms of a patient that signal the brain that the patient is full, or satiated. While these techniques are less invasive than some of the other existing treatments, statistics to date have shown that the amount of weight lost by using such techniques is less than satisfactory.
- Currently marketed drugs for weight loss, such as XENICAL®, MERIDIA® and Phen fen have largely failed, due to unacceptable side effects and complications, and sometimes to an ineffective amount of weight loss. Other drugs that are on the horizon include ACCOMPLIA® and SYMLIN®, but these are, as yet, unproven.
- The risk and invasiveness factors of currently available surgeries are often too great for a patient to accept to undergo surgical treatment for his/her obesity. Accordingly, there is a need for less invasive, yet effective surgical treatment procedures for morbidly obese patients (patients having a BMI of 35 or greater). Also, since the current surgical procedures are currently indicated only for those patients having a BMI of 40 or greater, or 35 or greater when co-morbidities are present, it would be desirable to provide a surgical procedure that would be available for slightly less obese patients, e.g., patients having a BMI of 30 to 35 who are not indicated for the currently available surgical procedures. It would further be desirable to provide a surgical procedure that would be indicated for obese patients having a BMI in the range of 30-35, as well as for more obese patients.
- The present invention provides methods, devices, tools, instruments and systems for treating a patient to induce weight loss.
- At least one method embodiment comprises the steps of: passing a device, including an expandable member in a collapsed configuration, through an opening in the skin of the patient, and into the abdominal cavity of the patient; anchoring at least a portion of the expandable member, relative to at least one structure in the abdominal cavity, without piercing the stomach; and expanding the expandable member to an expanded configuration in a space in the abdominal cavity to perform at least one of: prevention of expansion of the stomach of the patient into the space; and compression of a portion of the stomach.
- A method of implanting a weight-loss treatment device by connecting the device to an anchoring frame is provided, including the steps of: passing the anchoring frame into the abdominal cavity of the patient; anchoring the anchoring frame to at least one structure in the abdominal cavity, without piercing the stomach; passing the device, including an expandable member in a compressed configuration, into the abdominal cavity of the patient; and passing the device over the anchoring frame to anchor the device to the anchoring frame.
- A method of implanting a weight-loss treatment device by connecting the device to an anchoring frame is provided, including: passing the anchoring frame into the abdominal cavity of the patient; passing the device, including an expandable member in a collapsed configuration, into the abdominal cavity of the patient; and passing the device over the anchoring frame to mechanically lock the device to the anchoring frame and to anchor the anchoring frame to at least one structure in the abdominal cavity, without piercing the stomach.
- An implantable device for inducing weight loss is provided, including: an expandable main body member configured to be positioned adjacent a portion of a stomach of a patient, within the abdominal cavity of the patient; the expandable member being inflatable with pressurized fluid, wherein the expandable body member comprises a wall surrounding an internal chamber, the wall being substantially impervious to the pressurized fluid; wherein the expandable main body member further comprises a safety valve configured to open when a pressure inside the expandable main body exceeds a predetermined maximum pressure; and a reserve chamber in fluid communication with the safety valve to receive at least a portion of the pressurized fluid in the internal chamber of the expandable main body member when the safety valve opens.
- An anchoring frame for anchoring a device to an internal structure in a patient's body is provided, including: an elongated main body having proximal and distal ends; at least one channel running substantially over a length of the main body; a contact surface adapted to contact the internal structure in the patient's body; anchors positioned in the anchoring frame for being driven through the contact surface and into the internal structure; and a deployment driver slidable through at least one of the at least one channels, wherein sliding the deployment driver through the at least one channel drives the anchors through the contact surface.
- A combination of an implantable device engaged with an anchoring frame is provided, wherein the implantable device include an expandable member having at least one key extending therefrom or groove formed therein; the anchoring frame includes an elongated main body having proximal and distal ends, and at least one channel or rail running substantially over a length of the main body; and wherein the rail is receivable in the groove and the at least one key is receivable in the channel to mechanically connect the device with the anchoring frame.
- An anchoring frame for anchoring a device to an internal structure in a patient's body is provided, including: an elongated main body having proximal and distal ends; at least one channel running substantially over a length of the main body; a contact surface adapted to contact the internal structure in the patient's body; anchors positioned in the anchoring frame for being driven through the contact surface and into the internal structure; and a deployment driver slidable through at least one of the at least one channels, wherein sliding the deployment driver in a first direction through the at least one channel contacts the driver with first portions of the anchors and drives the anchors through the contact surface, and wherein subsequently sliding the deployment driver in a second direction through the at least one channel contact the driver with second portion s of the anchors and retracts the anchors from extending through the contact surface.
- An anchoring frame deployment tool configured to deliver an anchoring frame percutaneously to a surgical target area in a patient is provided, the tool including: a handle for manual operation by a user; an elongated shaft extending distally from the handle; and an engagement feature provided on a distal end portion of the shaft, configured to engage a channel or a rail of the anchoring frame.
- An anchoring frame deployment tool is provided, including: an elongated shaft having a proximal portion and a distal portions rotatably linked to the proximal portion; an actuator mechanically linked to the distal portion and operable by a user to rotate the distal portion in first and second opposite directions relative to the proximal portion; and a recess or cavity formed in the distal portion shaped and dimensioned to receive the anchoring frame therein.
- An anchoring frame unlocking tool is provided, including: a handle for manipulation by a user; an elongated shaft extending distally from the handle; and a lock depressor extending radially from a distal end portion of the elongated shaft, the lock depressor configured to be mounted on and to slide over a rail of an anchoring frame, and to depress automatic locking structures as the lock depressor passes over the automatic locking structures.
- An implantable device for treatment of obesity is provided, including: an expandable main body member configured to be positioned adjacent a portion of a stomach of a patient, within the abdominal cavity of the patient; the expandable member being inflatable with pressurized fluid; two sets of looped tabs extending substantially along two lines in a longitudinal direction of the expandable main body member, wherein, in an un-expanded configuration in which the main body member lies substantially flat, the two lines are offset, and wherein the main body member is configured to be rolled up, in the unexpanded configuration, into a compact configuration wherein the two lines align and set two sets of looped tabs align so that a shaft, rod or wire can be inserted through the looped tabs to maintain the expandable main body member in the compact configuration.
- An introducer configured to deliver an implantable device into an abdominal cavity of a patient via a percutaneous, laparoscopic or mini-laparoscopic procedure is provided, including: a proximal shaft portion; a splittable introducer housing forming a distal portion of the introducer, the splittable introducer including a plurality of jaws pivotally mounted to the proximal shaft portion and pivotable between an open configuration and a closed configuration, wherein in the closed configuration, the jaws define an internal space configured and dimensioned for receiving the implantable device therein; and an actuator extending proximally of the jaws and operable by a user to open and close the jaws.
- An introducer configured to deliver an implantable device into an abdominal cavity of a patient via a percutaneous, laparoscopic or mini-laparoscopic procedure, the introducer comprising: an inner sheath, the inner sheath comprising a distal end portion configured to receive the device wrapped there around in a compact configuration; and an outer sheath dimensioned to slide over the inner sheath and the device in the compact configuration, to maintain the device in the compact configuration while delivering the device; wherein the outer sheath is retractable from the distal end portion of the inner sheath and the device, to expose the device to be extracted for implantation at a surgical target site, and wherein the distal end portion of the inner sheath is bendable at an angled to a longitudinal axis of the introducer, when the outer sheath is retracted, to reorient the device to facilitate extraction thereof.
- An access member attachment system is provided, including: a tool having a handle at a proximal end portion thereof; a working end at a distal end portion thereof, the working end including a socket shaped and dimensioned to receive an access member therein and to maintain an orientation of the access member relative to the working end during attachment of the access member to a patient; and an anvil configured to slide over a conduit to which the access member is to be attached.
- A method of attaching an access member to a conduit in fluid connection with an expandable member implanted in an abdominal cavity of a patient is provided, wherein the method includes: sliding an anvil over the conduit at a location external of the abdominal cavity; inserting the anvil through an opening in the abdominal wall while continuing to slide the anvil over the conduit; orienting an anvil surface of the anvil against an inner surface of the abdominal wall; while holding the anvil surface pressed against the inner surface of the abdominal wall, driving the access member against an outer surface of the abdominal wall, thereby driving attachment members of the access member through the abdominal wall and against the anvil surface, whereby the attachment members are deformed against the anvil surface, thereby anchoring the access member to the abdominal wall.
- An access member having undeployed and deployed configurations is provided, including: at least one port adapted to be placed in fluid communication with a conduit, the access member having a first outside diameter at a distal portion thereof, in the undeployed configuration, that is less than a second outside diameter of the access member at a distal portion thereof when in the deployed configuration.
- A quick connect access member for attachment to a patient in fluid communication with a conduit in fluid communication with an expandable member implanted in an abdominal cavity of a patient is provided, wherein the access member includes: a base having a contact surface adapted to abut an inner surface of an abdominal wall of the patient; a tubular spacer having a length adapted to span a thickness of the abdominal wall, a proximal end portion of the spacer being provided with a lip; and an external portion connectable to the tubular spacer with a snap fit and configured to press against an external surface of the abdominal wall.
- A quick connect access member for attachment to a patient in fluid communication with a conduit in fluid communication with an expandable member implanted in an abdominal cavity of a patient is provided, wherein the access member includes: a base having a contact surface adapted to abut an inner surface of an abdominal wall of the patient, the base including a socket portion having one or more sets of spring-loaded bearings or detents and a tubular spacer having a length adapted to span a thickness of the abdominal wall; and an external portion connectable to the base portion, the external portion have a distally extending tubular portion have at least one annular recess circumscribing an external surface thereof, configured to mate with the one or more sets of spring loaded bearings or detents.
- A method of treating a patient is provided, including: passing a device including an expandable member through the skin of the patient, through the abdominal wall of the patient and into the abdominal cavity of the patient; expanding the expandable member in a space in the abdominal cavity to perform at least one of: prevention of expansion of the stomach of the patient into the space; and compression of a portion of the stomach; and anchoring the expanded expandable member against the abdominal wall of the patient.
- A method of treating a patient is provided, including: passing a device including an expandable member through a minimally invasive opening through the skin of the patient and the abdominal wall of the patient, and into the abdominal cavity of the patient; accessing a tether looped through a positioning member on the expandable member from a second minimally invasive opening; and drawing the tether through the second minimally invasive opening and drawing on the position member to reorient the expandable member.
- An implantable device for treatment of obesity is provided, including: an expandable main body member configured to be positioned adjacent a portion of a stomach of a patient, within the abdominal cavity of the patient; the expandable member being inflatable with pressurized fluid; and an attachment tab extending from the expandable main body member.
- In at least one embodiment, the attachment tab comprises at least one structural member therein, the at least one structural member being deformable to facilitate passage through a small opening in a patient, and wherein the at least one structural member returns to an undeformed configuration upon entering the abdominal cavity to orient the attachment tab toward a structure in the abdominal cavity to attach the attachment tab to.
- A method of f treating a patient is provided, with the method including: passing a flexible endoscope through an opening in the skin of the patient, and into the abdominal cavity of the patient; passing a device including an expandable member in a collapsed configuration over the flexible endoscope and into the abdominal cavity of the patient; anchoring at least a portion of the expandable member, relative to at least one structure in the abdominal cavity; and removing the flexible endoscope from the patient.
- A method of treating a patient is provided, including: passing a flexible wire through an opening in the skin of the patient, and into the abdominal cavity of the patient; viewing through a distal end portion of the flexible wire; passing a device including an expandable member in a collapsed configuration over the flexible wire and into the abdominal cavity of the patient; and anchoring at least a portion of the expandable member, relative to at least one structure in the abdominal cavity.
- These and other advantages and features of the invention will become apparent to those persons skilled in the art upon reading the details of the methods, devices, tools, instruments and systems as more fully described below.
-
FIG. 1 illustrates the anatomy of the abdominal cavity and its contents, and surrounding features. -
FIG. 1A is an illustration of a diaphragm in an isolated view, illustrating the conformation of the diaphragm as it exists in the body. -
FIG. 2 illustrates the diaphragm in position relative to the rib cage. -
FIGS. 3A and 3B show views of a main body of a device with a shape and size approximating the shape and size of a full (post-prandial) stomach. -
FIGS. 3C and 3D illustrate two variations of a device, wherein the inferior portion of the expandable member inFIG. 3D is longer and thus extends further inferiorly and medially than the inferior portion of the expandable member shown inFIG. 3C . -
FIG. 4 illustrates (by arrows) potential locations on the stomach wall that can be displaced or compressed by one or more expandable devices as described herein. -
FIG. 5 is a photograph of an expandable member formed by sputtering a layer of titanium over a polyurethane expandable member formed in a shape as described with regard toFIGS. 3A-3B above. -
FIG. 6 illustrates an embodiment of a device that employs two expandable members. -
FIGS. 7A-7C illustrate a “nested chamber” configuration of an expandable member, at various stages of inflation. -
FIG. 8A illustrates safety valves installed in both expandable members. -
FIG. 8B illustrates an alternative embodiment, in which a safety valve is in fluid communication with a reserve expandable member. -
FIGS. 9A-9C illustrate an expandable member that includes excess material for additional expansion capacitance, and operation thereof. -
FIGS. 10A-10F illustrate an expandable member that is formed from a linear string of multiple expandable cells (or, alternatively fixed size hollow balls), that can be inserted into the patient one at a time, thereby minimizing the inside diameter requirement of an introducer used to deliver the expandable cells. -
FIG. 11 illustrates a device having been inserted into the abdominal cavity in a manner as described, expandable member having been inflated and the device having been anchored. -
FIGS. 12A-12K illustrate steps that may be carried out during a procedure for percutaneously implanting an expandableextra-gastric device 10 according to an embodiment of the present invention. -
FIGS. 12L-12N illustrate variations of the method depicted inFIGS. 12A-12K . -
FIGS. 13A-13D illustrate an embodiment of an anchoring frame that can be used for anchoring a device in the abdominal space. -
FIG. 14A illustrates an example of a device provided with keys configured to slide within a channel of an anchoring frame. -
FIG. 14B shows an end view of a key inserted into a channel of an anchoring frame. -
FIG. 14C shows an example of a key inserted into a channel of an anchoring frame, wherein the enlarged portion of the key is spherically shaped. -
FIG. 14D illustrates the device ofFIG. 14A having been mounted on an anchoring frame. -
FIG. 15A illustrates another embodiment of ananchoring frame 600 that employs a rail configuration for receiving a device thereover. -
FIG. 15B is an end view of a deployment member configured to slide over arail 618 of an anchoring frame. -
FIG. 15C shows an end view of a device having one configuration (T-shaped cross-section) of channel configured to slide over a rail of an anchoring frame. -
FIG. 15D shows the device ofFIG. 15C having been mounted on an anchoring frame. -
FIG. 15E is a schematic, sectional illustration (viewed from the foot of the patient with the patient lying on his back) of a device anchored to the abdominal wall via an anchoring frame. -
FIG. 16A illustrates an embodiment of an anchoring frame that includes an actuation mechanism that can be use to anchor the frame to tissue (deploy) as well as to release the frame from such anchoring. -
FIG. 16B illustrates the sharp (distal) ends of anchors deployed out through openings in the contact surface of the anchoring frame. -
FIG. 16C illustrates a tool configured to engage with the deployment member and anchoring frame shown inFIGS. 16A-16B . -
FIG. 17 illustrates an anchoring frame deployment tool that can be used for percutaneous delivery of an anchoring frame. -
FIG. 18A illustrates another embodiment of an anchoring frame deployment tool. -
FIG. 18B is an enlarged partial illustration of the tool ofFIG. 18 a showing the distal end portion. -
FIG. 19A illustrates locks on an end portion of an anchoring frame. -
FIG. 19B illustrates tabs being inserted to depress the locks ofFIG. 19A . -
FIG. 20A shows an anchoring frame unlocking tool that can be used to unlock an anchoring frame to free a device that has been automatically locked into position along the anchoring frame. -
FIG. 20B illustrates an end view of the distal end of the tool ofFIG. 20A . -
FIG. 20C schematically illustrates use of the tool ofFIG. 20A to unlock a device from an anchoring frame so that the device can be removed from the site. -
FIG. 21A illustrates an embodiment of a device provided with looped tabs. -
FIG. 21B illustrates the looped tabs ofFIG. 21A aligned with each other, with a rod or wire inserted through the loops to maintain the device in a rolled up configuration. -
FIG. 21C illustrates an expandable compaction member that may be formed to roll up when inflated, but can be opened up or spread apart or held open in a relatively flattened out configuration in its non-expanded (deflated) state. -
FIG. 21D shows the compaction member ofFIG. 21C maintaining a device in a compacted or collapsed configuration. -
FIG. 21E illustrates a rigid exoskeleton provided to receive an expandable member and maintain it in a compressed or otherwise non-expanded configuration. -
FIG. 21F shows an alternative configuration for placing an expandable member in a compacted or collapsed configuration. -
FIG. 21G shows an expandable member compressed in a capsule that is formed of a water soluble gel or skin. -
FIG. 21H illustrates an embodiment having a flexible, expandable exoskeleton. -
FIGS. 21I-21J illustrate an expandable member that is formed in an elongated tube configuration. -
FIG. 21K illustrates an alternative to the use of tabs in the embodiment ofFIGS. 21I-21J . -
FIG. 22A illustrates a device maintained in a compact configuration by insertion within a sheath. -
FIG. 22B illustrates an expandable member being deployed via an introducer having a splittable introducer housing at a distal end portion thereof. -
FIG. 22C illustrates the compacted device (including expandable member) having been received in the introducer, with the splittable jaws having been closed around the compacted expandable member to maintain it in a compact configuration. -
FIG. 22D illustrates rotation of the compacted expandable member by manipulation of tethers. -
FIG. 22E illustrates the beginning of extraction of the expandable member. -
FIG. 22F illustrates an introducer having an outer sheath that slides freely over an inner sheath. -
FIG. 22G illustrates an expandable member that has been folded over and then rolled up around a distal end portion of the inner sheath of the introducer ofFIG. 22F . -
FIG. 22H illustrates extraction of the expandable member from the inner sheath ofFIG. 22G . -
FIGS. 22I-22J illustrate tongue-rolling of an expandable member. -
FIG. 22K illustrates a tongue-rolled expandable member having bee inserted into an introducer that comprises a rigid, closed-ended (at the proximal end) sheath or tube. -
FIGS. 22L-22M illustrate another variation of an arrangement for compacting a device and maintaining it the compact configuration for delivery into the abdominal cavity. -
FIG. 22N illustrates an optional use of a sheath with the arrangement previously shown inFIGS. 22L-22M . -
FIG. 22O shows a further alternative arrangement, in which the sheath and device after rolling and compressing according to the techniques described above with regard toFIGS. 22L-22M , is back-loaded on an endoscope. -
FIGS. 22P-22Q illustrate an embodiment of an endoscope provided with an expandable distal tip/lens. -
FIG. 22R shows a variant of the tip/lens ofFIGS. 22P-22Q . -
FIG. 22S illustrates an alternative to use of a flexible, steerable endoscope, wherein a wire, that is viewable therethrough, is used. -
FIG. 23 illustrates a device deployment tool that can be used to deploy a device 1 over an anchoring frame. -
FIGS. 24A-24C illustrate an access member attachment tool and use of the tool for rapid attachment of an access member to a patient. -
FIG. 25A shows use of hook and loop type fasteners or other interlocking mechanism used for a quick connect mechanism to attach an access member to the abdominal muscle. -
FIG. 25B illustrates a quick-connect access member having a ring provided with one or more magnets having polarity on the surface facing access member that is opposite the polarity of the surfaces of magnets facing the ring. -
FIGS. 25C and 25D illustrate undeployed and deployed configurations, respectively, of an access member having deployable anchors. -
FIGS. 25E and 25F illustrate undeployed and deployed configurations, respectively, of an access member having a spring member that functions to anchor the access member to a patient. -
FIGS. 25G-25H show an embodiment of an access member that is connectable via a snap fit that provides a clamping action between a base and an external portion. -
FIG. 25I illustrates an anchoring frame provided with an interlock on a proximal end portion thereof. -
FIG. 25J illustrates a tool for deploying an engagement member into the interlock ofFIG. 25I . -
FIG. 25K shows an embodiment of access member that is connectable via an automatic engagement mechanism that functions like a chuck for a pneumatic tool. -
FIG. 25L-25M show another variation of an air hose-like type of quick connector. -
FIG. 26A illustrated a device being anchored wherein a conduit is actively employed in the anchoring. -
FIG. 26B illustrates tissue ingrowth-enhancing material provided at an interface between the expandable member and the inner wall of the abdominal muscle. -
FIG. 26C illustrates an example of a device including a loop (similar to a belt loop). -
FIG. 26D illustrates positioning of a device by applying a traction force to the loop shown inFIG. 26C . -
FIG. 26E illustrates a distal end portion of an elongated needle having a hooked slot. -
FIG. 26F illustrates a step of attaching an attachment tab to the abdominal wall, according to one embodiment using a laparoscopic procedure. -
FIG. 26G shows an example of a device having three positioning loops longitudinally spaced along an expandable member. -
FIG. 26H illustrates a segmented positioning member having multiple positioning features or channels within a loop. -
FIG. 26I shows a device having an attachment tab extending from a superior portion of an expandable member and another attachment tab extending from an inferior portion of the expandable member. -
FIG. 27A illustrates an example of a device with multiple attachment tabs. -
FIG. 27B illustrates an example of a device having threeattachment tabs 150 extending from the inferior portion of expandable member, where the tabs are interjoined by margin portions at the sides of the main bodies of the tabs. -
FIG. 27C schematically illustrates various features that may be provided for attachment of a device within the abdominal cavity, any of which may be used individually, or in any combination with any of the other features disclosed. -
FIG. 28 illustrates one configuration of attachment tab, wherein the main body portion includes a tissue ingrowth-enhancing material. -
FIG. 29A illustrates a device having attachment tabs provided with multiple structural members. -
FIG. 29B illustrates a device with inflatable attachment tabs. -
FIGS. 29C-29E illustrate another variation of a self-expanding attachment tab. -
FIGS. 29F-29G show a device provided with a self expanding attachment tab. -
FIGS. 29H-29I illustrate another example of a device provided with a self expanding attachment tab. -
FIG. 29J illustrates one example of connectors, whereby one of the connectors includes resiliently deformable tangs, which are received and locked in the other of the connectors upon joining. -
FIG. 30A illustrates the orientation of an expandable member of a device when implanted in a patient according to one embodiment of the present invention. -
FIG. 30B illustrates a more flattened surface conformation of a portion of an expandable member, relative to the curvature of the remainder of the expandable member. -
FIGS. 31A-31D illustrate an expandable member having an inflatable portion that provides a surface for conforming to the abdominal structure to be anchored to, wherein this portion is expandable independently of the expandable member. -
FIG. 32A shows an example of a device having two expandable members wherein a conduit connecting to at least one of the expandable members extends proximally from the expandable members, such as through an opening in an attachment tab. -
FIG. 32B illustrates overlaying banding strips and adhering the ends of the banding strips on opposite sides of a conduit to an attachment tab. -
FIG. 32C illustrates a banding sleeve that extends over a majority of the length of the radius (or distance from where attachment tab connects to expandable member to the free edge perimeter) of the attachment tab. -
FIG. 32D illustrates manipulation of one or more conduits to move and position attachment tab(s) into a desired location against the anterior abdominal wall. -
FIG. 32E illustrates a device having separate attachment tabs. -
FIG. 32F illustrates a device having a segmented attachment tab. -
FIG. 33 illustrates a distal end portion of a flexible endoscope that may be used in a procedure to assist visualization of the placement of a device during an implantation procedure. -
FIG. 34 illustrates anchoring of an expandable member using a feature including ratcheted teeth. - Before the present devices and methods are described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
- Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
- Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.
- It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a tube” includes a plurality of such tubes and reference to “the incision” includes reference to one or more incisions and equivalents thereof known to those skilled in the art, and so forth.
- The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
- Definitions
- A “compliant” material refers to a material that is stretchable or expandable. This expansibility allows the material to increase in dimension substantially more than a noncompliant or semi-compliant material, prior to failure. For example, when formed as a balloon structure, a compliant material comprises an expansibility property of being able to increase its radius, beyond its formed radius, under pressure applied into the balloon, by 100 percent or more, without rupturing.
- A “noncompliant” material refers to a material that, when formed as a balloon structure, can increase its radius beyond its formed radius, under pressure applied into the balloon, only up to about 10 percent or less prior to rupturing.
- A “semi-compliant” material refers to a material that, when formed as a balloon structure, can increase its radius beyond its formed radius, under pressure applied into the balloon, by an amount between about 10 percent and about 100 percent, prior to rupturing.
- The “wall” of the stomach refers to all of the layers that make up the stomach wall, including the mucosa, submucosa, muscular layers and serosa. A “layer”, “layer of the stomach wall” or “stomach wall layer” refers to a mucosal layer, submucosal layer, muscular layer or serosal layer.
- A “proximal” end of an instrument is the end that is nearer the surgeon when the surgeon is using the instrument for its intended surgical application.
- A “distal” end of an instrument is the end that is further from the surgeon when the surgeon is using the instrument for its intended surgical application.
- An “internal body structure” when referred to as a structure to which a device is to be anchored, refers to a structure internal to the skin of a patient, and which can be within the abdominal cavity of the patient, or just outside of it, such as including the outer surface of a wall that partially defines the abdominal cavity. Structures to which a device can be anchored include, but are not limited to: one or more ribs, the intercostal muscles, the abdominal surface of the diaphragm, the stomach (but where the anchor does not pass through the wall of the stomach), the anterior abdominal wall, the posterior abdominal wall and the lateral abdominal wall, the esophagus, the angle of his in the stomach, the gastro-intestinal junction, the gastro-esophageal junction, the columnar ligaments of the diaphragm near the gastro-esophageal junction, the superior aspect of the omentum, peritoneum, liver, connective tissues, ligaments, and blood vessels.
- A “body floss wire” is a wire that enters and exits the body in two locations and passes inside the body between the two locations. This arrangement allows excellent control of the tension on the wire, as forces can be applied at both end portions of the wire that enter and exit the body. Additionally, this arrangement provides good control of devices being passed along the wire.
- The preferred embodiments of the present invention prevent the possible issue of erosion caused by an expandable member, by not requiring anchoring to the stomach, and further, by not requiring a compression force to be applied when the stomach is not full of food. By allowing the stomach to move freely in the constrained spaced provided by the expandable member, the stomach's possible expansion size will be decreased, but there will be less opportunity for the formation of pressure necrosis since no one region will be subjected to concentrated forces. With the device in place, there is substantially no distensibility of the stomach as normal exists with an unconstrained stomach. With distensibility restricted and gastric volume reduced, as the patient ingests food, the intra-gastric pressure will rise to a level sufficient to produce satiety without distension or volume expansion of one or more regions of the stomach. The device occupies so much volume in the abdominal cavity that the stomach does not substantially depart from the shape set by the device even when filled with food. Another physiological benefit of the device is that the stomach's ability to relax in response to ingestion of food is reduced or eliminated, through producing earlier satiety. One additional physiological benefit of the expandable member may further be to substantially reduce the actual volume of the stomach itself, remodeling the organ as the muscle contracts into its new shape over the period of weeks or months (just as the heart remodels when constrained from over-expansion). Remodeling the stomach allows the expandable member to be implanted temporarily. The preferred embodiments also are positioned in a location to completely or mostly fill the space normally occupied by the fundus, thus moving the stomach medially and wedging the stomach between the expandable member and the medial and anterior aspects of the liver, and the spine posteriorly. This position also ensures that the expandable member is almost entirely maintained underneath the diaphragmatic umbrella beneath the ribs on the left side, thus concealing the expandable member, and preventing it from producing an unsatisfactory cosmetic result. Further, the preferred embodiments can have elements for anchoring on one or more locations along the abdominal cavity wall to prevent migration. Further, the preferred embodiments are provided with an outer surface that is very atraumatic. Embodiments described at least one expandable member, preferably an inflatable member, made of a material or material composite that is impermeable to gas, as well as embodiments having at least two expandable members, with one expandable member being inflated with a gas and another expandable member being inflated with a liquid.
- The device embodiments of the present invention can be placed with a number of minimally invasive techniques, such as those often referred to as percutaneous, laparoscopic, mini-laparoscopic, or key-hole. Particularly important in at least one embodiment, the procedure requires no general anesthesia and typically only a single, small opening in a patient is required to deliver an implantable device. In particular, in at least one embodiment the procedure can be performed outside of an operating room setting with local anesthesia or conscious sedation and generally without pressurized insufflation.
- Abdominal Cavity Anatomy
-
FIG. 1 illustrates the anatomy of the abdominal cavity and its contents, and surrounding features. Theabdominal cavity 100 is shown divided among four quadrants, the upperright quadrant 102, upperleft quadrant 104, lowerleft quadrant 106 and lowerright quadrant 108, as divided by themedian axis 110 andtransverse axis 112. The lower edge of the ribcage is illustrated by the dottedline 114 and the diaphragm is shown at 116. As seen inFIGS. 1A and 1B , thediaphragm 116 is shaped like a parachute and sits within the ribs. Theesophagus 118 passes through thediaphragm 116 and joins with thestomach 120. Theleft lobe 122 of theliver 121 lies anteriorly of theesophagus 118 and the fundus-cardia junction 119. In one aspect of the invention, an expandable device is implanted in an extra-gastric location (i.e., outside of the stomach) generally indicated at 124, and then expanded to occupy a space that the fundus of the stomach would ordinarily expand into when the stomach is filled with food. The expanded device prevents this expansion by the fundus, thereby limiting the volume of the cavity in the stomach to a much smaller volume than if the fundus had been allowed to expand into the space. Alternatively, the device is expanded to apply pressure to the fundus of the stomach in a downward direction (e.g., in a direction toward thetransverse axis 112 shown, with some transverse movement toward themedian axis 110 shown), and optionally, additionally to the main body of the stomach, to reduce the volume inside the stomach to effect satiety in the patient with relatively less food ingested, relative to what the patient would require for satiety without the implant in place. - Devices
- At least some embodiments of devices described herein can be implanted percutaneously, with a relatively quick and simple procedure that requires no general anesthesia and wherein only a single, small opening in a patient is required to deliver the device, which typically has a single expandable member that is self anchoring or can be easily anchored to maintain the simplicity and minimal invasiveness of the procedure.
- In other embodiments, more complex configurations of expandable members are provided, where a device can contain one or more expandable members and implantation and anchoring can be performed laparoscopically. Any of the devices described herein can, of course, be implanted using open surgical procedures. Devices that can be implanted percutaneously can alternatively be implanted using laparoscopic procedures.
- Devices described herein can be implanted permanently, but are also configured for reversibility, to facilitate relatively simple removal procedures, should it be desired to remove a device. Alternatively, devices according to the present invention can be implanted temporarily, such as over a period of months, and then removed or disabled when further treatment is no longer required, or to allow an alternative treatment to be applied.
- Device Body Configurations
-
FIGS. 3A and 3B show views of adevice 10 having amain body 10 m,10 em with a shape and size approximating the shape and size of the full (post-prandial) stomach 120 b. Although main body 10 m need not be expandable/collapsible to perform restriction of stomach expansion, main body 10 m is typically formed from one or moreexpandable members 10 em as will be described in further detail below, for better performance of intended functions and to allow less invasive procedures for implanting the same. -
Main body 10 m,10 em includes curved left and right sides 10 l and 10 r, respectively (FIG. 3A shows the posterior surface ofmain body 10 m,10 em), wherein the left side 10 l is convex and the right side 10 r is concave such that themain body 10 m, 10 em takes on a somewhat kidney-shaped configuration. However, the superior portion 10 s is substantially larger and more bulbous than the inferior portion 10 l, since the fundus portion of thestomach 120 expands much more than the antrum upon receiving food. Thus, as seen in the right side view ofFIG. 3B , the superior portion 10 s is very bulbous and almost spherical, with a larger cross section than the inferior portion 10 i, while the inferior portion is more nearly hemispherical, with the center portion of the main body tapering from the superior portion 10 s to the inferior portion 10 i. Configured as such, themain body 10 m,10 em, when implanted properly, will occupy the space that naturally exists from thestomach 120 to expand into when expanding from a pre-prandial configuration to a post-prandial configuration. By severely limiting this expansion capability, the patient is thereby able to consume only a significantly smaller volume of food than possible if the implant were not present. -
Device 10 sizes will likely vary depending on the size of the skeletal system of the patient into whichdevice 10 is to be implanted, particularly the size of the rib cage. Further variations may be made to tweak or adjust the amount of restriction along any desired location of the stomach that interfaces withdevice 10. One typical variation is in the length and/or size (diameter or expandability capacitance) of the inferior portion 10 i.FIGS. 3C and 3D illustrate two variations ofdevice 10 in which the inferior portion of theexpandable member 10 em inFIG. 3D is longer and thus extends further inferiorly and medially than the inferior portion of the expandable member shown inFIG. 3C . In both cases, expandable member is shown in an expanded configuration, and a full,unrestricted stomach 120 is illustrated behind theexpandable member 10 em to illustrate the relative amount of restriction that each expandable member shown would impose on thestomach 120. - At least a portion of main body member 10 m may be expandable. The entire main body 10 m may be made of an
expandable member 10 em. When in an expanded configuration,expandable member 10 em can optionally only abut or lie adjacent to the pre-prandial stomach wall, without imparting any significant deformation forces thereto. However, when the patient eats and the stomach begins to fill,expandable member 10 em in this case prevents thestomach 120 from expanding into the volume occupied byexpandable member 10 em. In such a case, thestomach 120 becomes “deformed” as it attempts to expand and can only expand in a limited fashion, if at all, around a portion of the perimeter ofexpandable member 10 em. Thus, upon expanding thedevice 10, thedevice 10 expands in the space(s) normally occupied by thestomach 120 as thestomach 120 expands when receiving food. Thusdevice 10 exerts pressure on, or at least prevents expansion of the fundus and optionally, the antrum. In embodiments where theexpandable device 10 is not attached to the stomach, the stomach is free to perform its normal function of mixing food in the stomach for digesting and pushing food out of the stomach. During all of this movement the stomach may slip behind, beside or on top of the expandable device, but the internal volume of the stomach will be held to its smaller volume as theexpandable device 10 em is occupying the space into which the stomach would normally expand. Further details of methods for treatment of obesity, including procedures for implanting devices described herein are described below. - As noted above, an
expandable device 10 can be implanted adjacent a surface of the stomach wall, either in contact therewith or at a predetermined distance therefrom, to prevent expansion of thestomach 120 into a volume occupied by theexpandable device 10. Alternatively, some embodiments of the devices described herein can be configured and placed to exert an external compression on one or more locations of the stomach to deform the stomach wall, thereby decreasing the internal volume of the cavity within the stomach that accepts food and liquid intake.FIG. 4 illustrates (by arrows) potential locations on thestomach 120 wall that can be compressed (or restricted from expanding) by one ormore devices 10 as described herein. - In one embodiment,
expandable member 10 em shown inFIGS. 3A-3B is composed of aninflatable member 10 em. Inflatable members described herein can be inflated with gas or liquid or both. Examples of gases or liquids that can be used to inflate inflatable members/devices 10 include, but are not limited to: carbon dioxide, helium, isotonic dextrose solution, iostonic saline solution, air. - It may be preferable to inflate at least a portion of the
expandable member 10 em shown inFIGS. 3A-3B with one or more gases, to minimize the weight of the implanteddevice 10, as an expandable member of the configuration shown can have an internal volume approaching a liter, when filled, and a heavier, fluid-filled device of this type may be more noticeable to the patient. Alternatively,devices 10 can be inflated with a porous gel that is porous or microporous to encapsulate air or other gas bubbles, thereby reducing the weight of the gel while still permitting it to apply volumetric pressure to expand an inflatable member. Such gels may be settable, such as ultra-violet (uv) curable or otherwise chemically curable, or, alternatively, can remain in the gel state, so that they can be readily removed or added to, to increase or decrease the amount of inflation/expansion of the expandable member. Gels can be made from a flowable viscoelastic substance made of a polymer mixture, such as silicone oil, boric acid, hyaluronic acid, polyacrylic acid or combinations thereof, for example. The gel, as delivered into theexpandable member 10 em (e.g., such as by injection or the like) can be aerated or infused with carbon dioxide or an inert gas to create a deformable or non-deformable cellular structure that encapsulates the gas in cells, and thus has relatively low mass but still has significant resistance to compression or deformation. - When inflating an inflatable member with a pressurized gas, some materials, especially the compliant materials such as silicone, polyurethane and the like, may have an inherent porosity as it is stretched during the expansion, such that it may not adequately maintain a desired pressure within the membrane or wall of the inflatable member over an extended period of time. This seepage or slow leakage of gas from the inflatable member may require a patient to have the implant checked more frequently then required for other physiological concerns, to ensure that it is maintaining adequate pressure and thus is expanded to the extent desired to perform the desired amount of deformation of the stomach. Materials such as silicone and polyurethane have a good history of long term biocompatibility when used as implants and are two of the preferred materials for use in making
devices 10. - The inflatable members of the inflatable devices described herein can include compliant, noncompliant or semi-compliant materials, or any combination of these. Examples of compliant materials suitable for use in an inflatable member as described herein include, but are not limited to: silicone, latex rubber, and polyurethane. Examples of useable semi-compliant materials include, but are not limited to: nylon, polyethylene, polyester, polyamide and polyurethane, see for example, U.S. Pat. No. 6,500,148, which is hereby incorporated herein, in its entirety, by reference thereto. Polyurethane, nylon, polyethylene and polyester can be compliant or semi-compliant materials, depending upon the specific formulation and hardness or durometer of the material as produced. Examples of noncompliant materials that can be used in the construction of inflatable members described herein include, but are not limited to: polyethylene terepthalate (PET) and urethane. Urethane can be a compliant, semi-compliant or non-compliant material depending upon its specific formulation and hardness or durometer. Compliant, semi-compliant and noncompliant categories are not solely material limited, but are better defined by their expansion characteristics, as noted above. Some materials are best suited for use in one of these categories (e.g., silicone and latex work well to make compliant structures), but other materials can be formulated and/or constructed to provide compliant, semi-compliant or noncompliant properties.
- One way of eliminating or substantially reducing seepage, such as when an expandable member comprises a compliant material that is stretched to a degree that would normally exhibit such seepage, is to provide a very thin metallic coating over the compliant material using a biocompatible metal to form the coating, as the metal layer is substantially nonporous when the integrity of such layer is maintained.
FIG. 5 is a photograph of anexpandable member 10 em formed by sputtering a layer of titanium over a polyurethane expandable member formed in a shape as described with regard toFIGS. 3A-3B above.FIG. 5 shows theexpandable member 10 em in an expanded configuration. In order to avoid wrinkles in the metallized layer of theexpandable member 10 em, the compliant material (e.g., polyurethane in this case) was stretched over a mold configured in an expanded shape of the expandable member and welded in this three dimensional configuration, while inverting the seams, so that the smooth, seamless configuration shown resulted. Other biocompatible metals (e.g., silver, gold, tantalum, palladium, platinum or some other biocompatible metal) may be substituted for titanium, and compliant materials other than polyurethane (e.g., silicone, latex rubber, etc.) can be substituted for the substrate of such anexpandable member 10 em. - Another approach to reducing seepage is by co-extrusion, e.g., co-extruding EVOH (ethylene-vinyl alcohol copolymer) and polyurethane to form the
expandable member 10 em, with or without a metallic coating as described above. - Further descriptions of methods and materials for making a metallic coated expandable member can be found in provisional application Ser. No. 60/877,595 which was incorporated by reference above.
-
FIG. 6 illustrates an embodiment of a device that employs twoexpandable members 10 em 1 and 10 em 2. The two expandable members in this case are separately and independently expandable, and may be expanded both by the same expansion medium (or by mechanical expansion methods/features described herein), or may be expanded by different expansion media or techniques or mechanical features, to provide what is termed herein as a hybrid device. In the example shown inFIG. 6 , bothexpandable members 10 em 1 and 10 em 2 are designed to be inflated by gas, liquid, combination of gas and liquid, foams or any of the other inflation media described above. In one particular hybrid embodiment,expandable member 10 em 1 is inflated by one or more gases andexpandable member 10 em 2 is inflated by a liquid such as isotonic saline or isotonic dextrose solution, for example. Sinceexpandable member 10 em 1 contains a large volume, as noted above, this expandable member is inflated with a gas so as to be less noticeable by the recipient patient when implanted. In use of this hybrid configuration,expandable member 10 em 1 is fully inflated to occupy the space into which the stomach would normally expand when taking in food. Accordingly,expandable member 10 em 1 may be designed as a “fixed volume” expandable member, such that this expandable member will be expanded to a predetermined pressure so as to occupy a known volume.Expandable member 10 em 2, having a much smaller expanded volume thanexpandable member 10 em 1 (for example, the volume of 10 em 1 can be about 75 to about 80 percent of the total volume of the implant, i.e., about 75 to 80 percent of the combined volumes of 10 em 1+10 em 2) uses a liquid medium for expansion thereof, as noted above.Expandable member 10 em 2 may be designed as a variable volume expandable member, so that expansion thereof can be varied to add to the fixed volume ofexpandable member 10 em 1 in the amount desired. In use, this liquid medium can be used to adjust the degree of expansion ofexpandable 10 em 2, once the expansion ofexpandable member 10 em 1 has already been established to further compress into thestomach 120 or to better interface with the surface of the stomach, as the liquid in a less than fully expandedexpandable member 10 em 2 is able to conform well to the surface shape of the stomach. - One particular location that many surgeons are interested in restricting and/or compressing is the Angle of His, and
expandable member 10 em 2 is placed to provide further compression capability at this location of thestomach 120 whendevice 10 is implanted as described. Also, since liquid is relatively incompressible,expandable member 10 em 2 exhibits less give, causing the stomach to be deformed at the interface between the stomach andexpandable member 10 em 2, rather than compression ofexpandable member 10 em 2. Further, the liquid-filledchamber 10 em 2 provides a softer surface to interface with the stomach then would the surface of a pressurized, fully expanded gas-filled chamber. Still further, because liquid is relatively incompressible, a user knows how much additional volume theexpandable member 10 em 2 is being expanded by (and thus also the relative degree of additional compression provided) when a specific volume of liquid is inputted throughlumen 12 2. Thus, for example, if a physician adds 60 cc of liquid throughlumen 12 2, the physician will know that the volume ofexpandable member 10 em 2 has expanded by 60 cc. Further, the use of liquid in the expandable member (such asexpandable member 10 em 2) may provide relatively more pressure in preventing expansion of the stomach due to the density of the device, relative to one that is filled with gas. Further, the liquid may feel more “organ-like”, since organs are primarily liquid, and therefore be generally better tolerated by the stomach and other organs in the abdominal cavity. Still further,expandable member 10 em 1 can be expanded to a state where the properties of this expandable chamber do not exhibit significant seepage, so that this pressure can be maintained for an extended period of time.Expandable member 10 em 2 on the other hand, can be expanded to a much greater percentage without concern about seepage, since materials used are much less porous to liquid. For example,expandable member 10 em 1 may be made of one or more plies of titanium-coated polyurethane, as described above, andexpandable member 10 em 2 may be formed of silicone. For example, the siliconeexpandable member 10 em 2 can expand up to at least 800 percent of its normal volume. - In the example shown in
FIG. 6 ,expandable member 10 em 2 is shown partially inflated. When fully deflated, the external surface ofexpandable member 10 em 2 can be compressed to contact and conform to the adjacent wall ofexpandable member 10 em 1 that it overlies. Further infusion of fluid intoexpandable member 10 em 2 causes it to expand outwardly in the directions indicated by the arrows inFIG. 6 . Thus, as can be seen,expandable member 10 em 2 in this example has been placed to primarily effect compression of the fundus (or further reduction of the space provided for the fundus to normally expand into). However, the invention is not limited to this design, asexpandable member 10 em 2 could be lengthened to also provide further expandability in the region of the antrum of the stomach, or could be provided to expand only against the antrum. Further, other placements of such a secondaryexpandable member 10 em 2 can be designed to tailor the directionality of additional compression forces (and/or space filling) to be applied. - In
FIG. 6 , adual lumen conduit 12 is provided for inputting expansion media into the twoexpandable members 10 em 1 and 10 em 2. Thus lumen 12 1 leads toexpandable member 10 em 1 andlumen 12 2 extends intoexpandable member 10 em 1 and leads intoexpandable member 10 em 2. Alternatively,lumen 12 2 can extend externally overexpandable member 10 em 1 and then enter intoexpandable member 10 em 2. - Further variations and embodiments of devices having
expandable members 10 em 1 and 10 em 2 are described in provisional application Ser. No. 60/877,595 which was incorporated by reference above. - The reduction in volume of the “full” stomach that can be achieved by filling the space that the stomach normally expands into and/or compression of the stomach that is achievable by any of the devices described is in the range of about 700 cc to about 1,200 cc. The adjustable range of
device 10 can be about zero cc to about 650 cc or about 50 to 600 ml, typically about 100 to 500 ml or 100 to 400 ml, wherein variations in these ranges can be achieved by varying the degree of expansion of one or moreexpandable members 10 em. With a hybrid device described above theexpandable member 10 em 1 is expanded to occlude most, if not all of the space into which the fundus (and optionally antrum) would normally expand when taking in food, with any medial space remaining betweenexpandable member 10 em 1 and the empty stomach being fillable by adjusting the degree of expansion ofexpandable member 10 em 2. Thus, for example, if the full volume capacity of a stomach 120 (with no implant impeding its expansion) is about 1,000 cc, thendevice 10 can be configured to initially displace about 400 to 600 cc of volume, so that the stomach's remaining capacitance is about 400 to 600 cc. Over time,device 10 can be expanded to occupy 800 to 900 cc of space, so that the stomach's capacity is reduced to about 100 to 200 cc. This adjustment can be done incrementally over time, for example. Ahybrid device 10 such as the one described with regard toFIG. 6 can be implanted and the initial volume displacement referred to can be achieved by inflatingexpandable member 10 em 1 with gas, for example. Further subsequent reductions in the stomach's capacity can be achieved by adding fluid toexpandable member 10 em 2 to expand this member as desired. - As noted above, the expandable members described herein may be expanded by an expansion medium (such as liquid, gas, gas and liquid, foam, etc.) or by mechanical expansion methods and/or features. It should be further noted here that a single expandable member can be expanded (and/or maintained at a desired degree of expansion) by a combination of one or more expansion media and one or more mechanical expansion methods and/or features. We refer to these as complex expandable members and examples of such are described below. Thus, for example, an expandable member that is inflated by gas pressure may be further supported by some other expansion means, such as a mechanical expansion member. This mechanical expansion member can alleviate some of the pressure that would otherwise be required to maintain the expandable member at a predetermined size (volume). Further, if seepage occurs, the secondary (mechanical) expansion member can maintain the expandable member at the desired volume. It is further noted here that a complex expandable member can be used in a
device 10 having a single expandable member, such as like that shown inFIG. 5 , or may be combined with one or more additional expandable members, e.g., like the example shown inFIG. 6 , wherein the one or more additional expandable members may be expandable by expansion medium or expansion method and/or features, or may also be a complex expandable member. In at least one embodiment,device 10 is provided with a complex expandable member having the shape ofexpandable member 10 em 1 inFIG. 6 above, and a secondexpandable member 10 em 2, like that described inFIG. 6 above is provided as a fluid expandable member. Further examples and embodiments of devices employing at least one complex expandable member are provided in provisional application Ser. No. 60/877,595. -
FIGS. 7A-7C illustrate a “nested chamber” configuration of anexpandable member 10 em, in which chambers 10 c 1-10 c 4 (although different numbers of chambers can be provided, which number may be two, three, or more than four) can be sequentially expanded, to vary the size of the expandable member and thus the amount of restriction and/or compression of the stomach to be applied bydevice 10. Adjacent chambers are separated by a baffle ormembrane 36 that may be formed of the same material as the wall ofexpandable member 10 em, with each baffle ormembrane 36 containing at least one one-way valve 38 therein.Valves 38 are configured to open at progressively greater pressures, so that the chambers can be opened sequentially and only to the extent desired, based on the amount of pressure applied throughconduit 12. Reduction in the overall volume ofexpandable member 10 em can be achieved by passing a guide wire throughconduit 12 and through allvalves 38.Valves 38 open when the guidewire is extended therethrough, allowing the contents of each chamber to funnel out throughconduit 12, thereby deflating the expandable member. After this, the chambers can again be sequentially inflated as described to achieve the desired volume. - More specifically, in the example shown, the
valve 38 in themembrane 36 separating chambers 10 c 1 and 10 c 2 opens at a lower pressure than thevalve 38 inmembrane 36 separating chambers 10 c 2 and 10 c 3. Similarly, thevalve 38 in membrane 26 separating chambers 10 c 2 and 10 c 3 opens at a lower pressure than thevalve 38 inmembrane 36 separating chambers 10 c 3 and 10 c 4. The relative locations of the chambers are not limited to those shown, but can be altered to utilize the effects of the pressure-controlled sequential expansion to first occupy primary spaces desired to be filled to block expansion of the stomach, or to apply pressure to the stomach, with subsequently expanding chambers expanding to provide supplemental space filling/pressure in adjacent areas. An operator could choose only to inflate chamber 10 c 1 by inflating to a pressure less than that at which thevalve 38 between chambers 10 c 1 and 10 c 2 opens at. InFIG. 7A , expandable member has been inflated to a pressure greater than the pressure at whichvalve 38 separating chambers 10 c 1 and 10 c 2 opens at. Therefore, both chambers 10 c 1 and 10 c 2 have been inflated. This may provide sufficient restriction/compression for some patients, or for initial treatment of a patient. In some cases, even inflation of only chamber 10 c 1 may be sufficient for early treatment or for patient's having a relatively small rib cage, for example. After progress in losing weight has been made over time, or for patients with a larger rib cage, for example, the operator may want to increase the size and/or length ofexpandable member 10 em (in the example shown, both are accomplished). By inputting more gas throughconduit 12 to establish a higher pressure to meet or exceed the pressure at which valve 38 (positioned between chambers 10 c 2 and 10 c 3) opens,valve 38 is force open, thereby inflating chamber 10 c 3, as illustrated inFIG. 7B . Chamber 10 c 4 can be inflated by increasing the pressure still further to open thevalve 38 between chambers 10 c 3 and 10 c 4, as illustrated inFIG. 7C . - Any inflatable
expandable member 10 em described herein, whether inflatable by gas, liquid or some combination thereof may be provided with a safety valve. Thus, for example,FIG. 8A illustrates each ofexpandable members 10 em 1 and 10 em 2 being provided with asafety valve 40.Safety valve 40 may be a flapper valve or other type of pressure release valve that opens when a predetermined pressure has been exceeded. Thus,safety valve 40 prevents overpressurization/overfilling of the expandable member that it is installed in.Safety valve 40 can be particularly valuable if the patient that the expandable member is implanted in is subjected to trauma (e.g., automobile accident, fall or other sudden impact that would spike the pressure in the expandable member and possibly cause catastrophic failure), or, in the case of an expandable member inflated with gas, in situations such as cabin depressurization in an aircraft, etc. When pressure within the expandable member has returned below the predetermined pressure (through escape of gas and or fluid from the safety valve 40) safety valve closes again, thereby retaining the remaining gas and/or fluid. -
FIG. 8B illustrates an alternative embodiment, in whichsafety valve 40 is in fluid communication with a reserveexpandable member 10 emr. In this case, if the patient is exposed to any of the conditions described above (which may also include simply moving from a low altitude location, e.g., sea level, to a location high in the mountains, for example) or any condition that would causeexpandable member 10 em to significantly expand, thereby causing the compliant material that it is made of to become more porous resulting in leakage of gas therethrough, the rise in relative pressure that would ordinarily cause such an expansion instead openssafety valve 40 and gas passes therethrough and into reserveexpandable member 10 emr that is formed of a noncompliant material. Reserveexpandable member 10 emr is shown in an expanded configuration in phantom lines inFIG. 8B . The noncompliant material of reserveexpandable member 10 emr prevent gas loss, and the gas in reserveexpandable member 10 emr can then be recaptured intoexpandable member 10 em when the patient has returned to the “normal” altitude from where he started, or once the traumatic event has ended. -
FIGS. 9A-9C illustrate anexpandable member 10 em that includes excess material for additional expansion capacitance, whether inflated by gas or liquid or some combination thereof.Expandable member 10 em can be made from any of the materials and by any of the techniques described previously. In this embodiment,excess material 42 is provided, such as in the form of pleats, folds, corrugations, or the like, and this portion of the expandable member does not expand upon initial expansion of the expandable member. That is, at a first pressure P1, at which theexpandable member 10 em is inflated (seeFIG. 9A ), theexcess material 42 remains in its compact configuration. At a somewhat higher pressure P2>P1, the excess material begins expanding, seeFIG. 9B . The amount of this expansion can be varied by varying the inflation pressure, so as to control the amount of additional expansion ofexpandable member 10 em via expansion ofexcess material 42.FIG. 9C showsexpansion member 10 em fully expanded, such as when a pressure P3>P2 or pressure higher than P3 has been inputted to expandable member to cause a complete expansion of the excess material. The folds of theexcess material 42 may be thicker and/or less compliant than the material that makes up the rest of theexpandable member 10 em in order to provide the additional resistance to expansion. Alternatively, or additionally, the folds of the excess material may be partially and temporarily fixed together, such as by partial thermal bonding or other mechanism of adhesion, for example. -
FIGS. 10A-10F illustrate anexpandable member 10 em that is formed from a linear string of multipleexpandable cells 46, that can be inserted into the patient one at a time, thereby minimizing the inside diameter requirement of an introducer used to deliver theexpandable cells 46.Cells 46 may all be inflated together, substantially simultaneously. Alternatively, valves may be provided between the cells so that they can be sequentially, individually inflated. Further alternatively, the valves may allow sequential inflation, all at the same time with a single inflation step, but prevent loss of inflation media once it has entered the cells. Accordingly, if one cell fails and deflates, the remainder of thecells 46 remain fully inflated. Accordingly, this embodiment lends itself very well to percutaneous implantation procedures. Of course this embodiment could also be implanted using laparoscopic procedures or open surgical procedures, but it provides a particular advantage for use in percutaneous delivery, as noted. Typically thecells 46 are inflated after delivery into the abdominal cavity. However, thecells 46 may alternatively be inflated while outside of the patient's body and then inserted into the abdominal cavity. -
Cells 46 ofexpandable member 10 em are connected in fluid communication with one another viaconduits 12 that connectadjacent cells 46.Conduits 12 are flexible, so that the string or chain ofcells 46 can be readily deformed and manipulated to assume a variety of shapes. One ormore anchoring tabs 48 are provided extending from eachcell 46, but not in fluid communication with thecell 48, so that thesetabs 48 can be sutured through, tacked or stapled without losing pressure from thecell 46. -
FIG. 10B illustrates acartridge 50 thatexpandable member 10 em can be delivered from during a percutaneous implantation, to delivercells 46 into a patient's abdominal cavity. Thecells 46 and interconnectingconduits 12 that form the long string of the expandable member are rolled or bunched up inside ofcartridge 50 for subsequent one at a time delivery ofcells 46 into the patient's anatomy.FIG. 10C shows anintroducer 52 that is configured to receivecartridge 50 and advance the string ofcells 46 one at a time therefrom for delivery thereof, as described below. After insertion ofcartridge 50 intointroducer 52, as indicated by the arrow betweenFIGS. 10B and 10C , and formation of a small percutaneous opening into a patient's abdominal cavity (e.g., less than about 7 cm or less than about 6 cm or less than about 5 cm or less than about 4 cm or less than about 3 cm), the distal end ofintroducer 50 is inserted into the abdominal cavity and located adjacent a target surgical site where it is desired to fill space to restrict the expansion capacity of the stomach and/or to apply compression to the stomach, as schematically illustrated inFIG. 10D . Note thatexpandable member 10 em has been arranged in the introducer so that the distalmost tab 48 extends distally of the distal end ofintroducer 52. - Upon positioning the distal end of
introducer 52 at the target location, the distalmost tab 48 can then be fixed to anchor the distal most cell in a desired location. Anchoring can be performed by stapling, tacking or suturing, for example, and can be to any structure adjacent thestomach 120, but typically not to thestomach 120 itself. Typically,cells 46 will be stapled viatabs 48 to at least one of thediaphragm 116 and anteriorabdominal wall 127. With this initial fixation, the first (i.e., distal-most)cell 46 can be driven out ofintroducer 50, such as by actuation of actuator 54, for example. Alternatively, actuator 54 may be configured to install staples, tacks or sutures throughtabs 48, andcells 46 may be removed from introducer, by retracting the introducer proximally to draw the fixedcell 46 out of the distal end of the introducer, seeFIG. 20E .Cells 46 can be inflated individually after stapling or other fixation, or may all be inflated after finishing of the installation of allcells 46 to be used, or may be inflated prior to installing. The introducer can then be advanced distally again to the target location to anchor the next inline cell 46. This process can be repeated until asmany cells 46 have been anchored as necessary to fill the desired volume of space, as illustrated atFIG. 10F . The cartridge ofcells 46 does not have to be used entirely, as the surgeon can sever a link betweenadjacent cells 46 so as to tailor the number ofcells 46 used in a particular procedure. The severed proximal end can then be caped or sewn shut (after any further inflation performed, if necessary), or connected in fluid communication with anaccess port 80. When cells are provided with valves, as described above, no further inflation should be necessary after severing.Introducer 52 is then removed from the port and the port is closed, leaving a custom designed, custom-shapedexpandable member 10 em in place, with the shape and volume being determined by the placement of thecells 46 and the number ofcells 46 placed. - Implantation
- As noted above,
device 10 can be implanted so that, whenexpandable member 10 em is expanded to an expanded configuration,expandable member 10 em can apply compression to thestomach 120 wall, or optionally only abut or lie adjacent to thepre-prandial stomach 120 wall, without imparting any significant deformation forces thereto. However, when the patient eats and the stomach begins to fill,expandable member 10 em in either case prevents thestomach 120 from expanding into the volume occupied byexpandable member 10 em. Thus, either the stomach is initially “deformed” bydevice 10, or thestomach 120 becomes “deformed” as it attempts to expand and can only expand in a limited fashion, if at all, around a portion of the perimeter ofexpandable member 10 em. In either case, thestomach 120 is prevented from expanding to the extent that was possible prior to implantation ofdevice 10. - Thus, upon expanding the one or more expandable members, the
device 10 expands in the space(s) normally occupied by thestomach 120 as thestomach 120 expands when receiving food. Thusdevice 10 exerts pressure on, or at least prevents expansion of the fundus and optionally, the antrum and/or portions of the stomach intermediate the fundus and antrum. - As noted above, an
expandable device 10 can be implanted adjacent a surface of the stomach wall, either in contact therewith or at a predetermined distance therefrom, to prevent expansion of thestomach 120 into a volume occupied by theexpandable device 10.Device 10 can be inserted, in a contracted or compressed configuration, so as to minimize the cross-sectional area of the device as it passes, through the skin of a patient, through the abdominal wall of the patient and into the abdominal cavity. This delivery may be accomplished percutaneously or laparoscopically, for example. Once in the abdominal cavity,device 10 is positioned in a space adjacent thestomach 120, so as to fill the space and not compress the pre-prandial stomach, or alternatively to additionally provide some compression of the pre-prandial stomach, when expandable member(s) is/are expanded. As mentioned previously this positioning is to orient the device to generally follow the contours of thestomach 120 and surrounding organs, as the shape ofdevice 10 is designed for the same. - Once properly positioned,
expandable member 10 em is expanded, either by inflation or mechanical means, or both, to occupy the desired space in the abdominal cavity.FIGS. 3C and 3D illustrate examples ofdevices 10 as properly positioned and in expanded configurations. Thus, expansion of at least one expandable member accomplishes at least one of: prevention of expansion of thestomach 120 of the patient into the space occupied by expandeddevice 10; and compression of a portion of thestomach 120 by expandeddevice 10.Device 10 may be anchored to one or more structures in the abdominal cavity. For example,FIG. 11 30 illustrates adevice 10 having been inserted into the abdominal cavity in a manner as described, andexpandable member 10 em having been inflated. Any of thedevices 10/expandable members 10 em described herein may be provided with one ormore anchoring tabs 150 attached thereto. In the example shown inFIG. 11 30, anchoringtabs 150 have been bonded to the surface ofexpandable member 10 em, such as with a silicone room temperature vulcanizing (RTV) adhesive, for example.Tabs 150 may also have material thereon that encourages tissue ingrowth to provide permanent fixation oftabs 150 to the anteriorabdominal wall 127 or other interior abdominal structure, to fortify the fixation provided by staples, sutures, tacks or the like. Alternatively, asingle tab 150 can be placed aroundexpandable member 10 em to extend from and cover all of the areas covered by the threetabs 150 shown inFIG. 11 . It would be readily apparent to those of ordinary skill in the art that other combinations of number of and shapes oftabs 150 could be substituted. -
Tabs 150 are anchored to a structure (other than the stomach) in the abdominal cavity to maintain the desired positioning and orientation ofdevice 10 relative to thestomach 120. InFIG. 11 30,tabs 150 have been attached to theabdominal wall 127 via sutures, staples, tacks or the like 154 to fixtabs 150 with respect to theabdominal wall 127.Port 90 is shown anchored to the opposite (external) side of theabdominal wall 127. - Further, additionally or alternatively, a
portion 156 of the surface ofexpandable member 10 em that does not come into contact withstomach 120 can be roughened or provided with some porosity (wherein the porosity does not extend all the way through the wall of theexpandable member 10 em) to promote adhesion and/or tissue ingrowth for anchoringdevice 10. -
FIGS. 12A-12K illustrate steps that may be carried out during a procedure for percutaneously implanting an expandableextra-gastric device 10 according to an embodiment of the present invention. Prior to making an incision, the local area (the area of the skin in and surrounding the location where the incision is to be made) may be prepared by disinfecting with alcohol and or betadine. Additionally, the patient may be given a mild sedative or may be on conscious sedation. Though not preferred, the procedure can also be carried out under general anesthesia. - Next a powerful local anesthetic such as marcaine (bupivicaine) or other powerful anesthetic, optionally mixed with an epinephrine or other vasoconstrictor to reduce any bleeding that might result from mild trauma can be injected into the local area through the
skin 125 of the patient 1 down to the muscular layer and to infiltrate the fat layer and entire local area (the anesthetic portion of the mixture may not be needed if the procedure is performed under general anesthesia). Injection may be performed using asyringe 219, as illustrated inFIG. 12A , or other injection tool. After allowing time for the injected anesthesia to take effect, asmall incision 223 is made in theskin 125 of the patient 1, with ascalpel 229 or other surgical cutting tool, in the local area over the surgical target area wheredevice 10 is to be implanted. Optionally, in the example shown, theincision 223 is made slightly inferior to the lower rib line 114 (FIG. 12A shows a frontal schematic view of the abdominal portion of the patient 1). Alternatively, a needle (e.g., veress needle 501) can be inserted, without the need to make theincision 223, as illustrated inFIG. 12L . A conventional veress needle does not have a lumen for a guidewire. By adding a small sheath outside the shaft of the veress needle apparatus, a modified veress needle is created such that aguidewire 502 can be easily introduced through the sheath.FIG. 12L further illustrate that the location of insertion in well below the xiphoid, to the left of midline, near the palpated edge of the costal cartilages. It is noted that in the alternative method illustrated inFIG. 12A , thatincision 223 can also be made in this location. -
FIG. 12B shows an access sheath orcannula 535 being inserted to guide delivery and placement ofdevice 10 and anchoring during later steps of the procedure described below. A trocar 536 (shown in phantom lines inFIG. 12B ) may optionally be inserted along with insertion of sheath/cannula 535 in order to facilitate formation of a pathway into which sheath/cannula 535 is inserted, and then removed from the sheath prior to insertion of any other objects such asdevice 10, instruments, etc. Insertion of the sheath/cannula 535 can be performed without any additional visualization provided (i.e., just by eyesight), or may be guided by use of an endoscope 537 (shown in phantom lines) and/or with fluoroscopic visualization. Ifendoscope 537 is used,trocar 536 is removed after partial insertion of sheath/cannula 535 and then endoscope is inserted through sheath/cannula 535 to guide the remaining insertion to be performed, and particularly, the final placement of sheath/cannula 535. - Once sheath/
cannula 535 has been properly placed to the satisfaction of the surgeon (e.g., in one example, sheath/cannula 535 is inserted into a region about three to four inches below the level of the inferior border of theliver 121 at or immediately to the right of midline) the same anesthetic or mixture of anesthetics used to numb the incision site prior to making theinitial incision 223 can be injected into the abdomen through cannula/sheath 535 to numb the site interiorly of the abdominal wall. - Next, as shown in
FIG. 12C , aguidewire 502 is inserted through cannula/sheath 535.Guidewire 502 may be inserted under fluoroscopic visualization, 3-D RF or electromagnetic visualization (e.g., using preexisting or real-time data sets from MRI, cat scan, three-dimensional ultrasound, or other three-dimensional data set, etc.) or blindly to pass around thestomach 120 so that it rides against thediaphragm 116 and is thereby guided along thediaphragm 116 until reaching or closely approaching thespleen 128. Alternatively, a rod may be inserted instead ofguidewire 502, wherein the rod is stiffer thanguidewire 502 and/or have variable regions of stiffness or flexibility greater than those ofguidewire 502. Additionally, the rod may have a lager cross-sectional area thanguidewire 502 and optionally may have one or more lumens therethrough for delivery of suction, irrigation, injection of other fluids, injection of medicaments, etc. The rod may be inserted in similar manner to guidewire 502 by may be less likely to kink. The rod may be pre-shaped to more rigidly define a course of travel ofdevice 10 that it guides, relative to use of theguidewire 502, which is typically flexible. Optionally, a flexible endoscope can be inserted through cannula/sheath 535 to visualize guidewire orrod 502 and confirm that it has been properly placed. - Once properly placed, an
anchoring frame 600 and an anchoringframe delivery tool 630 on whichanchoring frame 600 is mounted (in a manner as described in greater detail below) are advanced overguidewire 502 and into sheath/cannula 535 (seeFIG. 12D ) after which anchoringframe delivery tool 630 is operated to deliver anchoringframe 600 into the target position along the abdominal wall, where it is anchored there. Prior to anchoring, the surgeon will check to ensure that no bowel, omentum or other tissue is located between the anchoringframe 600/tool 630 and theabdominal wall 127. After anchoring theanchoring frame 600 to theabdominal wall 127, anchoring frame delivery tool is then removed from sheath/cannula 535 and offguidewire 502.FIG. 12E illustrates a sectional view of the patient 1 (viewed from the feet of the patient) that shows the anchoring of anchoringframe 600 to theabdominal wall 127, with the anchoringframe delivery tool 630 having been removed.FIG. 12F is a schematic illustration from a frontal view perspective, like those ofFIGS. 12A-12D , showing theanchoring frame 600 anchored in place against theabdominal wall 127, as also shown in the sectional view ofFIG. 12E . - Once anchoring frame has been anchored to the target location, as illustrated in
FIGS. 12E and 12F , a device deployment tool 660 having already been preloaded with adevice 10 in a collapsed or compressed configuration, is next advanced over theguidewire 502 and over anchoringframe 600 in a manner described in greater detail below. Positioning of thedevice 10 can be monitored during this delivery using fluoroscopy, X-ray, CT or MRI visualization guidance, for example, or simply via direct visualization with an endoscope, such as a flexible endoscope inserted through sheath/cannula 535, for example. Alternatively an endoscope may be inserted into device deployment tool 660 or other tool to perform such viewing, or an endoscope can be inserted through an additional opening through the patient accessing the abdominal cavity.Device 10 is advanced to the end of anchoring frame where it automatically locks into position there.FIG. 12G shows a sectional illustration ofdevice 10 having been locked into position on anchoringframe 600, with device delivery tool 660 having been removed. - At this stage, when the surgeon is satisfied that
device 10 has been properly positioned and locked to anchoringframe 600, cannula/sheath 535 and guidewire 502 are both removed. Fordevices 10 that include one or more inflatableexpandable members 10 em, at least oneconduit 12 will remain extending fromdevice 10, proximally out through theincision 223 having been made in the patient. The one ormore conduits 12 can then be used to inflate the one or more expandable members. For devices that do not include an inflatableexpandable member 10 em, aconduit 12 is not necessarily required, although there may be one present, depending upon the type of mechanically expandable member(s) that is/are used. For example, a conduit may be provided to insert a wire therethrough to mechanically expand theexpandable member 10 em. Otherwise, if aconduit 12 is not included, then the one or more expandable members are expanded in a manner as has already been described. - Getting back to
devices 10 having at least one inflatable expandable member, one or moreexpandable members 10 em may be inflated at this stage to test the amount of displacement and positioning of the device when in an expanded configuration, which may help to determine whetherdevice 10 will perform as intended. One method of testing in this manner is with the use of an intra-gastric sizing device 310 (e.g. an intra-gastric balloon catheter) in a manner as described in application Ser. No. 11/407,701. Additionally, or alternatively, testing may be performed by visually observing the effects of expansion, such as by inputting radiopaque fluid into thestomach 120, and/or by observing the expansion of the device when it is provided with one or more radiopaque indicators, as has already been described previously. Visualization, in such instances may be performed fluoroscopically or with other X-ray visualization, for example. -
FIG. 12H illustrates expansion of a firstexpandable member 10 em 1 using pressurized gas, for example. At this time, an intra-gastric sizing device may optionally be already in position, and typically is placed and inflated to the desired size prior to expandingexpandable member 10 em 1. For devices having only oneexpandable member 10 em, expansion of this expandable member would then be performed to accomplish the desired amount of space restriction as indicated by feedback from intra-gastric sizing device 130, for example. In the example shown, where two expandable members are provided,expandable member 10 em 1 is typically inflated to a predetermined pressure where it has been determined that the expandable member has not expanded or stretched to a degree where the leakage rate of gas through the member is unacceptable. Typically, a maximum pressure will have been predetermined where the leakage rate is not excessive, andexpandable member 10 em 1 will not be expanded by a pressure that is greater than this maximum pressure. If the resulting degree of expansion ofexpandable member 10 em 1 does not provide sufficient displacement, then the second expandable member is expanded, such as by inputting pressurized liquid intoexpandable member 10 em 2, to expand it until sufficient displacement has been achieved, such as confirmed by visualization and/or feedback from intra-gastric sizing device, for example, seeFIG. 12I . - At this time,
conduits expandable members 10 em 1, 10 em 2, or the pressures can be released, thereby allowingexpandable members 10 em 1, 10 em 2. It is easier procedurally to release the pressures and so this is typically done. However, the surgeon may choose to clamp off the conduits to maintain at least partial pressures in the expandable members to ensure that they maintain the observed positions. In any case, conduit(s) 12 are next trimmed to an appropriate length for connection with anadjustment member 80, as illustrated inFIG. 12J . - Conduit(s) 12 are then connected to a mating connector on
adjustment member 80 or to adeployment tool 370 configured to mateconduit 12 withadjustment member 80, and, after connection ofconduit 12 toadjustment member 80, adjustmentmember deployment tool 370 is then used to anchoradjustment member 80 to the patient. By advancingdeployment tool 370 into the patient, the portion of conduit that had extended from the patient 1 is pushed back into the patient, until the adjustment member is positioned in the target location where it is intended to be anchored. This positioning can be verified using any of the previously described visualization techniques, or can be performed blindly, with feedback from palpitation, for example. In the example shown inFIG. 12K ,adjustment member 80 is anchored subcutaneously, to the external surface of theabdominal wall 127. As has been disclosed previously,adjustment member 80 can alternatively be anchored subcutaneously, to an inner layer of the skin for example, or otherwise in thefat layer 131 without being anchored directly to theabdominal wall 127. Onceadjustment member 80 has been anchored in the desired location,deployment tool 370 is withdrawn and the one or more expandable members are reinflated, if they had been previously deflated, or topped off, if theconduits 12 were clamped to maintain some pressure, to return the one or more expandable members to their desired sizes. In this way, the patient can begin to experience beneficial weight loss from the effects ofdevice 10 on thestomach 120 beginning immediately after completion of the procedure, unlike current procedures, which typically require around six weeks before a return visit to “complete” the procedure to make it effective in helping weight loss. The same type or types of monitoring can be used here, as described above with regard toFIGS. 12H-12I , to provide feedback as to when the one or more expandable members have been expanded by the desired amount. Alternatively, one or more of the one or more expandable members may be left in an unexpanded configuration, with the patient being allowed to heal and then return to have the expandable members(s) inflated. Further alternatively,device 10 may be implanted in combination with a constricting band, such as the LapBand™ or similar implant to improve results from such constricting band, or to make weight loss efficacious where prior implantation of such a constricting band has not been efficacious. For example, a constricting band generally useful for restricting the amount of solid food ingested by the patient 1. However, a patient 1 may “cheat” the effectiveness of a constricting band approach by drinking high caloric liquids, for example. For example, a patient could drink a thirty-two ounce milkshake and this would pass right through the constriction established by the constricting band. However, withdevice 10 implanted and expanded as described, the stomach is preventing from expanding, even by high caloric liquids. - Once the surgeon is satisfied that the expandable member(s) have been expanded by the desired amount, or if the expandable members(s) are to be left in a contracted (unexpanded or partially expanded) state, the patient is closed, including, suturing the
skin 125 at the site of theincision 223. -
FIGS. 12L-12N illustrate variations in the percutaneous procedure described above that can be alternatively performed. As already noted above,FIG. 12L schematically illustrates percutaneous insertion of a guidewire through aneedle 501, wherein the incision and sheath insertion steps ofFIG. 12A-12B need not be carried out.FIG. 12M illustrates the insertion ofguidewire 502 to follow the contour of the caudal surface of the diaphragm as it is pushed up and around thestomach 120, as far as the spleen, like described inFIG. 12C above. The distal end ofguidewire 502 may be provided in a “J” shape or other bent shape to make it more atraumatic. - Once the
guidewire 502 has been placed as desired,needle 501 is pulled off ofguidewire 502 and removed. A port 535 (similar to a laparoscopic port or other access sheath orcannula 535 is then inserted through the opening made byneedle 501, as illustrated inFIG. 12N . Installation of anchoringframe 600,device 10 andaccess member 80 may then be performed as described above with regard toFIGS. 12D-12K . In another variation regarding expandingexpandable members 10 em, for adevice 10 having two expandable members,expandable member 10 em 1 may be expanded with gas after theaccess member 80 is installed/anchored, andexpandable member 10 em 2 may be expanded with fluid, after completion of the procedure and some passage of time (e.g., during a follow-up visit). - Any of the variations of the procedure described above may be executed under fluoroscopic visualization, 3-dimensional navigation or other CT/MRI guidance. Further alternatively, any of these procedures may be performed as mini laparoscopic procedures (e.g., where the entire abdominal space is not insufflated, but only a small portion is and general anesthesia is not used; or where at least one of the steps involving insertion into the abdominal cavity is performed without direct visualization provided by an endoscope, for example. Anchoring of anchoring
frame 600 may be performed as a separate step of the procedure, as shown and described above, or, alternatively, may be combined with thedevice 10 insertion and positioning part of the procedure, wherein the act of sliding thedevice 10 over the anchoring frame drives the anchoring of theanchoring frame 600 at the same time thatdevice 10 is positioned (slid) thereon. All tools referenced in the above procedure may include lumens to permit insertion of other tools and/or devices therethrough, including, but not limited to: endoscopes, wires, etc. and/or to allow delivery of suction, irrigation, and/or other substances. Alternatively to mounting theadjustment member 80 toconduit 12 in any of the manners described above, adjustment member may be pre-attached or integral withconduit 12. As already noted previously,device 10 may include one or more chambers (expandable members) and may also contain fluids, gases, structural members, foams and/or other space occupying materials. - Referring to
FIGS. 13A-13D , an embodiment of ananchoring frame 600 is illustrated that can be used for anchoring adevice 10 in the abdominal space, such as, but not limited to the manner described above with regard toFIGS. 12A-12K , for example.FIG. 13A illustrates a perspective view of anchoring frame in an undeployed configuration, i.e., when anchors 102 have not been deployed to anchor the anchoring frame. In the undeployed configuration, anchoringframe 600 has acontact surface 604 that is configured, shaped and dimensioned to conform to a tissue surface in the abdominal cavity to which theanchoring frame 600 is to be anchored.Openings 606 are provided that extend from an inner surface of anchoring frame, through the wall on which thecontact surface 604 is formed, and through thecontact surface 604.Openings 606 are arranged for delivery of anchors 602 therethrough and are thus aligned with anchors 602 as will be described in greater detail below. Although shown as substantially straight, anchoring frame andcontact surface 604 may have a curvature that is formed to follow the general contour of the structure in the abdominal cavity that it is to be anchored to. Thus, for example, for anchoring to theabdominal wall 127 in the procedure describe above, anchoringframe 600 andcontact surface 604 are curved to conform to the contour of theabdominal wall 127 just below thediaphragm 116. Thus, the curvature (or straightness) of theanchoring frame 600 andcontact surface 604 is dictated by the contour of the tissue surface that it is intended to be anchored to. Thus, anchoringframe 600 can be substantially rigid and shaped with a predefined curvature (or shape) ofcontact surface 604 to match that of the tissue surface that it is to be anchored to. Alternatively, and preferably, anchoring frame may be flexible, so that when compressive forces are applied to it, by applying a force distally to the proximal end of anchoringframe 600, such as with anchoringframe deployment tool 630, for example, while the distal end of anchoring frame is fixed, such as by being abutted up against a ball end of a guidewire, for example, the compressive force causes theframe 600 andcontact surface 604 to bend and thereby abut against the surface of the tissue to be anchored to.Frame 600 andsurface 604 may be structurally biased so as to be predisposed to bending in one direction away from the longitudinal axis of theframe 600, as opposed to bending in the opposite direction, to ensure that the contact surface bows out in the direction where it will contact the tissue structure to which it is to be anchored. - Within the
channel 608 are positioned a series ofanchors 610 such as staples, tacks, spikes or other sharpened mechanical member configured to be driven into the tissue and to maintain anchoring within the tissue after piercing it. The staples of other sharpened mechanical members are positioned inframe 600 in small channels and are completely retracted so as not to extend throughsurface 604 asframe 600 is being delivered into the abdominal cavity. Adeployment member 612 is provided within anchoringframe 600 that is configured for deploying the anchors.Deployment member 612 includes anenlarged driver 613 located distally ofanchors 10, and a cable orwire 614 that extends proximally fromdrive 613 and out the proximal end of anchoringframe 600. Cable/wire 614 has sufficient length so that when anchoring frame is placed in position on the target area in the abdominal cavity to which it is to be anchored, the proximal end portion of cable/wire 614 still extends out of the patient 1 (such as out of theincision 223 in the procedure described above, for example). - When
frame 600 is positioned in the abdominal cavity at the target location where it is to be anchored, e.g., against the abdominal wall,frame 600 is held motionless against the target area while deployment member is retracted proximally. Ifframe 600 is a flexible frame, constant pressure is exerted in a distal direction against the frame to ensure that it remains buckled/bent against the target area, so that it conforms to and contacts the target surface (e.g., abdominal wall). By pulling on cable/wire 614 while holdingframe 600 substantially motionless,deployment driver 613 is retracted proximally throughchannel 608, as illustrated inFIG. 13C . As it is retracted,driver 613 contacts anchors 610 driving them out throughopenings 606 and into the tissue, thereby anchoringframe 600 to the tissue as desired. Upon completely withdrawingdeployment member 614/driver 613, andopen channel 608 is then provided for guiding one or more keys provided on adevice 10 that are slidable in channel and are configured to be prevented from pulling through the slot at the bottom of thechannel 608. - To further enhance anchoring of
frame 600, all of a portion ofsurface 604 may be covered with aningrowth layer 616, such as a fabric layer (e.g., polyethylene terepthalate or other porous, biocompatible fabric) or other porous layer configured to encourage tissue ingrowth. -
FIG. 14A illustrates an example of adevice 10 provided withkeys 618 configured to slide withinchannel 608 while being prevented from sliding out throughslot 608 s. Thus,keys 608 are generally matching to the cross-sectional configuration ofchannel 608, while each having aneck portion 618 n of narrower dimension that is configured to slide withinslot 608 s.FIG. 14B shows an end view ofkey 618 inserted intochannel 608 offrame 600. Alternatively, key 618 need not have a cross sectional shape that matches the cross-sectional shape ofchannel 608, as long as the enlarged portion ofkey 618 is too large to pass through slot 618 s, yet small enough to slide withinchannel 608, andneck 618 n is of small enough dimension to slight throughslot 608 s.FIG. 14C shows an example of a key 618 wherein the enlarged portion is spherically shaped.Keys 618 are not limited to the shapes described but can take on virtually any cross-sectional shape, as long as the requirements in size described above are met, relative to cooperating withchannel 608 and slot 608 s. Of course, some cross-sectional shapes are more advantageous than others with regard to functionality, such as minimizing resistance/friction between thekeys 618 andchannel 608 asdevice 10 is deployed overframe 600. - The number of
keys 618 attached todevice 10 is also variable and may vary from one up to several dozen. Lengths of the keys (relative to the longitudinal axis of frame 600) can also be a variety of sizes, up to and including, a continuous key that extends over the full length ofchannel 608.FIG. 14D illustrates thedevice 10 ofFIG. 14A having been mounted on anchoringframe 600 ofFIGS. 13A-13D . Of course, during the insertion ofdevice 10 into the abdominal cavity target area,device 10 will typically be in a compact, collapsed configuration to minimize its size during the delivery and as it is mounted on anchoringframe 600. An exception may be in a situation wheredevice 10 is implanted using an open procedure. -
FIG. 15A illustrates another embodiment of ananchoring frame 600 that employs a rail configuration for receiving a device thereover. Anchoringframe 600 is constructed similarly to any of the variations described above with regard toframe 600 inFIGS. 13A-13D , including thecontact surface 604,optional ingrowth layer 616, anchors 610, andopenings 606.Frame 600 is installable over a removable wire, such asguidewire 502, for example, with the wire being removable after completion of the procedure. In this arrangement, however, rather than having achannel 608 to slidably receive one ormore keys 618, rail orbeam 618 functions as a key with respect to a channel or groove 608 formed indevice 10 that slides over rail orbeam 618. As with thekeys 618 ondevice 10, the rail orbeam 618 need not be T-shaped in cross-section, as shown inFIG. 15A , as long as the enlarged portion ofrail 618 is too large to pass throughslot 608 s in thechannel 608 ofdevice 10, yet small enough to slide withinchannel 608, andneck 618 n is of small enough dimension to slide throughslot 608 s. Likewise channel 608 need not be T-shaped in cross section, but may have some other cross-section shape that forms an enlarged portion to slide withinchannel 608 and is impassable throughslot 608 s, and aneck portion 618 n that is slidable withinslot 608 s. - In order to deploy
anchors 610 into the tissue to anchor theanchoring frame 600 ofFIG. 15A ,deployment member 612 in this case is provided to slide overrail 618 as illustrated in the end view ofFIG. 15B (anchors 610 are not shown, for simplicity of illustration, since the mechanism for driving theanchors 610 bydriver 613 is the same as that described with regard toFIG. 13B above).Deployment member 612 includes anenlarged driver 613 that is located in the channels formed on both sides of neck 616 n that is located distally ofanchors 610, prior to deployment, and a cable orwire 614 that extends proximally fromdriver 613 and out the proximal end of anchoringframe 600. Cable/wire 614 has sufficient length so that when anchoring frame is placed in position on the target area in the abdominal cavity to which it is to be anchored, the proximal end portion of cable/wire 614 still extends out of the patient 1 (such as out of theincision 223 in the procedure described above, for example). - When
frame 600 is positioned in the abdominal cavity at the target location where it is to be anchored, e.g., against the abdominal wall,frame 600 is held motionless against the target area while deployment member is retracted proximally. Ifframe 600 is a flexible frame, constant pressure is exerted in a distal direction against the frame to ensure that it remains buckled/bent against the target area, so that it conforms to and contacts the target surface (e.g., abdominal wall). By pulling on cable/wire 614 while holdingframe 600 substantially motionless,deployment driver 613 is retracted proximally to slide alongrail 618. As it is retracted,driver 613 contacts anchors 610 on both sides ofneck 618 n, thereby driving them out throughopenings 606 and into the tissue, thereby anchoringframe 600 to the tissue as desired. Upon completely withdrawingdeployment member 614/driver 613, rail is then unobscured bydriver 613, so that thechannel 608 ofdevice 10 can be slid thereover. -
FIG. 15C shows an end view ofdevice 10 having one configuration (T-shaped cross-section) ofchannel 608 configured to slide overrail 618 to securedevice 10 to anchoringframe 600.FIG. 15D showsdevice 10 ofFIG. 15C having been mounted on anchoringframe 600 ofFIGS. 15A-15B . Note thatchannel 608 can extend over a length ofdevice 10 that is much greater than the length offrame 600, to provide guidance of delivery of the distal end of the device, even though the distal end ofdevice 10 is not engaged withframe 600 whendevice 10 has been installed in the intended position as shown inFIG. 15D . -
FIG. 15E is a schematic, sectional illustration (viewed from the foot of the patient with the patient lying on his back) ofdevice 10 anchored to theabdominal wall 127 via anchoringframe 600, withdevice 10 shown in an expanded configuration. -
FIG. 16A illustrates an embodiment of ananchoring frame 600 that includes an actuation mechanism that can be use to anchor theframe 600 to tissue (deploy) as well as to release theframe 600 from such anchoring. In this case,deployment member 612 is provided in achannel 608 above arail 618 that is configured to receivedevice 10 thereover, anddeployment member 612 is configured to not only anchor theframe 600 to a tissue surface, but is also operable to reverse this anchoring, so as to allow removal or repositioning and re-anchoring offrame 600. Thus, the enlarged members ordrivers 613 ofdeployment member 612 include deployment driver surfaces 613 a and retraction driver surfaces 613 b as illustrated inFIG. 16A . Upon slidingdeployment member 612 relative to frame 600 in a direction to contact deployment driver surfaces 613 a with anchors 610 (i.e., to the left, as shown inFIG. 16A ) and continuing to slidedeployment member 612 in that direction, deployment driver surfaces 613 a drive anchors to rotate so as to extend the sharp (distal) ends of anchors out ofopenings 606, as illustrated inFIG. 16B . Deployment driver surfaces 613 a are abrupt or steep and may even be formed as substantially perpendicular to the longitudinal axis offrame 600. Retraction driver surfaces 613 b are ramped or cammed so as to allow the rotation of the opposite (proximal) ends down intochannel 608 without contactingdeployment member 612 during deployment of the distal ends. - Thus,
FIG. 16B illustratesanchors 610 in the deployed configuration, wherein, whencontact surface 604 is contacted to a tissue surface and anchors 610 are deployed in this manner, this anchorsframe 600 to the tissue. Should the operator wish to remove anchoringframe 600, or reposition it,deployment member 612 is slid in the opposite direction relative to frame 600 (i.e., to the right inFIG. 16B ). This causes retraction driver surfaces to contact the proximal ends 610 p ofanchors 610, and continued movement ofdeployment member 612 causes drivers 613 p to reverse rotateanchors 610 to the positions shown inFIG. 16A . These deployment and retraction functions are repeatable. That is, after retracting theanchors 610 as described, anchoring frame can be repositioned on a tissue surface, anddeployment member 612 can be actuated again to deployanchors 610 and thereby anchor theframe 600 to the new location. -
FIG. 16C illustrates atool 625 configured to engage withdeployment member 612 and anchoringframe 600 and, when engaged, can be used to move, orient and position anchoring frame, as well as operatedeployment member 612 to deployanchors 610 and/or retractanchors 610.Tool 625 includes anelongated shaft 627 having sufficient length so that whentool 625 is engaged withanchoring frame 600 anddeployment member 612 in a manner as described hereafter, a proximal end portion oftool 625, including actuators to be manipulated by a surgeon or other user, extend out of the body of the patient 1, even whenframe 600 has been inserted into the abdominal cavity as far as it needs to be advanced to anchor it at a desired location. The distal end oftool 625 includes aquick release mechanism 628 configured to engage with engagement features 615 on a proximal end portion of anchoringframe 600. For example,quick release mechanism 628 may include a plurality of hooks orteeth 628 h that engage. with engagement features 615 provided as mating or interengaging hooks to teeth. The hooks orteeth 628 h can be drawn toward one another, radially inwardly, such as by rotation ofquick release actuator 629, for example, so that they no longer engage withengagement members 615, but can be slid therepast, quickly releasingtool 625 from anchoringframe 600. - A
cam driver 629 is formed at a distal end of a cam driver shaft 629 d that is axially drivable with respect toshaft 627 by pivotingcam driver actuator 631 relative toshaft 627. Aslidable safety lock 633 may be provided onshaft 627 that is slidable in a first direction to prevent pivoting ofactuator 631 relative toshaft 627, thereby preventing inadvertent deployment or retraction ofanchors 610 whencam driver 629 oftool 625 is engaged withdeployment member 612, such as by engagement with camdriver engagement member 612 c, for example. By slidingsafety lock 633 in the opposite direction, this unlocksactuator 631 and the operator can then eitherpivot actuator 631 towardshaft 627 to drivedeployment member 612 to deployanchors 610, orpivot actuator 631 away fromshaft 627 to retract anchors into anchoringframe 600. Upon quick release oftool 625 fromframe 600 as described,cam driver 629 can be released from camdrive engagement member 612 c by simply rotatingtool 625 about its longitudinal axis so thatcam driver 629 andengagement member 612 c become misaligned. -
FIG. 17 illustrates an anchoringframe deployment tool 630 that can be used for percutaneous delivery of anchoringframe 600.Tool 630 includes ahandle 632 for manual operation by a user (e.g., surgeon) and an elongated,rigid shaft 634 extending distally therefrom. Anengagement feature 636 is provided onshaft 636 for engaging with anchoring frame and securing it during the delivery thereof. For example, engagement feature may be a rail, e.g., a t-shaped rail or other cross sectional configuration that slides within a channel inframe 600, somewhat like a tongue-and-groove fitting, or may include a channel that slides over a rail portion offrame 600, etc. Anactuator 638 is provided onhandle 632 that is actuatable to trigger staples or othermechanical members 610 to be driven through the openings inframe 600 to extend through thesurface 604 and into the target internal abdominal structure (e.g., abdominal wall) toanchor frame 600 thereto. One or more lumens may be provided throughshaft 634 for delivery of irrigating fluids (or other substances) and for application of suction to the distal end ofshaft 634, viaports -
FIG. 18A illustrates another embodiment of an anchoringframe deployment tool 630 that is configured to receive anendoscope 537 therein to facilitate viewing of the placement of anchoringframe 600. A video camera 538 may be provided onendoscope 537 so as to monitor the visualization on a screen, or, optionally, viewing may be performed directly through an ocular. -
Shaft 634 articulates, via one or more articulatingjoints 644. Anarticulation actuator 646 is provided on ornear handle 630 for operation by a user to control the articulation of adistal portion 634 d ofshaft 634 with respect to aproximal portion 634 p ofshaft 634. In the example shown,articulation actuator 646 is a rotatable wheel that is rotatable in a first direction to articulatedistal portion 634 d in a first angular direction about joint 644, while rotation ofactuator 646 in the opposite direction articulatesdistal portion 634 d in the opposite direction.Articulation actuator 646 and/or articulation joint 644 provide frictional resistance, so that whenactuator 646 is not being rotated,distal portion 634 d is maintained in its orientation relative toproximal portion 634 p. - A window or
opening 648 is provided proximally of articulating joint 644 to enable viewing through the distal end ofendoscope 537 that is positioned inshaft 634 at the location of opening/window 648 whenendoscope 537 is inserted intotool 630. Window/opening 648 may be an opening (e.g., cutout), or may be a window, e.g., a cutout that is sealed over with a transparent material. -
Distal portion 634 d includes a recess orcavity 650 configured to receive anchoringframe 600 therein. Thus, recess orcavity 650 is shaped and dimensioned to receive anchoringframe 600 therein and to confine anchoringframe 600 from movements axially with respect to the longitudinal axis ofdistal portion 634 d.Frame 600 may be received in recess, cavity or slot 650 by friction fit and/or a releasable clamping mechanism (not shown, see co-pending application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3, FIGS. 36A-36D and description thereof)) may be optionally provided on opposite sides of slot, recess orcavity 650 for releasably clampingframe 600 wherein it is received therein, with clamping and releasing motions being controlled by a clamp actuator (not shown, see co-pending application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3, FIGS. 36A-36D and description thereof)). application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3) is hereby incorporated herein, in its entirety, by reference thereto.FIG. 18B shows an enlarged partial view ofshaft 634 with anchoringframe 600 mounted withindistal end portion 634 d, and showing the distal end ofendoscope 537 withinproximal end portion 634 p. - In use, after insertion and placement of
guidewire 502, such as in a percutaneous procedure as described above,deployment tool 630 is passed overguidewire 502, with the proximal end of guidewire first being inserted into the distal end ofshaft 634, throughshaft 634 and handle 632 and proximally out ofhandle 632, as illustrated inFIG. 18A . By insertion oftool 630 into the abdominal cavity, the abdominal wall (e.g., the anterior abdominal wall can be directly visualized byendoscope 537/camera 538 viewing through opening/window 648. This visualization is performed to ensure that that is no tissue located between the anchoring site (e.g., anterior abdominal wall 127) and anchoringframe 600 prior to anchoring theframe 600 to the anchoring site. Once it has been visually confirmed that there is no tissue intervening betweenframe 600 and the anchoring site,actuator 646 is manipulated to rotatedistal portion 634 d up against the anchoring site, thereby contactingsurface 604 to the anchoring site.Anchors 610 are then deployed into the anchoring site, such as by a mechanism described above for example. In an alternative embodiment, needles and sutures may be substituted foranchors 610, such as described in application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3, FIG. 36C and description thereof). Adeployment actuator 652, such as a trigger, lever or other equivalent mechanical actuator can be provided onhandle 632 for operation by the user. Thus when actuator 652 (FIG. 18A ) is actuated, this retractsenlarged member 613 to driveanchors 610 into the tissue, thereby anchoring theframe 600. Deployment actuator may be provided with a safety mechanism or lock 654 that can be locked up until the time that the operator is ready to deploy theanchors 610, to prevent inadvertent deployment ofanchors 610 before theframe 600 has been properly positioned and is ready to be anchored. - When
device 10 has been fully inserted into its intended position relative to anchoringframe 600, device is locked into this position byautomatic lock 620.FIGS. 19A-19B show one embodiment of anautomatic lock 620 that may be provided on the proximal end offrame 600 on the underside of the top portion oftrack 618.FIGS. 19A and 19B show partial views of anchoringframe 600 withanchors 610 not being shown for simplicity of illustration. InFIG. 19A , locks 620 are shown deployed. Locks 220 may be spring steel or some other biased members that are biased toward the deployed configuration shown inFIG. 19A , while being deformable so as to lie substantially parallel or flush with the underside. Thus, when thechannel 608 rides over theenlarged portion 618 at the bottom of the rail, in this case in a tongue and groove type of interfit, the top surfaces on opposite sides ofslot 608 contact theundersurface 618 u of the top portion of theframe 600 and are guide therealong. As the top surfaces ride overautomatic locks 620, they depress them towards the undersurface so that the device is able to slide along the rail. Once theentire channel 608 ofdevice 10 has passed locks 620 (distally thereof), locks resiliently spring back into the conformation shown inFIG. 19A , thereby preventingdevice 10 from being retracted proximally back off offrame 600. Detents and/or other stopping structure (not shown) are provided at the distal end portion of theframe 600 to preventchannel 608 from being slid too far distally with respect to anchoringframe 600/enlarged portion 618. - Prior to anchoring the
frame 600 to the desired target tissue, automatic locks are held recessed (in an unlocked configuration) against theundersurface 618. This is necessary to allow the retraction of theenlarged member 613 ofdeployment member 612 during deployment ofanchors 610. For example,lock prevention tabs 622 may be inserted inslots 624 to maintain a biasing force onlocks 620 to keep them in the unlocked configuration.Tabs 622 may be integrated, such as to form a U-shaped member like shown inFIG. 19B and a wire orsuture 626 extends proximally therefrom and has a length sufficient to extend out of the patient 1, even whenframe 600 is located in its intended anchoring position. Afterenlarged member 613 has been retracted throughframe 600 to driveanchors 610 into the target tissue, in a manner as already described above, anddeployment member 612/enlarged member 613 has been removed from anchoringframe 600, the operator pulls on wire/suture 626, thereby slidingtabs 622 out of their respective positions and removingtabs 622form anchoring frame 600. Upon this removal, locks 620 resiliently spring back into the locked configuration shown inFIG. 19A . -
FIG. 20A shows an anchoringframe unlocking tool 670, that can be used to unlock the anchoring frame tofree device 10 that has been automatically locked into position along anchoringframe 600. For example, it may be difficult to removeframe 600 if tissue has ingrown into tissue ingrowth surfaces provided onsurface 604, so this removal mechanism makes it much easier to remove the expandable member(s) 10 em for replacement, or withdrawal if no longer indicated.Tool 670 includes a handle 672, andelongated shaft 674 and alock depressor 676 at the distal end ofshaft 674.Lock depressor 676 is configured to be mounted and slide overrail 618 and includesdepressor portions 676 d that extend above the portion that fits overrail 618 and that press againstautomatic locks 620 to depress them to the unlocked configuration asdepressor 676 is slid over therail 618.FIG. 20B shows an end view oftool 670 that illustrates a configuration of alock depressor 676 according to one embodiment. Optionally, an actuator 678 may be provided to actuate the depressor portions form a retracted configuration to the extended configuration shown inFIG. 20B . -
FIG. 20C schematically illustrates use oftool 670 to unlockdevice 10 from anchoringframe 600 so thatdevice 10 can be removed from the site.Tool 670 is inserted (e.g., throughincision 233 in the percutaneous procedures described above, or along any other approach provided by other procedures, such as mini-laparoscopic, laparoscopic, open, etc.) andlock depressor 676 is mounted overrail 618.Tool 670 is then distally advanced overrail 618. Aslock depressor 676 advances distally, it depresses theautomatic locks 620, as shown. Upon full depression oflocks 620, or simply by distally advancingtool 670 untillock depressor 676 contacts the proximal end ofchannel 608 of thedevice 10,device 10 is now ready to be removed off offrame 600. By applying retraction force toconduit 12,channel 608 slides proximally overchannel 618, thereby withdrawingdevice 10 andtool 670 together.Tool 670 may be operated to maintain contact with the proximal end ofchannel 608 to ensure thatlocks 620 remain unlocked aschannel 608 is withdrawn thereover. In an alternate method, locks 620 may be formed with thin enough material so that an impulsive tug onconduit 12 is sufficient to bendlocks 620 over backwards to allow channel 608 (and thus device 10) to be withdrawn off offrame 600. - As noted above,
device 10 is provided in a compact (non-expanded) configuration during delivery, at least when delivering by a percutaneous, mini-laparoscopic or laparoscopic procedure.FIG. 21A illustrates an embodiment ofdevice 10 provided with loopedtabs 682, with one set 682 a extending lengthwise (e.g. relatively aligned along channel 608) on one side ofexpandable member 10 em, and an alternating set 608 b on the opposite side of theexpandable member 10 em. With expandable member in a deflated configuration, expandable member can be rolled in the direction indicated by arrows inFIG. 21A about its longitudinal axis, so that theexpandable member 10 em is rolled up on itself to form a compact structure resembling a cylinder. Once rolled up into this configuration, loopedtabs wire 684 can be inserted through the loops of loopedtabs device 10 in the rolled up configuration, as shown inFIG. 21B . It is noted thatchannel 608 is still exposed on an external surface of the device even when in the rolled up condition, so that it can be mounted and slid overrail 618 during the delivery ofdevice 10. Oncedevice 10 has been positioned overframe 600/rail 618 in the desired location,wire 684, which has sufficient length to extend out of the patient even whendevice 10 is mounted in the intended position onframe 600, can be withdrawn by an operator, thereby freeing the expandable member. Upon inputting of gas and/or liquid toexpandable member 10 em, it unfurls and assumes its expanded configuration. Although devices that are attached by ananchoring frame 600 typically will not require further anchoring, it is noted that such procedures are not limited to anchoring using only the anchoring frame, as any of the other attachment or anchoring techniques and features may optionally be used in addition to anchoring with ananchoring frame 600. In this regard, it is noted that loopedtabs 682 may be used as attachment areas, e.g., through which sutures, staples or tacks, etc. may be driven to further attachdevice 10 to the patient. Still further, whether or not used to attachdevice 10, looped tabs also provide convenient and safe areas for manipulation by the use of tools, such as graspers, etc. It is further noted that this type of compaction feature can be provided for devices that are not attached to ananchoring frame 600, but are attached by other means described herein, or are attached only by attachingtabs 682 to tissues within the patient. - Alternatively, an
expandable compaction member 686 may be provided to surround and compactexpandable member 10 em for delivery thereof as illustrated inFIGS. 21C-21D . For example,expandable compaction member 686 may be a thermoformed balloon that is formed to roll up when inflated, but can be opened up or spread apart or held open in a relatively flattened out configuration in its non-expanded (deflated) state as illustrated inFIG. 21C . This open configuration allows a rolled up or otherwise compressed expandable member to be placed onexpandable compaction member 686.Expandable compaction member 686 is then inflated/expanded via conduit 6861, whereupon it assumes it rolled-up configuration, thereby substantially surrounding the compactedexpandable member 10 em as illustrated in the end view ofFIG. 21D . In this configuration, theexpandable member 10 em andcompaction member 686 are deliverable into the abdominal cavity for location at the intended surgical target site. - Once in the intended surgical target site, i.e., in the location where it is desired to expand the
expandable member 10 em,compaction member 686 may then be deflated and then withdrawn from its encapsulation ofexpandable member 10 em and from the abdominal cavity. Optionally, expandable member may first be attached to a rail or to some other fixation point to prevent it from being withdrawn ascompaction member 686 is withdrawn. After removal ofcompaction member 686,expandable member 10 em can be expanded in the course of a procedure as described with regard to any of the embodiments described herein or in any of the disclosures for which priority has been relied upon. -
FIG. 21E illustrates another embodiment in which arigid exoskeleton 688 is provided to receiveexpandable member 10 em and maintain it in a compressed or otherwise non-expanded configuration for delivery into the surgical target area. For example, exoskeleton may be in the form of a rigid canister as illustrated inFIG. 21E , that functions similar to a film canister for 35 mm film. That is,expandable member 10 em can be rolled up or otherwise inserted intocanister 688 to be retained therein in a non-expanded state. Typically, at least an edge of theexpandable member 10 em will be left slightly protruding from the opening or slot 688 s provided inexoskeleton 688. In the example shown inFIG. 21E , the edge ofexpandable member 10 em protruding from opening 688 s includestabs 682, loopedtabs 682 a or other features for engaging with a rail or other anchored structure in theabdominal cavity 682. In the case of loopedtabs 682, of other feature for engaging a rail or other fixed structure, these features can be looped over or otherwise engage with the fixed structure in the abdominal cavity when the exoskeleton containing the compressed or otherwise non-expanded expandable member is inserted into the surgical target location in the abdominal cavity. Upon fixing the loopedtabs 682 a or other feature to the rail or other fixed structure,expandable member 10 em can then be extracted fromexoskeleton 688 by rotatingexoskeleton 688 in a rotational direction opposite to the direction of the arrows shown inFIG. 21E . This causes extraction of theexpandable member 10 em out of theexoskeleton 688 as illustrated by the directional arrows shown inFIG. 21E . Rotation can be effected by a rod orwire 689 that is fixed to a proximal end portion ofexoskeleton 688 and which may be rigid or flexible, but is torsionally rigid in either case. Alternatively,rigid exoskeleton 688 can be retracted in a linear direction opposite the directional arrows shown inFIG. 21E . This motion, applied against the force provided by the fixation ofexpandable member 10 em relative to at least one fixed structure in the abdominal cavity, cause extraction ofexpandable member 10 em out ofrigid exoskeleton 688 asrigid exoskeleton 688 moves away from the fixed/anchored portion ofexpandable member 10 em. - If
tabs 682 are provided on the edge ofexpandable member 10 em, one or more oftabs 682 may be temporarily or permanently anchored to a structure in the abdominal cavity, e.g., by suturing, stapling, tacking and/or adhesives or other alternative fixing members or substances, and then an unrolling motion like that described above can be carried out to extract theexpandable member 10 em. Alternatively, or if no additional features are present on the edge of theexpandable member 10 em, one ormore tabs 682 or the edge of theexpandable member 10 em can be grasped, by graspers, or other long slender tool and then exoskeleton 688 can be rotated as described. In any of the procedures described above, onceexpandable member 10 em has been completely extracted fromexoskeleton 688,exoskeleton 688 is withdrawn out of the patient to provide working space for continuing procedures to implantdevice 10. -
FIG. 21F shows still another alternative configuration for placingexpandable member 10 em in a compacted or collapsed configuration for delivery into the abdominal cavity to the surgical target area. In this example, expandable member is folded into an accordion-fold configuration so that the expandable member is folded over on itself along folds 687, similar to the way that a bicycle tube is packaged for sale. In this folded configuration,expandable member 10 em can be received in anexoskeleton 688 such as described above, or can be delivered via a sheath, for example. Additionally or alternatively,expandable member 10 em can be temporarily retained in the folded configuration by attaching the adjacent pleats or folds together using weak adhesive bonds that are broken whenexpandable member 10 em is expanded, by the force of the inflation fluid pressure, for example. - In another embodiment,
expandable member 10 em may be compressed in acapsule 692 that is formed of a water soluble gel orskin 692 s as illustrated inFIG. 21G . In this case, the compressedexpandable member 10 em is inserted into the abdominal cavity and to the surgical target area location whilesoluble skin 692 s maintainsexpandable member 10 em compacted. Ascapsule 692 enters the aqueous environment of the abdominal cavity,skin 692 s begins to dissolve. After a predetermined amount of time in the aqueous environment of the abdominal cavity,skin 692 has dissolved by a sufficient amount such that the input of expansion media intoexpandable member 10 em causesexpandable member 10 em to expand with sufficient force to rupturecapsule 692 if is has not dissolved to the extent where it has ruptured simply by dissolution. In either case,capsule 692 can be retracted out of the patient, using graspers, for example, but need not be, as it will completely dissolve with the passage of additional time. -
FIG. 21H illustrates an embodiment having a flexible,expandable exoskeleton 694. In this example,expandable member 10 em is surrounded byexpandable exoskeleton 694, which may be a pleated silicone capsule (or balloon), for example, or partially slitted silicone capsule or balloon, or may have either of these structures and be formed from polyurethane or other biocompatible elastomer, for example.Exoskeleton 694 is formed so that it maintains the compacted configuration shown inFIG. 21H as long asexpandable member 10 em does not contain an expansion medium or fluid. After placement of theexoskeleton 694 containingexpandable member 10 em at the desired surgical target site,exoskeleton 694 is inflated by inputting expansion medium (e.g., gas or liquid) through a lumen inconduit 12, and expansion medium is inputted through another lumen inconduit 12 causing expansion ofexpandable member 10 em. Alternatively, expansion medium inputted throughconduit 12 toexpandable member 10 em can expand bothexpandable member 10 em andexoskeleton 694 simultaneously, with the pleats or slits assisting the expansion.Exoskeleton 694 may be provided with one ormore tabs 682 that can be used to anchor theexoskeleton 694 in the expanded configuration, and this may also help to maintainexpandable member 10 em in the desired expanded volume, asexoskeleton 694 supports some of the load applied todevice 10 caused by expansion of the device against the structures in the abdominal cavity. -
FIGS. 21I-21J illustrate anexpandable member 10 em that is formed in an elongated tube configuration. This tube formation allowsexpandable member 10 em to be linearly deployed through a small opening in a patient (or alternatively, may be used in an open surgical procedure).Tabs 682 are provided at spaced locations along the elongated tube, and act as fixation or anchoring points along theexpandable member 10 em. Thus, portions of theexpandable member 10 em can be anchored as they are inserted into and arrive at the surgical target area, such as by stapling, suturing, tacking, etc.,tabs 682 to fixed structures within the abdominal cavity. In this way, elongated member can be laid out and fixed at the surgical target array in an almost infinite number of different configurations that are customizable according to the way that the user bends and fixes the portions of the expandable member. In the example shown inFIG. 21J , expandable member has been fixed in a serpentine configuration, but this embodiment in is in no way limited to this configuration, as a coiled configuration could be provided, or groups or bunches of portions could be configured, or many other customizable configuration can be fixed, including a more or less random distribution of the portions fixed to structures in the abdominal cavity. -
FIG. 21K illustrates an alternative to the use oftabs 682 in the embodiment ofFIGS. 21I-21J . In this case, aflange 682F is provided along one or more continuous lengths ofexpandable member 10 em, up to the full length of theexpandable member 10 em, to increase the flexibility of the choice of fixation points, since stapling, tacking or suturing can be performed anywhere along the one ormore flanges 682F. It is noted that this alternative feature is not limited to the elongated tubular form of an expandable member, as one ormore flanges 682 may be provided along any of theexpandable members 10 em described herein. - In another embodiment,
device 10 is compacted and maintained in a compact configuration by insertion within asheath 690 as illustrated inFIG. 22A .Sheath 690 does not completely encircleexpandable member 10 em, but includes a slit through which a rail or channel connected toexpandable member 10 em, and which is to be connected to frame 600, is exposed.Device 10 can be compacted into a compressed form using any of a variety of techniques, including, but not limited to: rolling (like described above, but wherein loopedtabs 682 are not required), accordion folding (like a bicycle inner tube when it is first purchased), tongue rolled (described in further detail below), randomly compressed by drawing and maintaining a vacuum on expandable member(s) 10 em, or other folding and compressing. -
FIG. 22B illustrates anexpandable member 10 em ofdevice 10 being deployed via anintroducer 696 having a splittable introducer housing at a distal end portion thereof. In the example shown, the distal end portion of introducer is split into two portions orjaws 696J that are pivotably mounted for rotation with respect to the remainder of theintroducer 696, for example, via pivot joint 696P. However, it is noted that the distal end portion may be splittable into three or more component jaws 696P, as this embodiment is not limited to splitting using only two jaws 696P. It is further noted thatjaws 696J do not have to form equal portions of the distal end ofintroducer 696 as shown.FIG. 22B showsexpandable member 10 em in a substantially flattened, non-expanded configuration, prior to further compacting it by rolling, accordion-folding, or otherwise further compacting theexpandable member 10 em/device 10 to be received in thesplittable jaws 696J ofintroducer 696, that form a housing for the compactedexpandable member 10 em for delivery into the abdominal cavity. A structure referred to as a “doghouse” surrounds theconduit 12 where it connects toexpandable member 10 em and may form a socket into whichconduit 12 is received. In any case, the doghouse strengthens the joint betweenconduit 12 andexpandable member 10 em, to minimize risk of failure at the joint. The doghouse may be made from the same material asconduit 12 and/orexpandable member 10 em.Conduit 12 extends trough the tube of theintroducer 696 and out of a proximal end portion thereof whendevice 10 is loaded in theintroducer 696. -
FIG. 22C illustrates the compacted device 10 (includingexpandable member 10 em) having been received in theintroducer 696, with thesplittable jaws 696J having been closed around the compactedexpandable member 10 em to maintain it in a compact configuration as it is delivered throughopening 223 and through an opening formed in theabdominal muscle 127 for a percutaneous implantation procedure. - Once
jaws 696J have completely passed through the opening in theabdominal muscle 127 and have been placed in the abdominal cavity in the vicinity of the desired location for placement ofexpandable member 10 em,jaws 696J are opened by manipulation oftethers 696T extending throughintroducer 696 and out of a proximal end thereof for manipulation by a user.Tethers 696T, although provided as a pair of tethers at the proximal end of theintroducer 696 and connected at the distal ends to a rod orroller 697 around whichexpandable member 10 em has been rolled up in this example. Alternatively, tethers 696T can be formed as onecontinuous tether 696T having two proximal ends extending out of the proximal end portion ofintroducer 696 and around whichexpandable member 10 em is rolled or folded at a distal end portion thereof. Upon applying tension totethers 696T when the operator/user pulls on the proximal end portions oftethers 696T extending proximally fromintroducer 696 while maintaining theintroducer 696 in a fixed position relative to theabdominal muscle 696, this rotates the compactedexpandable member 10 em (androller 697, when present) as illustrated inFIG. 22D , thereby also openingjaws 696J. Alternatively,jaws 696J may operate like laparoscopic graspers to open and close and are therefore opened first before applying tension ontethers 696T to extractdevice 10 in a manner described above. - When
device 10 has been properly oriented with respect tointroducer 696, as illustrated inFIG. 22E , one ormore tabs 682 may be fixed to a structure in the abdominal cavity, andexpandable member 10 em can then be extracted from its compact configuration, such as by unrolling (in the embodiment shown) unfolding, or otherwise extracting the expandable member from the compact state it assumed to be received in theintroducer 696, by withdrawing theintroducer 696 as the distal end of expandable member is retained by the fixation. Alternatively, graspers or other instrument may be used to grasp a distal most tab or a distal portion ofexpandable member 10 em to hold it relatively motionless asintroducer 696 is retracted and thus drawn away fromdevice 10, thereby extractingexpandable member 10 em, as the proximal ends ofjaws 696 are retracted back into the opening through the abdominal muscle, this closes the jaws, allowing them to be completely removed from the abdominal cavity, takingtethers 696T (andoptionally roller 697, if present) along with it. It should be noted that althoughdevice 10 is shown positioned substantially perpendicular to the longitudinal axis ofintroducer 696 as the desired orientation of thedevice 10 for extractingexpandable member 10 em, that this embodiment is not limited to this orientation. For example, a rolled up expandable member, as shown, may be oriented at an acute angle (in either direction) to the perpendicular to the longitudinal axis ofintroducer 696, depending upon various factors, such as the available working space, desired final orientation of theexpandable member 10 em, etc. Also,tabs 682,flange 682F or other attachment features can be anchored to structures within the abdominal cavity in an incremental fashion, asexpandable member 10 em can be incrementally extracted, a portion at a time, with anchoring being performed between incremental extraction steps. -
FIGS. 22F-22H illustrate operation of another delivery tool for use in delivering and facilitation of anchoring ofdevice 10 in the abdominal cavity. This tool also advantageously provides the ability to deliverdevice 10 by a percutaneous procedure or laparoscopic procedure. Of course, this tool can also be used in open procedures. The tool includes an inner sheath/delivery shaft 696 i about whichexpandable member 10 em can be rolled. In the example illustrated inFIG. 22G ,expandable member 10 em has been folded over and then rolled up around the distal end portion of inner sheath/delivery shaft 696 i. A portion of delivery shaft/inner sheath 696 i proximal of the portion about whichexpandable member 10 em is rolled, may be formed in abend 696 b as shown inFIG. 22G . Inner sheath/delivery shaft 696 i may be formed to have thebend 696 b as shown inFIG. 22G , when in an unbiased configuration, but is flexible so that inner sheath/delivery shaft 696 i can be biased into a substantially straight configuration. Alternatively, bend 696 b may be formed as a pivoted or hinged joint, which can be operated upon retraction of outer sheath 696 o therefrom. - As shown in
FIG. 22F , an outer sheath 696 o is provided that slides freely overinner sheath 696 i. After compactingexpandable member 10 em, such as by rolling it around the distal end portion ofinner sheath 696 i, the distal end portion ofinner sheath 696 i is biased to substantially straighteninner sheath 696 i, and outer sheath 696 o is slid distally over inner sheath 6961 to cover theexpandable member 10 em and maintain it in a compact or compressed configuration as shown inFIG. 22F . The tool anddevice 10 as shown inFIG. 22F are then ready for use. The distalend containing device 10/expandable member 10 em is inserted into the abdominal cavity, such as by delivery though a percutaneous or laparoscopic opening, for example. One in the vicinity of the intended implantation site (surgical target location), outer sheath 696 o can be retracted relative toinner sheath 696 i. As outer sheath 696 o is retracted to the extent that bend 696 b is no longer covered,inner sheath 696 i returns to its unbiased, bent configuration, as illustrated inFIG. 22G . At this time, the distal end portion ofexpandable member 10 em, and typically at least one attachment tab 682 (orattachment flange 682F, as shown inFIG. 22G ) are presented and the distal end portion ofexpandable member 10 em can be sutured, stapled, tacked, etc. to an internal structure in the abdominal cavity. By incrementally retractinginner sheath 696 i, incremental portions ofexpandable member 10 em can be extracted (e.g., unrolled and/or unfolded) with fixation of these portions being accomplished between the incremental extraction steps. Alternatively,expandable member 10 em can be nearly fully extracted or fully extracted after just the first fixation of the distal end portion has been accomplished, or even without any anchoring oftabs 682/682F if the surgeon desired to just grasp the distal end portion ofexpandable member 10 em with graspers or other temporary fixation tool asinner sheath 696 i is retracted.FIG. 22H illustrates the expandable member when is has been almost completely extracted. -
FIGS. 22I-22K illustrate operation of another delivery tool for use in delivering and facilitation of anchoring ofdevice 10 in the abdominal cavity. This tool also advantageously provides the ability to deliverdevice 10 by a percutaneous procedure or laparoscopic procedure. Of course, this tool can also be used in open procedures. The tool in this embodiment includes an introducer that comprises a rigid, closed-ended (at the proximal end) sheath ortube 696 that houses theexpandable member 10 em during delivery thereof, as illustrated inFIG. 22K . Anattachment tab 682 or other distal portion ofexpandable member 10 em may be left extending distally fromsheath 696 afterexpandable member 10 em is loaded intosheath 696 for delivery thereof, as shown inFIG. 22K . This facilitates grasping of the distal portion and/or anchoring thereof to a structure in the abdominal cavity, as described below. -
Expandable member 10 em, in a non-expanded or deflated state is substantially flattened and then rolled from both side edges (FIG. 22I ) toward a central axis, to form what is referred to as a “tongue-roll” configuration, as illustrated inFIG. 22J . By rolling upexpandable member 10 em from both side edges, this avoid twisting oflumen 12 which is located substantially in alignment with the central axis ofexpandable member 10 em in this case. The tongue-rolledexpandable member 10 em is then inserted into the open distal end ofintroducer 696 and slid into thesheath 696 of the introducer until configured as shown inFIG. 22K . In the example shown,lumen 12 is short and does not extend much (if at all) past the edge ofexpandable member 10 em. In cases wherelumen 12 is longer,lumen 12 can extend alongside the tongue-rolledexpandable member 10 em to extend out of the distal end opening ofsheath 696 and then bend back to run along the length ofintroducer sheath 696 so that a proximal end oflumen 12 extends out of the body with the proximal end ofsheath 696 as expandable member is placed in the abdominal cavity. - Since the introducer comprises a
rigid sheath 696, it can be used to perform blunt dissection while deliveringexpandable member 10 em to the intended surgical target location in the abdominal cavity. Once the distal end portion of the introducer/sheath 696 that containsexpandable member 10 em has been located in the vicinity of the surgical target location, the attachment tab 682 (orflange 682F) that extends distally of the distal end ofsheath 696 can be sutured, stapled, tacked, etc. to an internal structure in the abdominal cavity. By incrementally retractingsheath 696, incremental portions ofexpandable member 10 em can be extracted (e.g., and unrolled) with fixation of these portions being accomplished between the incremental extraction steps. Alternatively,expandable member 10 em can be nearly fully extracted or fully extracted after just the first fixation of the distal end portion has been accomplished, or even without any anchoring oftabs 682/682F if the surgeon desires to just grasp the distal end portion ofexpandable member 10 em with graspers or other temporary fixation tool assheath 696 is retracted. -
FIGS. 22L-22M illustrate another variation of an arrangement for compactingdevice 10 and maintaining it the compact configuration for delivery into the abdominal cavity. In another embodiment,device 10 is compacted and maintained in a compact configuration by insertion within asheath 690 as illustrated inFIG. 22A .Sheath 690 does not completely encircleexpandable member 10 em, but includes a slit through which a rail or channel connected toexpandable member 10 em, and which is to be connected to frame 600, is exposed.Device 10 can be compacted into the compressed configuration by rolling it inflexible sheath 690. In this case,sheath 690 can completely surrounddevice 10 when the device is to be anchored usingtabs 150. Once rolled up, such as by tongue-rolling or other rolling technique, thesheath 690 anddevice 10 assembly can be further compacted/compressed by drawing it through afunnel compactor 691 as illustrated inFIG. 22M , by pushing and/or pullingassembly FIG. 22M and/or pushing or pullingcompactor funnel 691 to the right inFIG. 22M . The small opening of thefunnel compactor 691 can be made to have an inside diameter of a maximum, predetermined size acceptable for delivery of the assembly through a small opening and into the abdominal cavity. - Further optionally, an additional sheath or
inserter 696 can be mounted over the small end ofcompactor funnel 691, as illustrated inFIG. 22N , so that the furthercompressed assembly inserter 696. The introducer orsheath 696 can then be inserted through a small opening in the skin of the patient and into the abdominal cavity, whereassembly sheath 696 may be open ended at both ends, and a pusher rod can be pushed through the proximal end opening of sheath orintroducer 696 to drive theassembly assembly device 10 can be positioned and anchored according to any of the techniques described herein.Sheath 690 is removed from the abdominal cavity and from the patient. -
FIG. 22O shows a further alternative arrangement, in whichsheath 690 anddevice 10 after rolling and compressing according to the techniques described above with regard toFIGS. 22L-22M , is back-loaded on a steerable,flexible endoscope 356. Alternatively,sheath 690 anddevice 10 can be wrapped and compressed around steerable,flexible endoscope 356 to backload theassembly compactor funnel 691. According to either of these techniques, after making asmall incision 223 in the patient, theendoscope 356 is advanced through the opening and into the abdominal cavity. Theendoscope 356 can be steered during this process to advance thedistal tip 790 thereof to a desired location in the abdominal cavity where it is desired to placedevice 10. Also, full insufflation of the abdominal cavity is not needed in order to deliverdevice 10 by this technique. Once thedistal tip 796 ofendoscope 356 has been steered and advanced to a desired location in the abdominal cavity,assembly endoscope 356 and ejected off of the distal end of endoscope.Device 10 may be delivered over ananchoring frame 600 using this technique, and/or ejected into the abdominal cavity for subsequent positioning and anchoring bytabs 150. - Optionally, as the
endoscope 356 assembly is being advanced, impulse puffs of pressurized gas can be intermittently applied through the distal end of endoscope 356 (or with an additional conduit that delivers these impulses to the location of (or just distal to) the distal end ofendoscope 356 to help open a pathway along which it is desired to steer theendoscope 356. Further alternatively,device 10 can be compacted and back-loaded aroundendoscope 356 withoutsheath 690. - Further alternatively and optionally,
endoscope 356 may be provided with an expandable distal tip/lens 790 e that is expandable distally away from and around thedistal end 790 of endoscope through which viewing is performed, as illustrated inFIGS. 22P-22Q . Thisexpandable tip 790 can be expanded to displace tissue away from viewingend 790 to provide a clear view so the that operator can more easily steer the distal end to a desired location. This arrangement does not require the use of “puffs” or impulses of pressurized insufflation gas, or any insufflation whatsoever.FIG. 22Q illustrates expandable tip/lens as an inflatable balloon which is shown in an inflated/expanded configuration.FIG. 22R shows a variant of the tip/lens 790 e in an expanded configuration, in whichballoon 790 is further reinforced bydeployable wires 791 that can be extended distally (as shown) and retracted proximally of thedistal end 790 when it is desired to have thetip 790 in a non-expanded (undeployed) configuration.Wires 791 can be biased toward the expanded configuration shown, so that they expand theballoon 790 e without the need to inflation gas or liquid into theballoon 790 e. Alternatively, balloon 70 e can be expanded by both gas or liquid (typically liquid) and the mechanical forces applied by expandingwires 791. -
FIG. 22S illustrates an alternative to use of a flexible,steerable endoscope 356 inserted and used as a guide rail for delivery of device 10 (as well as, optionally, other devices or instruments) thereover and into the abdominal cavity, as described above with regard toFIG. 22O . InFIG. 22S , aflexible wire 502 e that is similar in construction to guidewire 502, only slightly larger in cross-sectional diameter, includes one or more optical fibers extending the length thereof to facilitate viewing through thedistal end portion 502 de ofwire 502 e. Accordingly,wire 502 e can be inserted in the same manner asguidewire 502 and used for the same purposes. However, visualization can be performed as theflexible wire 502 e is being inserted and advanced, for visual verification that the distal end portion is being delivered to an intended location in the abdominal cavity. - Optionally,
wire 502 e may include an expandable tip, such as an inflatable balloon, like 70 e describe above with regard toFIG. 22Q . This balloon can be expanded to provided an enlarged visual field. By foregoing the steering mechanism of asteerable endoscope 356 and guiding thewire 502 e, assisted by visualization, into the abdominal cavity in a manner as described with regard to insertion ofguidewire 502, this allows 502 e to have a significantly smaller cross sectional area than asteerable endoscope 356. -
FIG. 23 illustrates adevice deployment tool 700 that can be used to deploydevice 10 over anchoringframe 600.Tool 700 includes ahandle 702 for manual operation by a user (e.g., surgeon) and anelongated shaft 704 extending distally therefrom.Shaft 704 in included a groove or rail that substantially matches a groove or rail offrame 600 over whichdevice 10 is to be mounted. Accordingly,device 10 slides over the groove or rail oftool 700 and can be delivered over guidewire orrod 502 into alignment with the groove or rail offrame 600 wheredevice 10 can then be pushed off of shaft (rail or groove) 704 and over the rail or groove offrame 600 to anchor theexpandable member 10 em of thedevice 10 to frame 600. One or more lumens may be provided throughshaft 704 for delivery of irrigating fluids (or other substances) and for application of suction to the distal end ofshaft 704, viaports -
FIGS. 24A-24C illustrate an accessmember attachment tool 730 and use oftool 730 for rapid attachment ofaccess member 80 to the patient 1. Accessmember attachment tool 730 includes ahandle 732 for handling and control by a user, and a workingend 736 at a distal end portion thereof. According to this approach, ananvil 738 is slid over conduit(s) 12 prior to connectingaccess member 80 to the distal end(s) of conduit(s) 12. Workingend 736 is configured to receivedaccess member 80 therein, e.g., working end may include a socket shaped and dimensioned to receiveaccess member 80 therein and to maintain the orientation of access member so as to control it during attachment to the patient. -
Anvil 738 is first delivered by manipulating (e.g., twisting and pushing) it throughopening 223 and through the opening in theabdominal muscle 127, as illustrated inFIG. 24B .Distal end 736 oftool 730 may be inserted into thefat layer 131 either before or after manipulatinganvil 738 into the desired orientation for use. Once anvil has been inserted through the opening in the abdominal muscle and manipulated to orient theanvil surface 738 s in contact with theabdominal muscle wall 127,tool 730 is used to driveaccess member 80 againstanvil surface 738 s as illustrated inFIG. 24C . An inner shaft oftool 730 clamps or otherwise engagestubing 12 and/oranvil 738 and draws them towardportion 736 whenactuator 744 is actuated.Access member 80 includes penetratingmembers 740 that extend distally from the contact surface of access member that contacts theabdominal muscle 127 as access member is driven againstanvil 738. Asaccess member 80 is driven againstanvil surface 738 s, penetratingmembers 740 are driven against theanvil surface 738 s and thereby bent over, as illustrated inFIG. 24C , thereby anchoring access member to the abdominal muscle wall. Driving ofaccess member 80 againstanvil 738 may be performed by simply pushing withhandle 732. Additionally, or alternatively, and further optionally,actuator 744 may be operably configured to deploy penetrating members distally from the contact surface ofaccess member 80 upon actuation of the actuator. - Alternative mechanisms may be used for attachment of
access member 80 to the patient 1. For example,FIG. 25A shows use of hook andloop type fasteners access member 80 to theabdominal muscle 127 of the patient 1. In the example shown, aring 747 that contains or is made of one of either hook or loop material (746 a or 746 b, respectively) is stapled or sutured to theabdominal muscle layer 127 to surround the opening in the abdominal muscle and conduit(s) 12. The contact surface of access member is provided with the other of either the hook or loop material, respectively, such that when access member is pushed againstring 747, the interlocking mechanism 746 (in this example, hook and loop materials) interlock, thereby attachingaccess member 80 to the patient. - In
FIG. 25B ,ring 747 is provided with one ormore magnets 748 b having polarity on the surface facingaccess member 80 that is opposite the polarity of the surfaces ofmagnets 748 a facingring 747.Ring 747 may be provided with anchors 749 and/or may be sutured, or adhered toabdominal muscle layer 127. By pressingaccess member 80 against the anchoredring 747,connection mechanism 748 connectsaccess member 80 to the patient 1 via the attraction forces ofmagnets -
FIGS. 25C and 25D illustrate undeployed and deployed configurations, respectively, of an access member having deployable anchors 750.Anchors 750 are extendable, for example, by collapsing external tubing using compression force. By retracting the inner tubing or shaft that is axially positioned insideanchors 750 with a distal end connected thereto, this drives anchors 750 into the extended configuration shown inFIG. 25D . That is, the functionality is like a moly-bolt.Anchors 750 include arms that are hingedly connected and which bend to expand outwardly, as they are compressed by retracting the internal tube. -
FIGS. 25E and 25F illustrate undeployed and deployed configurations, respectively, of an access member having aspring member 752 that functions to anchoraccess member 80 to the patient 1. In the undeployed configuration ofFIG. 25E ,spring member 752 is wound to as to assume a relatively small outside diameter. This wound configuration can be maintained by asafety lock 754 provided in access member that is actuatable between a locked and an unlocked position. After insertingaccess member 80 into position with respect to theabdominal muscle wall 127, so thatspring member 752 passes through the opening in the abdominal muscle and is located inside theabdominal muscle wall 127 as illustrated inFIG. 25E ,safety lock 754 is released, so thatspring member 752 unwinds to its deployed configuration, where it has a much larger outside diameter that is too large to pass back through the opening in theabdominal muscle 127, seeFIG. 25F . -
FIGS. 25G-25H show an embodiment of access member that is connectable via a snap fit that provides a clamping action betweenbase 80 b andexternal portion 80 e.Base 80 b is provided with a spacer 756 having a length about the same as the thickness of theabdominal muscle 127. The top portion of tubular spacer is provided with alip 756 a that has a outside diameter slightly greater than the inside diameter or the opening 758 a to socket 758.Base 80 b inserted through the opening in the abdominal muscle and oriented so thatcontact surface 80 sb aligns with the inner wall ofabdominal muscle 127 and spacer 756 extends out through the opening in theabdominal wall 127.External portion 80 e is then pressed againstbase 80 b with tubular spacer 756 aligned with socket 758, so thatlip 756 a snaps through opening 758 a and is retained within socket 758, thereby connectingaccess member 80 to theabdominal wall 127. - Anchoring
frame 600 may be provided with aninterlock 760 on a proximal end portion thereof, as shown inFIG. 251 . In this case, anchoringframe 600 is provided with sufficient length to extend to the location against theabdominal wall 127 where it is desired to attachaccess member 80. Interlock 760 may be provided with resilientlydeflectable teeth 762 that deform as engagement members 764 (FIG. 25J ) located onaccess member 80 are inserted therethrough. Engagement members may have threading or be otherwise formed to have alternating large and small diameter portions, so that the large diameter portions deflectteeth 762, while the small diameter portions allowteeth 762 to rebound thereagainst to form a lock relative to the adjacent large diameter portions. -
FIG. 25K shows an embodiment ofaccess member 80 that is connectable via anautomatic engagement mechanism 763 that functions like a chuck for a pneumatic tool. That is, the base portion that is inserted intra-abdominally includes a socket portion having one or more sets of spring-loaded bearings ordetents 765, and the external portion includes a tubular shaft to be inserted into the socket portion and which has one or moreannular recesses 767 configured to mate withdetents 765. Thus, when the tubular shaft of the external portion is inserted into the socket portion, the outer wall of the tubular shaft depressesdetents 765 allowing the tubular shaft to be further inserted. When aligned withannular recesses 767, detents resiliently return to their orientations shown inFIG. 25K and are received in recess(es) 767, thereby locking the two components ofaccess member 80 together on opposite sides of theabdominal muscle 127. -
FIGS. 25L-25M show another variation of an air hose type of quick connector. In either this embodiment or the embodiment ofFIG. 25K , the male and female connector parts can be reversed relative to the positions shown. In this embodiment,connector 769 may be provided either as a part ofaccess member 80, or simply as a connector for anchoringdevice 10 to theabdominal wall 127 and/or to provide a connection toconduit 12 that extends externally of the abdominal wall.Balls 765 and groove 767 function in the same way as described above with regard toFIG. 25K . However, in this instance,connector 769 includes a lockingsleeve 771 that slides overballs 765 to maintain them in the locked configuration (FIG. 25L ). Lockingsleeve 771 is retractable, as shown inFIG. 25M to allowballs 765 to deflect radially outwardly to allow insertion of the male portion of theconnector 769 into the female portion and then slidesleeve 771 back overballs 765 to lock them in position ingroove 767.Sleeve 771 may be spring biased toward the closed/locked position, wherein it can be manually retracted to the unlocked position. - As already noted,
device 10 may be implanted by a variety of different methods, including percutaneous methods (examples of which have been described in detail above and which typically do not require pressurized insufflation of the entire abdominal cavity, or generalized anesthesia, and one or more steps may be performed without direct visualization), laparoscopic methods (which typically include pressurized insufflation of the entire abdominal cavity and the patient 1 under general anesthesia), min-laparoscopic methods and open methods. In addition to anchoringdevice 10 via anchoringframe 600, or alternative thereto, other anchoring features and/or techniques may be employed. Any of the various features and/or techniques described herein may be used together, or separately, unless it use of one feature or technique would clearly preclude use of another specifically disclosed feature and technique and they would therefore not be useable together. - One such method of anchoring involves anchoring
device 10 to theabdominal wall 127 via tubing extending fromdevice 10 and through the abdominal wall. For example,conduit 12 may be used to accomplish such anchoring, as illustrated inFIG. 26A . In examples wheredevice 10 is implanted an expanded in the space along thediaphragm 116 as described above, it has been experienced, that, once expanded,expandable member 10 em maintains its position quite well in superior-inferior directions with tendency to move being more likely laterally. By anchoring device 10 e to the abdominalwall using tubing 12, this securesexpandable member 10 em from such lateral movements. Becausedevice 10 is less likely to move superiorly or inferiorly, this type of anchoring may be sufficient in itself for implantation ofdevice 10. An advantage of anchoring only by this technique is that no suturing or stapling inside the abdominal cavity is required. InFIG. 26A , alock nut 766 is threaded overtubing 12 to secureexpandable member 10 em in contact with the innerabdominal wall 127.Lock nut 766 may include a contact surface covered with tissue ingrowth material such as Dacron, polyester, or other porous material designed to encourage tissue ingrowth or may be formed entirely of a tissue ingrowth material. Further optionally,access member 80 may be configured to function as an anchor to replace the lock nut, whereinaccess member 80 can be fixed by any of the features described herein. This method of anchoring assists inpositioning device 10 and stabilizing it in its intended position. - In addition or alternative to providing tissue ingrowth enhancing material on the external side of the
abdominal muscle wall 127, tissueingrowth enhancing material 768 may be provided at the interface betweenexpandable member 10 em and the inner wall of theabdominal muscle 127, as illustrated inFIG. 26B . For example, a disk of tissueingrowth enhancing material 768 may be slid overconduit 12. Alternatively, one or more attachment tabs including tissueingrowth enhancing material 768 may be fixed todevice 10, such asexpandable member 10 em, as described in more detail below. Examples of tissue ingrowth-enhancing materials include, but are not limited to, expanded polytetrafluoroethylene (having an internodal distance typical of those materials used for vascular grafts); mesh materials made of polyester, polypropylene, or the like, typically with pores in the range of about 0.7 mm to about 1.5 mm or about 0.5 mm to about 1.2 mm; polyester having a maximum water permeability of about 1800 to about 4000 ml/cm2/min; or felts made of expanded polytetrafluoroethylene or polyester having a maximum water permeability in the range of about 550 to about 3050 ml/cm2/min. - In addition or alternative to anchoring
device 10 against an intra-abdominal structure (e.g., abdominal muscle wall or other structure) usingconduit 12,device 10 may be provided with apositioning member 770 that can be used to further position or relocatedevice 10 and assist in anchoringdevice 10 in such position or location.FIG. 26C illustrates an example of adevice 10 including a loop (similar to a belt loop, and which may be made of Dacron-reinforced tubing, for example) shaped positioning member 270. When used in a laparoscopic procedure or other procedure using multiple ports through the patient's skin and into the abdominal cavity,device 10 can be inserted through a first port. A suture ortether 59 can be looped throughpositioning member 770 and tied off to form a looped suture ortether 59. Then a surgeon or assistant can access the suture ortether 59 via an incision adjacent the port through which thedevice 10 was inserted, to hook, grasp or otherwise capture suture ortether 59 and pull it out through the incision where access was made (FIG. 26D ). For example, graspers, an elongated instrument having a hook at a distal end thereof, or other endoscopic instrument may be used to capture suture ortether 59 and pull it out of the opening though the patient's skin. This tension exerted on suture ortether 59 and pulling of the suture ortether 59 out of the patient drawsdevice 10 toward the opening through which suture or tether is drawn, thereby drawing an inferior surface ofexpandable member 10 em 1 up against theabdominal wall 127 in this example. Alternatively, tension may be applied to the suture ortether 59 as it extends from the opening through which thedevice 10 was inserted, to draw attachment tab(s) 150 up against the abdominal wall for attaching tab(s) 150 thereto. For a percutaneous procedure where only a single port is provided for delivery and implantation ofdevice 10 an additional puncture can be performed through the patient's skin and into the abdominal cavity, at a location where it is desired to draw suture ortether 59 through and to drawdevice 10 against an intra-abdominal structure. For example, an elongated needle 772 (FIG. 26E ) having a hookedslot 774 may be used to pierce the patient's skin, access the abdominal cavity, and capture suture ortether 59 in hookedslot 774.Needle 772 can then be retracted out of the patient 1 to draw suture ortether 59 out of the patient to drawdevice 10 against a structure in the abdominal cavity to anchor it there. -
FIG. 26F illustrates a step of attachingattachment tab 150 to theabdominal wall 127, according to one embodiment using a laparoscopic procedure. In this case, tension is applied to tether/suture 59 as it extends through theopening 223/port 390 a that was used to insertdevice 10 into the abdominal cavity. As tension is appliedgraspers 784 having been inserted throughport 390 d are used to manipulateattachment tab 150 to approximate it to theabdominal wall 150 for attachment thereto. Thus, tension may also be applied via thegraspers 784. Alaparoscopic stapler 786, inserted throughport 390 b is used to staple attachment tab(s) to theabdominal wall 127. Visualization of all operations can be provided viaendoscope 356 inserted throughport 390 c. It is noted that invention is not limited to the locations and number of ports shown, as the locations and numbers may vary. For example, an additional opening may be provided to insert a liver retractor for retraction of the liver during the procedure, such as was described in application Ser. No. 11/407,701 with regard toFIG. 67 . Also, the arrangement of the instruments shown may vary depending on need for the steps being performed. As one non-limiting example,stapler 786 may be inserted throughport 390 c whileendoscope 356 is inserted throughport 390 b. Further alternatively, suture/tether may be drawn through another port, as already noted above. This attachment process can be carried out in addition to fixingdevice 10 to ananchoring frame 600 according to any of the techniques described above, or alternative to it, where aframe 600 is not used. - Further optionally,
device 10 may be provided with a plurality ofpositioning members 770 such as positioning loops, for example, spaced longitudinally alongdevice 10. Two, three, four or moresuch members 770 may be provided alongexpandable member 10 em, for example.FIG. 26G shows an example ofdevice 10 having three positioningloops 770 longitudinally spaced alongexpandable member 10 em 1. By providingmultiple positioning members 770 that are longitudinally spaced, the same device can be used for patients having different anatomies that may have different positioning requirements for the expandeddevice 10 and or may have different volume requirements of a spaced to be filled bydevice 10. Depending upon theloop 770 selected by the surgeon to be used to position andanchor device 10,device 10 can be anchored, for example to theabdominal wall 127, with more or less of the surface ofexpandable member 10 em 1 drawn up against theabdominal wall 127. This in turn varies the angulation and positioning ofdevice 10 in the abdominal cavity. Typically, the surgeon will have an idea of which positioningmember 770 is to be used for the particular patient thatdevice 10 is being implanted in, for example, after studying the anatomy of the patient's abdominal cavity and structures therein, as provided by prior MRI or CT scanning for example. In such case, only onepositioning member 770 will have a suture ortether 59 looped there around to be used as described above. Alternatively, more than one, up to all of thepositioning members 770 may have a suture ortether 59 looped there around so that the surgeon can try alternative positioning with more that one positioning member, using one at a time successively and observing (such as by fluoroscopy, for example) the relative positions ofdevice 10 resulting from each use of adifferent positing member 770. The “best fit” can then be selected and used to complete the anchoring of the device. Prior to that however, the tethers orsutures 59 that are not chosen for final use in positioning are cut and removed through the opening that will be used to draw the selected tether or suture therethrough for positioning. Thus, these cut, non-selected tethers orsutures 59 are removed from the surgical site prior to use of the selected suture ortether 59 to perform attachment/anchoring ofdevice 10. - Still further, positioning
members 770 may be segmented 777 to provide multiple positioning features or channels 778 within a loop 770 (as illustrated inFIG. 26H ) ormultiple positioning members 770 may be spaced in a direction perpendicular to the longitudinal spacing (as indicated in phantom lines inFIG. 26G ) to provide further positioning control choices for orientingdevice 10 angularly about a longitudinal axis, as indicated by the direction oforientation adjustment 776 inFIG. 26G . The choice of positioningmember 770 among the longitudinally spacedmembers 770 varies the positioning about a transverse axis of device 10 (i.e., axis passing into the page and through the middle ofexpandable member 10 em 1. - To facilitate anchoring of
device 10 after positioning by positioning members,device 10 may be provided with one ormore attachment tabs 150.FIG. 26F illustrates a singlecontinuous attachment tab 150 that extends fromexpandable member 10 em 1 about a circumferentially extending portion of the surface of the inferior portion ofexpandable member 10 em 1.Attachment tab 150 may be bonded to the surface of expandable 10 em 1, such as with silicone dip layer, for example, or using room temperature vulcanizing silicone adhesive. Alternatively, unvulcanized silicone sheeting can be placed betweentab 150 andexpandable member 10 em and these layers can be vulcanized together using a heated press. Further alternatively, if the materials are made of polyurethane, a solvent bond can be made using a slurry mixture of polyurethane to bond apolyurethane tab 150 to a polyurethaneexpandable member 10 em. - Alternatively,
multiple attachment tabs 150 can be placed at locations aroundexpandable member 10 em to extend from and substantially cover areas covered by a largersingle attachment tab 150.FIG. 27A illustrates one such example of adevice 10 withmultiple attachment tabs 150, in this case, having threeattachment tabs 150. By providing multiple attachment tabs, the tabs are more easily able to conform to the structure that they are being attached to, particularly if there is some curvature or other surface shape other than planar in the structure. That is,tabs 150 can be overlapped to reduce the overall coverage of the structure to be attached to and this increases the convexity of the attachment surfaces formed bytabs 150 to better conform to a concave shape of an internal surface of the structure to be attached to (e.g., abdominal wall), or otherwise change to a surface shape to be conformed to, or spread apart to increase the convexity of the attachment surfaces formed bytabs 150, or otherwise change to a surface shape to be conformed to. The overlapping prevents folds or wrinkles that would otherwise occur with asingle tab 150 such as like that inFIG. 26F , and the spreading would just not be possible with a single tab like that shown inFIG. 26F . The use of attachment tab(s) 150 also gives the surgeon the option to not useaccess member 80 and/orconduit 12 to perform an anchoring function. This allowsaccess member 80 to be placed further away from the ribs, potentially offering the patient less discomfort, and also allowsconduit 12 to be placed so that it is not under tension to perform an anchoring function, thereby lessening the mechanical requirements forconduit 12. -
Attachment tabs 150, although typically located to extend from the inferior portion ofexpandable member 10 em, need not be so located, but can be placed to extend from any locations ondevice 10 orexpandable member 10 em. As one example,FIG. 26I shows adevice 10 having anattachment tab 150 extending from a superior portion ofexpandable member 10 em and anotherattachment tab 150 extending from an inferior portion ofexpandable member 10 em.Tab 150 will typically be provided with a tissue ingrowth material, such as any of the examples described above. In at least one embodiment, polyester-reinforced silicone sheeting forms the base structure oftab 150 and this is the material that is bonded onto a siliconeexpandable member 10 em. The tissue ingrowth-enhancing members orpatches 152 are then separately bonded onto the base structure. In at least one alternative embodiment, the base structure is made of polyester-reinforced polyurethane sheet, while the tissue ingrowth-enhancing member s orpatches 152 can be made of any of the same materials already described above.Tabs 150 can withstand a tensile force of at least about three to five pounds, on a suture looped therethrough, without tearing of the base structure or the suture ripping out of the base structure. - Tabs can be attached to an intra-abdominal structure by stapling, tacking, suturing or the like.
FIG. 28 illustrates one configuration ofattachment tab 150, wherein themain body portion 150 a includes a tissue ingrowth-enhancing material. However, amargin portion 150 b is provided that connects toexpandable member 10 em that is not tissue ingrowth promoting. Accordingly, after anchoringdevice 10 viaattachment tab 150 to a tissue structure within the abdominal cavity, the anchoring may be further fortified after a healing period by the ingrowth of tissue intomain body 150 a. However, since no tissue ingrowth occurs atmargin 150 b,device 10 can be more easily removed, if necessary, by cutting through themargin material 150 b, thereby releasingdevice 10 from the anchoredmain body portion 150 a. Further advantageously,margin portion 150 b can be made of clear material so as to also function as a “window” so that the surgeon can view through it while performing the attachment ofmain body 150 a to ensure that no bowel or other tissue not meant to be anchored to, exists betweenattachment tab 150 and the tissue intended to be anchored to, at the time of anchoring. For example,margin portion 150 b may be made of silicone or other transparent material that is biocompatible and has sufficient mechanical strength to maintain the attachment/anchoring function. -
FIG. 27B illustrates an example of a device having threeattachment tabs 150 extending from the inferior portion ofexpandable member 10 em, but where thetabs 150 are interjoined by margin portions at the side of themain bodies 150. The margin portions are separate to allowtabs 150 to be overlapped. Additionally,margins 150 b completely surround themain body portions 150 a in this embodiment. Potential suturing (or stapling, tacking, or the like) locations are indicated by thecircles 150 s shown on each of themain body portions 150 a. The circular structure shown centrally located between thetabs 150 is another tab that may include tissue ingrowth enhancing material and/or the base structure material oftabs 150. A positioning loop may be attached to the center of the circle or pass therethrough and be bonded beneath the circle, and used in a manner as described in application Ser. No. (application Ser. No. not yet assigned, Attorney's Docket No. EXPL-001CIP3, e.g., see FIGS. 22 and 23 and descriptions thereof). Alternatively or additionally, this circular structure may be a grasping feature for the surgeon to manipulate theexpandable member 10 em during the implantation process. In this case, the circular patch is bonded to the expandable member only over a central portion thereof, with a free edge or border that is not bonded, so that it can be grasped by graspers or other instrumentation. Backingstructure 10 ds may be made, for example, of a reinforced silicone sheet to help distribute the forces generated on attachment tabs anchored to the intra-abdominal structure, over a large area of theexpandable member 10 em. Thebacking structure 10 ds may be made of multiple layers of reinforced silicone with non-reinforced silicone sheeting at the margins to provide an interface withexpandable member 10 em that substantially avoids generation of stress concentrations. Thebacking structure 10 ds also provides structural support toexpandable member 10 em (e.g., to help prevent kinking) and helps define and maintain the expanded shape ofexpandable member 10 em in the expanded configuration. The substantially oval-shaped patch above the circular one is also a grasping feature. -
FIG. 27C schematically illustrates various features that may be provided for attachment ofdevice 10 within the abdominal cavity, any of which may be used individually, or in any combination with any of the other features disclosed. Any individual use or combination of these features may also be used in addition to anchoring with anchoringframe 600. “Active attachment” features or methods includes those that involve mechanical or chemical attachment of a portion of the device to the patient, including, but not limited to, sutures, tacks, staples, adhesives, etc. “Passive attachment” features or method refer to configuring a surface to enhance tissue ingrowth therein or to encourage encapsulation, for example. Thus, all or a portion ofexpandable member 10 em (and/or other component of device 10) may be provided with a roughened or “bumpy”surface 788, as such surfaces have been shown to encourage encapsulation of an implant. Also,porous surfaces 782 may be provided on any portion ofdevice 10 that is desired to be anchored, to encourage tissue ingrowth. Thus, for example,attachment tab 150 can be used solely as a passive attachment feature when it is not actively stapled, tacked or sutured to the abdominal wall, but is merely placed in apposition thereto, and includes aporous portion 782 that allows tissue to grow into it. Alternatively, attachment tab could be completely nonporous, such as made of silicone, and attached only actively, such as by stapling. Further alternatively,attachment tab 150 may function for both active and passive attachment when it is stapled, tacked, sutured or adhered to an intra-abdominal structure and also includes a porous portion that encourages tissue ingrowth. Further, any of the other components may include a tissue ingrowth surface on a part or all of such component to provide passive attachment. For passive attachment, a period of about three to about six weeks is generally sufficient to anchor a tissue ingrowth surface of the type described herein, with ingrown tissue. In one experiment a one square inch surface of such material, after three weeks implanted in a dog was found to hold eight pounds of force. The omentum may also be actively attached todevice 10 as serve as a buffer betweendevice 10 and other organs in the abdomen to reduce irritation. - Optionally, in order to assist the surgeon in properly orienting attachment tab(s) 150 for attachment to the intended intra-abdominal structure, attachment tab(s) may be provided with one or more structural members 152 (
FIG. 29A ) that are deformable, so thatattachment tabs 150 can be compacted to a compact configuration for delivery of device percutaneously or laparoscopically, but which resiliently return to their non-compacted shapes when a compacting force is no longer applied toattachment tabs 150. For example,structural member 152 may be a rib or sheet of shape memory material, such as nickel-titanium alloy or shape memory plastic, or may be made of spring steel (e.g., stainless steel). Alternatively,attachment tabs 150 may be inflatable, so that they can be expanded to a preshaped and predetermined orientation to facilitate the surgeon's placement of the attachment tabs against the tissue to be anchored to, and anchoring thetabs 150 to the tissue.Inflatable tabs 150 can have attachment features such as flanges at the borders thereof that are not inflatable so that sutures, staples, tacks, etc, can be passed therethrough to anchor thetabs 150 without deflating them. Theseinflatable tabs 150 may also include tissue ingrowth enhancing materials on portions thereof to encourage long term, permanent attachment of the tabs when tissue grows into this material. Ifmultiple attachment tabs 150 are provided, as inFIG. 29B , asingle conduit 153 may be provided to inflate/expand theattachment tabs 150, or multiple conduits may be provided. For example, aconduit 153 may be provided for the inferiorly locatedtabs 150, another conduit may feed the intermediately locatedtabs 153 and a third conduit may connect to the superiorly placedtab 150. Further alternatively, eachattachment tab 150 may be provided with adedicated conduit 153 in fluid communication therewith. -
FIGS. 29C-29E illustrate another variation of a self-expandingattachment tab 150. In this case,structural member 152 is a self-expanding wire frame configured to conform the attachment tab(s) to the intra-abdominal structure that attachment tab(s) 150 is/are intended to be anchored to.FIG. 29C illustratesattachment tab 150 in the self-expanded configuration, wherein wire-frame 152 is biased toward this configuration.Wire frame 152 may be made of spring steel (e.g., stainless steel), nickel-titanium alloy, or shape-memory polymer, for example. The self-expandingwire frame 152 may be sandwiched between layers of, or embedded in the material of the attachment tab(s), for example Dacron-reinforced silicone. -
FIG. 29D illustratesattachment tab 150 in a compressed configuration in preparation for loading into a sheath and/or insertion of device through a small opening in the patient 1.Wire frame 152 collapses into the shape shown under compressive forces applied radially inwardly ontab 150.FIG. 29E illustratesdevice 10 having been inserted into the abdominal cavity, whereuponattachment tab 150 expands via the self expansion ofwire frame 152 thereby orientingattachment tab 150 in approximation with theabdominal wall 127 and to conform to the curvature thereof for attachment thereto.Expandable member 10 em is illustrated in an expanded configuration. -
FIGS. 29F-29G show another example ofdevice 10 provided with a self expandingattachment tab 150. In this case, self-expandingmember 152 includes bands of resilient, self-expanding material such as any of those discussed above with regard towire frame 152. Self-expanding member may be sandwiched, or embedded intab 150 in a manner as also described previously.FIG. 29F showstab 150 fully expanded andexpandable member 10 em also in an expanded configuration.FIG. 31G illustrates expandable member in a contracted or deflated configuration.Self expanding member 152 in this embodiment is compressed by folding over the bands of the member towardexpandable member 10 em as shown. Conduit 12 (not shown) may pass through a central opening 152 o ofself expanding member 152 andtab 150. -
FIGS. 29H-29I illustrate another example ofdevice 10 provided with a self expandingattachment tab 150. In this case, self-expandingmember 152 includes folded bands or bows of resilient, self-expanding material, such as any of the previously mentioned materials. Bows are biased toward the folded-over configuration shown inFIG. 29H , where they provide an enlarged radius that preventstab 150 from passing back through the opening through which device was delivered into the patient and expandattachment tab 150 to conform to theabdominal wall 127 for attachment thereto.FIG. 29I showsexpandable member 10 em in a compressed configuration and self-expanding member also in a compressed configuration, in preparation for delivery ofdevice 10 through a small opening in a patient and into the abdominal cavity. In this embodiment,self expanding member 152 is compressed by applying tension to the proximal end thereof while holding the distal end relatively motionless, whereby it is pulled in the proximal direction to lengthen the self-expanding member, while straightening the bows and thus greatly reducing the radius ofself expanding member 152/attachment tab 150. Self-expanding member may be sandwiched, or embedded intab 150 in a manner as also described previously. - Further alternatively, the embodiment shown in
FIGS. 29H-29I may be made from straight bands of spring steel or other material described previously and thus be biased toward the smaller radius, collapsed configuration illustrated inFIG. 29I . In this case, the proximal and distal end rings ofstructural member 152 are provided with mating interlocking connectors 152L1 and 152L2, respectively. Thus, after insertion ofdevice 10 in the collapsed configuration shown inFIG. 29I , the proximal end connector 152L1 is pushed toward the distal end connector 152L2 while applying a pulling or tension force to the distal end connector 152L2 (for example, by applying tension to conduit 12). When connectors 152L1, 152L2 meet, they interlock, thereby maintaining structural member in the expanded configuration shown inFIG. 29H .FIG. 29J illustrates one example of connectors 152L1, 152L2, whereby one of the connectors includes resiliently deformable tangs, which are received and locked in the other of the connectors upon joining. Connectors 152L1, 152L2 are not limited to the type shown inFIG. 29J , but could be alternative types of mechanical connectors, such as arrangements designed to produce a snap fit, as would be readily apparent to those of ordinary skill in the art. - A portion of
expandable member 10 em may be customized to provide a surface shape that is tailored to better conform to an intra-abdominal structure to be anchored to. For example, for attachment to the inner surface of the anteriorabdominal muscle wall 127, theportion 10 ema of theexpandable member 10 em that contacts theabdominal wall 127 is provided to have a more flattened surface shape, relative to the contour of the remainder ofexpandable member 10 em.FIG. 30A illustrates the orientation ofexpandable member 10 em ofdevice 10 when implanted in a patient according to one embodiment of the present invention, wherein the hatchedportion 10 ema ofexpandable member 10 em indicates the portion that contacts theabdominal wall 127.Expandable member 10 em is placed anteriorly of the stomach and is oriented from an inferior and anterior portion against the anteriorabdominal wall 127 towards the spine in a posterior direction, and towards the head in the superior direction.FIG. 30B illustrates the more flattened surface conformation ofportion 10 ema relative to the curvature of the remainder ofexpandable member 10 em. Locations of optional attachment tab(s) 150 are indicated in phantom lines.Portion 10 ema is provided with a matching contour to the contour of theabdominal wall 127 in the location where it contacts theabdominal wall 127. This matching contour not only facilitates attachment of attachment tab(s) 150, but also facilitates proper orientation ofexpandable member 10 em, even when attachment tab(s) are not used to anchor at this location. - Alternatively, the
portion 10 ema that provides the surface for conforming to the abdominal structure to be anchored to (e.g., abdominal wall) may be provided on aninflatable member 10 em 3 that is expandable independently ofexpandable member 10 em (or 10 em 1 or 10 em 2) as illustrated inFIGS. 31A-31D .FIG. 31A showsinflatable member 10 em 3 in an expanded (inflated) configuration whileexpandable member 10 em is in a non-expanded or compressed configuration.FIG. 31B showsinflatable member 10 em 3 in an expanded (inflated) configuration andexpandable member 10 em in an expanded configuration.Separate access members 80 may be provided for inputting compressed liquid throughconduits expandable members 10 em and 10 em 3, respectively, as shown inFIG. 31A . Alternatively,conduits multi-channel access member 80. With bothexpandable members 10 em and 10 em 3 deflated, the members can be substantially flattened as illustrated inFIG. 31C .Expandable members 10 em and 10 em 3 can then be tightly rolled about the longitudinal axis ofdevice 10, in the direction of the arrow shown inFIG. 31C or direction opposite thereto, to form a compact, rolled device ready for delivery into a patient, seeFIG. 31D .Device 10 can be inserted in the arrangement shown, or, optionally, may be encased in a sheath (not shown) for delivery thereof. - After insertion of
device 10 though an opening in the patient and into the abdominal cavity,expandable member 10 em 3 can be expanded as shown inFIG. 31A (either before or after securement of the one ormore access members 80 to the patient) whereupon surface 10 ema closely approximates the inner anteriorabdominal wall 127.Surface 10 ema can then be attached to the abdominal wall by suturing, stapling, tacking, etc. one ormore attachment tabs 150 to the abdominal wall.Expandable member 10 em can next be expanded to fill the space for restricting expansion of the stomach (and optionally, compressing the stomach), or the patient 1 can be closed up and allowed a healing period prior to returning for expansion ofexpandable member 10 em. - To assist in orienting attachment tab(s) and
device 10 into an intended location and orientation to be implanted in,conduit 12 may be integrated with, or attached toattachment tab 150 to extend radially outward along the attachment tab. Sinceconduit 12 extends out of the body even afterdevice 10 has been inserted into the abdominal cavity, manipulation and positioning ofattachment tab 150 can be performed by pulling and/or pushing onconduit 12 from a location outside the body.FIG. 32A shows an example of adevice 10 having twoexpandable members 10 em 1, 10 em 2, wherein a conduit 12 (12 1 or 12 2, 12 2 in the example shown) for one of theexpandable members 10 em 1, 10 em 2, respectively) extends proximally fromexpandable members 10 em 1, 10 em 2, such as through an opening inattachment tab 150, and a conduit fluidly connected to the other of theexpandable members 10 em 1, 10 em 2 extends radially outward from the expandable member that it connects with, alongattachment tab 150. -
Conduit 12 may be sandwiched between layers ofattachment member 150 or may be fixed to the surface ofattachment member 150 for example, by overlaying banding strips 780 and adhering the ends of the banding strips on opposite sides ofconduit 12 toattachment tab 150, as illustrated inFIG. 32B . For example, banding strips 780 may be made of silicone or reinforced silicone (e.g., Dacron reinforced silicone) and may be adhered toattachment tab 150 using RTV (room temperature vulcanizing) silicone adhesive. As an alternative to the use of bandingstrips 780, abanding sleeve 782 may be provided that extends over a majority of the length of the radius (or distance from where attachment tab connects toexpandable member 10 em to the free edge perimeter) ofattachment tab 150, as illustrated inFIG. 32C .Banding sleeve 782 may be made of any of the same materials as bandingstrips 780 and may be adhered in the same way. - In use,
device 10 may be inserted through a smallpercutaneous opening 223, as described above, or through a port in a laparoscopic procedure, with bothconduits port 390 to capture one of the conduits (e.g.,conduit 12 1 as shown inFIG. 32D ) and draw it out of thesecond opening 390.Conduits abdominal wall 127. In the case of a percutaneous procedure, a small puncture can be made at 390, using atool 772 such as described with regard toFIG. 26E , for example, or other tool or combination of tool configured to perform a puncture and to capture aconduit 12, and the conduit can then be capture and withdrawn through theopening 390.Laparoscopic ports 390 may have a diameter of about ten to about twelve millimeters, up to about eighteen millimeters and as small as about five millimeters, although the typical size is about eight to twelve millimeters.Percutaneous opening 223 may be formed by an incision less than about seven cm, typically less than about five cm. - Alternatively,
conduits separate attachment tabs 150, as shown inFIG. 34E . By providing separate or segmented attachment features 150, this allows more flexibility in placement of theattachment tabs 150 as to anchoring location, and also may help in conforming to the tissues to be anchored to, but still provides the control of positioning and orientation of the inferior portion ofdevice 10 andattachment tab 150 that was described with regard toFIG. 32D above.Attachment tabs 150 may be separate, as shown inFIG. 32E , or this flexibility may also be provided by asegmented attachment tab 150 as illustrated inFIG. 32F , where 12 2o shows an opening through whichconduit 12 2 passes and 12 1o shows a tunnel or lumen through whichconduit 12 1 passes. If the outermost layer ofexpandable member 10 em is made of silicone, RTV silicone adhesive can be used to adhere attachment tab(s) 150 to the expandable member. One or more of theattachment tabs 150 may extend alongexpandable member 10 em, or may join withbacking support 10 ds to provide a larger surface area for force distribution. These extensions and/orbacking support 10 ds may optionally also be provided with one or more patches of tissue ingrowth-enhancing material. Further, the a portion or all of a side of expandable member, such as the anterior facing surface, as illustrated inFIG. 27B may be coated with a layer or otherwise structurally reinforced so as not to expand, or at least not expand as much as the remainder ofexpandable member 10 em, to prevent or at least reduce expansion of expandable member in the anterior direction, and thereby reduce any visible bulging on the external abdomen of the patient (i.e., skin appearance/shape outside the abdominal cavity), whileexpandable member 10 em is allowed to preferentially expand posteriorly and medially to effect filling of the space intended to be filled. - In an alternative attachment procedure,
tube FIG. 32D . However, in this alternative approach,attachment tabs 150 are not attached (at least not stapled, tacked or sutured to the abdominal wall, but they may be maintained to encourage tissue ingrowth, or a more conforming tissue ingrowth layer can be provided over an inferior portion ofexpandable member 10 em, or neither) to the abdominal wall. Rather,tubes device 10 as desired anddevice 10 is anchored viatube - In any of the procedures described herein, it may be advantageous to orient the patient on his back, with the table angled from about fifteen to about forty-five degrees, typically about thirty degrees, to elevate the head of the patient 1. This causes the organs in the abdominal cavity to shift in and inferior direction thereby providing more space in the superior portion of the abdominal cavity and adjacent the
diaphragm 116 to facilitate the insertion procedures. -
FIG. 33 illustrates a distal end portion of a flexible,endoscope 356 that may be used in a mini-laparoscopic or laparoscopic procedure to assist visualization of the placement ofdevice 10 during an implantation procedure.Endoscope 356 may be used with our without additional fluoroscopic visualization. For example, in an office setting, use ofendoscope 356 without any fluoroscopic visualization may be sufficient for a minimally invasive procedure such as described herein.Endoscope 356 includes anatraumatic lens 790 at a distal end portion thereof, with a camera or other visualization means 792 (e.g., optical fibers extending up to thelens 790 or a CCD camera placed just proximally of lens 790) to provide an image that is delivered to the proximal end ofendoscope 356 outside of the body of the patient. Theshaft 794 ofendoscope 356 is flexible, may be constructed according to existing flexible catheter technology and typically has an outside diameter of five mm or less, preferably about four mm or less, more preferably about three mm or less. The diameter ofendoscope shaft 794/lens 790 is in the range of about two to about ten mm, typically about five mm. The distal end portion ofendoscope 356 is steerable, as illustrated by the phantom lines inFIG. 33 , andendoscope 356 may be maneuvered or steered into a surgical site to provide a desired view, as well as steered, once in a desired site, to provide panning of a location in the abdomen. Steering may be controlled by wires that run along the length of viewing fibers withinshaft 794 up to thetip 790. The wires that the proximal end portion are connected to a steering mechanism that tensions the wires and causes deflections at the tip of thescope 356. For a more detailed description, see Breedveld et al., “A New, Easily Miniaturized Steerable Endoscope”, IEEE Engineering in Medicine and Biology, November/December 2005, pp. 40-47, which is hereby incorporated herein, in its entirety, by reference thereto. Alternatively,endoscope 356 may be inserted through a guide catheter for delivery of the distal end portion to a desired location. - Once the distal end of
endoscope 356 has been maneuvered into a desired viewing location, aballoon 796, that is mounted annularly aroundshaft 794 just proximal oflens 790, can be inflated to lift adjacent tissues to improve the visualization throughlens 790. - Another feature for anchoring
expandable member 10 em ofdevice 10 is illustrated inFIG. 34 . This feature includes ratcheted teeth (e.g., spacedteeth 800 and acollar 802. Theteeth 800 are spaced alongconduit 12 and annularly surround the conduit wall to radially extend outward therefrom.Teeth 800 have an outside diameter at a distal portion thereof that is larger than the inside diameter ofcollar 802, and the proximal end portions ofteeth 800 have an outside diameter that is less than the inside diameter ofcollar 802. Further,teeth 800 are deformable, and tapered to allow them to be pulled throughcollar 802. As atooth 800 passes throughcollar 800 it deforms to allow the passage, and then re-expands to its original configuration. Since the distal ends ofteeth 800 are not tapered or beveled,teeth 800 are prevented from passing back throughcollar 802 in the distal direction. Thus, upon insertion, initial placement and expansion ofexpandable member 10 em, the surgeon can next place collar 892 up against the external surface of theabdominal wall 127, as shown inFIG. 34 , and pullconduit 12 proximally therethrough to pull one or more ofteeth 800 throughcollar 802, thereby anchoringexpandable member 10 em to the abdominal wall. The surgeon can adjust the positioning ofexpandable member 10 em, according to the number ofteeth 800 that are pulled throughcollar 802, wherein theteeth 800 andcollar 802 function like a ratchet. Theconduit 12 extending proximally ofcollar 802 is connected to accessmember 80 which can also be attached to the abdominal wall at another location. This arrangement also relieves stress fromaccess member 80 and the connection ofconduit 12 withaccess member 80. - While the present invention has been described with reference to the specific embodiments thereof, it should be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process step or steps, to the objective, spirit and scope of the present invention. All such modifications are intended to be within the scope of the claims appended hereto.
Claims (17)
1-158. (canceled)
159. An implantable device for treatment of obesity, said device comprising:
an expandable main body member configured to be positioned adjacent a portion of a stomach of a patient, within the abdominal cavity of the patient; said expandable member being inflatable with pressurized fluid; and
an attachment tab extending from said expandable main body member.
160. The implantable device of claim 159 , comprising at least one said attachment tab extending from a superior portion of said expandable member.
161. The implantable device of claim 159 , comprising at least one said attachment tab extending from an inferior portion of said expandable member.
162. The implantable device of claim 159 , wherein said attachment tab comprises a material that encourages tissue ingrowth.
163. The implantable device of claim 162 , further comprising a border between said attachment tab and said expandable member, said border comprising a material that substantially prevents tissue ingrowth.
164. The implantable device of claim 159 comprising three of said attachment tabs circumferentially spaced about and extending from an inferior portion of said expandable member.
165. The implantable device of claim 159 , wherein said attachment tab comprises at least one structural member therein, said at least one structural member being deformable to facilitate passage through a small opening in a patient, and wherein said at least one structural member returns to an undeformed configuration upon entering the abdominal cavity to orient said attachment tab toward a structure in the abdominal cavity to attach said attachment tab to.
166. The implantable device of claim 159 , wherein said attachment tab is at least partially inflatable.
167. The implantable device of claim 159 , wherein said attachment tab comprises a self-expanding attachment tab that is deformable to a compact configuration for passage through a minimally invasive opening in a patient, and wherein said attachment tab self-expands upon entering the abdominal cavity.
168. The implantable device of claim 167 , wherein said self-expanding attachment tab comprises a self expanding wire frame.
169. The implantable device of claim 167 , wherein said self-expanding attachment tab comprises bands of resilient, self-expanding material.
170. The implantable device of claim 167 , wherein said self-expanding attachment tab comprises bows of resilient, self-expanding material.
171. The device of claim 159 , further comprising a conduit in fluid communication with said expandable main body member, said conduit extending proximally from said expandable main body member.
172. The device of claim 171 , wherein a portion of said conduit is sandwiched between layers of said attachment tab.
173. The device of claim 171 , wherein a portion of said conduit extends radially outward from said expandable member along said attachment tab.
174-184. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/820,249 US20070270892A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/407,701 US8070768B2 (en) | 2006-04-19 | 2006-04-19 | Devices and methods for treatment of obesity |
US83328406P | 2006-07-24 | 2006-07-24 | |
US87759506P | 2006-12-28 | 2006-12-28 | |
US11/716,985 US8342183B2 (en) | 2006-04-19 | 2007-03-10 | Devices and methods for treatment of obesity |
US11/820,249 US20070270892A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/716,985 Continuation US8342183B2 (en) | 2006-04-19 | 2007-03-10 | Devices and methods for treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070270892A1 true US20070270892A1 (en) | 2007-11-22 |
Family
ID=39321791
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/716,985 Expired - Fee Related US8342183B2 (en) | 2006-04-19 | 2007-03-10 | Devices and methods for treatment of obesity |
US11/820,411 Pending US20070250088A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,416 Pending US20070250089A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,249 Pending US20070270892A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,355 Pending US20070250087A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,417 Pending US20070250090A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US12/214,441 Abandoned US20080255602A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,515 Abandoned US20080262520A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,518 Active 2029-08-03 US8356605B2 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,514 Abandoned US20080262523A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US13/550,794 Abandoned US20120283766A1 (en) | 2006-04-19 | 2012-07-17 | Devices and Methods for Treatment of Obesity |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/716,985 Expired - Fee Related US8342183B2 (en) | 2006-04-19 | 2007-03-10 | Devices and methods for treatment of obesity |
US11/820,411 Pending US20070250088A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,416 Pending US20070250089A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
Family Applications After (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/820,355 Pending US20070250087A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US11/820,417 Pending US20070250090A1 (en) | 2006-04-19 | 2007-06-18 | Devices and methods for treatment of obesity |
US12/214,441 Abandoned US20080255602A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,515 Abandoned US20080262520A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,518 Active 2029-08-03 US8356605B2 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US12/214,514 Abandoned US20080262523A1 (en) | 2006-04-19 | 2008-06-18 | Devices and methods for treatment of obesity |
US13/550,794 Abandoned US20120283766A1 (en) | 2006-04-19 | 2012-07-17 | Devices and Methods for Treatment of Obesity |
Country Status (3)
Country | Link |
---|---|
US (11) | US8342183B2 (en) |
EP (2) | EP2079407A2 (en) |
WO (1) | WO2008085291A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010016054A1 (en) * | 2008-08-03 | 2010-02-11 | Lunguard Ltd. | Enteral feeding device, system comprising it, methods and uses thereof |
US20110009896A1 (en) * | 2008-01-29 | 2011-01-13 | Peter Forsell | Apparatus for treating obesity |
US7976554B2 (en) | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8001974B2 (en) | 2006-04-19 | 2011-08-23 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8192455B2 (en) | 2003-08-13 | 2012-06-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
WO2016053636A1 (en) | 2014-10-03 | 2016-04-07 | Gyrus Acmi, Inc., D.B.A. Olympus Surgical Technologies America | Hybrid introducer |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7695427B2 (en) | 2002-04-26 | 2010-04-13 | Torax Medical, Inc. | Methods and apparatus for treating body tissue sphincters and the like |
US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7699863B2 (en) * | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US20100081863A1 (en) * | 2008-09-30 | 2010-04-01 | Ethicon Endo-Surgery, Inc. | Methods and devices for performing gastrectomies and gastroplasties |
US20080161935A1 (en) * | 2006-09-01 | 2008-07-03 | Albrecht Thomas E | Method for inducting weight loss using a coil for insertion into a hollow body organ |
US8920305B2 (en) | 2007-01-19 | 2014-12-30 | Advanced Bariatric Technology, Llc | Vertically oriented band for stomach |
US9301826B2 (en) * | 2008-02-18 | 2016-04-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9393093B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
US9044235B2 (en) | 2008-02-18 | 2015-06-02 | Covidien Lp | Magnetic clip for implant deployment device |
US9833240B2 (en) * | 2008-02-18 | 2017-12-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9398944B2 (en) | 2008-02-18 | 2016-07-26 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US9034002B2 (en) * | 2008-02-18 | 2015-05-19 | Covidien Lp | Lock bar spring and clip for implant deployment device |
US8758373B2 (en) * | 2008-02-18 | 2014-06-24 | Covidien Lp | Means and method for reversibly connecting a patch to a patch deployment device |
US9393002B2 (en) * | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
US8162969B2 (en) | 2008-10-16 | 2012-04-24 | Obalon Therapeutics, Inc. | Intragastric device |
US20100100115A1 (en) * | 2008-10-20 | 2010-04-22 | Wilson-Cook Medical Inc. | Foam filled intragastric balloon for treating obesity |
EP4344013A2 (en) * | 2009-01-29 | 2024-03-27 | Implantica Patent Ltd. | Obesity treatment |
JP5415925B2 (en) * | 2009-03-02 | 2014-02-12 | オリンパス株式会社 | Endoscope |
US8747297B2 (en) * | 2009-03-02 | 2014-06-10 | Olympus Corporation | Endoscopic heart surgery method |
US8911392B2 (en) | 2009-04-08 | 2014-12-16 | E2, Llc | Systems and methods for treatment of obesity and type 2 diabetes |
US8403877B2 (en) * | 2009-07-01 | 2013-03-26 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
US8574184B2 (en) * | 2009-07-01 | 2013-11-05 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
US20110004146A1 (en) * | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating of Obesity and Type 2 Diabetes |
US20110004234A1 (en) * | 2009-07-01 | 2011-01-06 | Endocore Llc | Systems and Methods for Treatment of Obesity and Type 2 Diabetes |
US9295574B2 (en) | 2009-07-01 | 2016-03-29 | E2, Llc | Systems and methods for treating obesity and type 2 diabetes |
US20110004236A1 (en) * | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating Obesity and Type 2 Diabetes |
US8475401B2 (en) * | 2009-07-01 | 2013-07-02 | E2 Llc | Systems and methods for treating obesity and type 2 diabetes |
US8496608B2 (en) * | 2009-07-01 | 2013-07-30 | E2 Llc | Systems and methods for treating obesity and type 2 diabetes |
EP2481377A4 (en) * | 2009-09-22 | 2017-12-20 | Olympus Corporation | Space-securing device |
US8870898B2 (en) | 2010-01-05 | 2014-10-28 | GI Windows, Inc. | Self-assembling magnetic anastomosis device having an exoskeleton |
BR112012016666A2 (en) | 2010-01-05 | 2018-06-05 | Beacon Endoscopic Corp | methods and apparatus for magnetically induced compression anastomosis between adjacent organs. |
JP5770208B2 (en) | 2010-01-14 | 2015-08-26 | パビリオン・メディカル・イノベーションズ・リミテッド・ライアビリティ・カンパニーPavilion Medical Innovations, LLC | System and method for obesity treatment |
US8636683B2 (en) * | 2010-01-14 | 2014-01-28 | Pavilion Medical Innovations, Llc | Systems and methods for bariatric therapy |
EP2528512B1 (en) | 2010-01-29 | 2018-04-11 | Advanced Bariatric Technology, LLC | Surgical clamp |
US9233016B2 (en) * | 2010-10-18 | 2016-01-12 | Apollo Endosurgery, Inc. | Elevating stomach stimulation device |
NO3117865T3 (en) | 2011-01-21 | 2018-04-07 | ||
US20130226219A1 (en) * | 2011-01-21 | 2013-08-29 | Obalon Therapeutics, Inc. | Intragastric device |
CN104302345B (en) * | 2012-03-18 | 2019-01-01 | 特洛玛泰克解决方案私人有限公司 | A kind of equipment for entering and treating for blood vessel |
US20130261379A1 (en) * | 2012-04-02 | 2013-10-03 | Vibrynt, Inc. | Devices and Methods for the Treatment of Obesity |
WO2013176993A1 (en) * | 2012-05-19 | 2013-11-28 | G. I. Windows, Inc. | Self-assembling magnetic anastomosis device having an exoskeleton |
WO2013183058A2 (en) | 2012-06-07 | 2013-12-12 | Tulip Medical Ltd. | Expanded device |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
CN109805978B (en) | 2012-08-09 | 2022-07-26 | 高级肥胖症治疗技术公司 | Polymer overmolded bariatric clamp and method of installation |
US10137023B2 (en) | 2012-09-14 | 2018-11-27 | Medibotics Llc | Colonnade (TM) expandable intragastric food flow lumen device |
BR102013029585B1 (en) | 2012-11-20 | 2021-02-02 | Cook Medical Technologies LLC. | catheter set for applying an endoluminal sleeve and method for preparing a catheter set for delivering an endoluminal sleeve |
US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
US9662466B2 (en) * | 2013-03-15 | 2017-05-30 | Sanovas, Inc. | Imaging stylet for intubation |
CA2902644C (en) * | 2013-03-15 | 2020-09-22 | Obalon Therapeutics, Inc. | Intragastric device |
EP3091962B1 (en) | 2013-12-05 | 2022-06-08 | Epitomee Medical Ltd. | Retentive devices and systems for in-situ release of pharmaceutical active agents |
EP3171790A1 (en) | 2014-07-23 | 2017-05-31 | GI Windows Inc. | Magnetic anastomosis devices and methods of delivery |
CN116172648A (en) | 2014-08-26 | 2023-05-30 | 高级肥胖症治疗技术公司 | Bariatric clamp with suture portions, magnetic inserts and curvature |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
US20220062621A1 (en) | 2015-02-24 | 2022-03-03 | Elira, Inc. | Electrical Stimulation-Based Weight Management System |
CA2977584C (en) | 2015-02-24 | 2024-03-05 | Elira Therapeutics, Inc. | Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
EP3297545A1 (en) | 2015-05-08 | 2018-03-28 | GI Windows Inc. | Systems, devices, and methods for forming anastomoses |
US11337839B2 (en) | 2016-07-07 | 2022-05-24 | Advanced Bariatric Technology, Llc | Inflatable bariatric clamp |
WO2018085079A1 (en) | 2016-11-04 | 2018-05-11 | Obalon Therapeutics, Inc. | Pressure control system for intragastric device |
US10869689B2 (en) | 2017-05-03 | 2020-12-22 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
WO2019023279A1 (en) * | 2017-07-24 | 2019-01-31 | Advanced Bariatric Technology, Llc | Improved clamp installation tool |
US11083581B2 (en) * | 2017-12-04 | 2021-08-10 | Edwards Lifesciences Corporation | Expandable heart valve coaptation device |
CN111465351A (en) * | 2017-12-11 | 2020-07-28 | 豪洛捷公司 | Ultrasonic localization system with advanced biopsy site markers |
WO2019232527A1 (en) | 2018-06-02 | 2019-12-05 | G.I. Windows, Inc. | Systems, devices, and methods for forming anastomoses |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US20210153959A1 (en) * | 2019-11-26 | 2021-05-27 | Intuitive Surgical Operations, Inc. | Physical medical element affixation systems, methods, and materials |
US20220008068A1 (en) * | 2019-12-13 | 2022-01-13 | Dinesh Vyas | Stapler apparatus and methods for use |
US20230056943A1 (en) * | 2019-12-13 | 2023-02-23 | Dinesh Vyas | Stapler apparatus and methods for use |
US11589864B2 (en) | 2019-12-13 | 2023-02-28 | Dinesh Vyas | Stapler apparatus and methods for use |
EP4243914A1 (en) * | 2020-11-13 | 2023-09-20 | Nagajyothi, K. | Pressure induced deflatable foley's catheter |
JP2024516146A (en) | 2021-04-20 | 2024-04-12 | ジーアイ ウィンドウズ, インコーポレイテッド | Systems, devices and methods for endoscopic or laparoscopic magnetic navigation - Patents.com |
EP4285875A1 (en) * | 2022-06-02 | 2023-12-06 | Caranx Medical SAS | Device and method for partitioning an internal tissue |
Family Cites Families (286)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734299A (en) | 1956-02-14 | Igudolph | ||
US233475A (en) | 1880-10-19 | l vandermark | ||
US659422A (en) | 1900-06-12 | 1900-10-09 | George W Shidler | Surgical instrument. |
US789467A (en) | 1903-06-12 | 1905-05-09 | Stillman A West | Method of tying knots. |
US780392A (en) | 1903-09-14 | 1905-01-17 | Brown Straw Binder Company | Straw-bundle tie. |
US1461524A (en) | 1922-12-05 | 1923-07-10 | Ball And Socket Mfg Company | Cuff button |
US2607624A (en) | 1950-08-04 | 1952-08-19 | Strohm E Lippert | Telescopic sprinkler |
US2579192A (en) | 1950-08-15 | 1951-12-18 | George H Sciaroni | Suturing instrument |
US2646298A (en) | 1952-07-15 | 1953-07-21 | Joseph C Leary | Method of knot tying |
US2825592A (en) | 1954-01-06 | 1958-03-04 | Semple James Mckenzie | Portable knot tying device for smooth filaments |
US2897624A (en) | 1958-06-27 | 1959-08-04 | Frederick O Yakel | Conservation fishhooks |
US3326586A (en) | 1965-07-09 | 1967-06-20 | Robert M Frost | Snell knot tying tool |
US3470834A (en) | 1968-03-08 | 1969-10-07 | Dennison Mfg Co | Fastener attaching device |
FR1574897A (en) | 1968-05-27 | 1969-07-18 | ||
US3521918A (en) | 1968-08-14 | 1970-07-28 | Richard L Hammond | Fishline knotting fixture and cutter |
US3675639A (en) | 1970-05-11 | 1972-07-11 | Hugo S Cimber | Device for and method of temporary sterilizing a female |
US3713580A (en) * | 1970-07-14 | 1973-01-30 | J Mickleson | Animal control means |
US3664435A (en) | 1970-11-09 | 1972-05-23 | Worthington Corp Worthington C | Hydraulic hammer with automatic stopping action |
US3713680A (en) | 1971-02-09 | 1973-01-30 | S Pagano | Knot typing device for barrel knots |
US3756638A (en) | 1972-02-22 | 1973-09-04 | L Stockberger | Knot tyer |
US3873140A (en) | 1973-10-15 | 1975-03-25 | Moodus Sports Products | Fish hook holder and knot tying device |
US3931667A (en) | 1974-05-08 | 1976-01-13 | Dennison Manufacturing Company | Interlocking attachment device |
US3976079A (en) | 1974-08-01 | 1976-08-24 | Samuels Peter B | Securing devices for sutures |
US4006747A (en) | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4060089A (en) | 1975-09-03 | 1977-11-29 | United States Surgical Corporation | Surgical fastening method and device therefor |
US4133315A (en) | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
US4246893A (en) | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US4210148A (en) | 1978-11-03 | 1980-07-01 | Stivala Oscar G | Retention suture system |
DE2853289C2 (en) | 1978-12-09 | 1980-12-18 | B. Braun Melsungen Ag, 3508 Melsungen | Button for surgical use |
US4472226A (en) | 1979-10-03 | 1984-09-18 | Minnesota Mining And Manufacturing Company | Silicone gel filled prosthesis |
US4328605A (en) * | 1979-11-09 | 1982-05-11 | T-Plastech Company | Cord clamp |
US4328805A (en) | 1980-10-03 | 1982-05-11 | Akopov Ernest M | Method of suturing the organs of the gastrointestinal tract |
US4416267A (en) | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4899747A (en) | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
US6656182B1 (en) | 1982-05-20 | 2003-12-02 | John O. Hayhurst | Tissue manipulation |
US4458681A (en) | 1982-06-10 | 1984-07-10 | Hopkins Donald A | Stomach clamp for and method of proximal gastric partitioning |
US4823794A (en) | 1982-07-12 | 1989-04-25 | Pierce William S | Surgical pledget |
US4485805A (en) | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
US4493323A (en) | 1982-12-13 | 1985-01-15 | University Of Iowa Research Foundation | Suturing device and method for using same |
US4558699A (en) | 1983-01-03 | 1985-12-17 | Bashour Samuel B | Method of and apparatus for restricting the passage of food through the stomach |
US4592342A (en) | 1983-05-02 | 1986-06-03 | Salmasian Samuel S | Method for appetite suppression and weight loss maintenance and device |
DE3415680A1 (en) * | 1983-12-30 | 1985-07-11 | Dynamit Nobel Ag, 5210 Troisdorf | COMPRESSED GAS ACTUATED MECHANICAL POWER ELEMENT |
US4621640A (en) | 1984-01-09 | 1986-11-11 | Mulhollan James S | Mechanical needle carrier and method for its use |
US4750492A (en) | 1985-02-27 | 1988-06-14 | Richards Medical Company | Absorbable suture apparatus, method and installer |
US4955913A (en) | 1985-03-28 | 1990-09-11 | Robinson Walter C | Surgical tie |
US4723547A (en) | 1985-05-07 | 1988-02-09 | C. R. Bard, Inc. | Anti-obesity balloon placement system |
US4592339A (en) | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
US4696288A (en) | 1985-08-14 | 1987-09-29 | Kuzmak Lubomyr I | Calibrating apparatus and method of using same for gastric banding surgery |
US4669473A (en) | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
US4705040A (en) | 1985-11-18 | 1987-11-10 | Medi-Tech, Incorporated | Percutaneous fixation of hollow organs |
USRE34021E (en) | 1985-11-18 | 1992-08-04 | Abbott Laboratories | Percutaneous fixation of hollow organs |
US4694827A (en) | 1986-01-14 | 1987-09-22 | Weiner Brian C | Inflatable gastric device for treating obesity and method of using the same |
US4803985A (en) | 1986-02-14 | 1989-02-14 | Hill Carl W | Gastroplasty method |
US4738255A (en) | 1986-04-07 | 1988-04-19 | Biotron Labs, Inc. | Suture anchor system |
US4739758A (en) | 1986-05-19 | 1988-04-26 | Criticare Systems, Inc. | Apparatus for stomach cavity reduction |
US5123914A (en) | 1986-05-19 | 1992-06-23 | Cook Incorporated | Visceral anchor for visceral wall mobilization |
US4744365A (en) * | 1986-07-17 | 1988-05-17 | United States Surgical Corporation | Two-phase compositions for absorbable surgical devices |
US4714281A (en) | 1987-01-02 | 1987-12-22 | Peck Richard M | Device and method for tying a twisted clinch knot |
US4744364A (en) | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4898156A (en) | 1987-05-18 | 1990-02-06 | Mitek Surgical Products, Inc. | Suture anchor |
US5084061A (en) | 1987-09-25 | 1992-01-28 | Gau Fred C | Intragastric balloon with improved valve locating means |
US5304197A (en) | 1988-10-04 | 1994-04-19 | Cordis Corporation | Balloons for medical devices and fabrication thereof |
US5002550A (en) | 1989-06-06 | 1991-03-26 | Mitek Surgical Products, Inc. | Suture anchor installation tool |
DE69029141T2 (en) | 1989-09-08 | 1997-04-10 | Boston Scient Corp | ANGIOPLASTY WITH LOW PHYSIOLOGICAL STRESS |
US5454365A (en) | 1990-11-05 | 1995-10-03 | Bonutti; Peter M. | Mechanically expandable arthroscopic retractors |
US5269809A (en) | 1990-07-02 | 1993-12-14 | American Cyanamid Company | Locking mechanism for use with a slotted suture anchor |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5033481A (en) | 1990-10-12 | 1991-07-23 | Inamed Development Company | Intraoperative or interoperative longitudinal tissue expander |
US5129912B2 (en) | 1991-01-07 | 2000-01-11 | Urohealth Systems Inc | Device and method for applying suture |
US5188104A (en) | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5100421A (en) | 1991-02-05 | 1992-03-31 | Cyprus Endosurgical Tools, Inc. | Christoudias curved needle suture assembly |
US5112310A (en) | 1991-02-06 | 1992-05-12 | Grobe James L | Apparatus and methods for percutaneous endoscopic gastrostomy |
US5405352A (en) | 1991-04-09 | 1995-04-11 | Weston; Peter V. | Suture knot, method for its formation and use, and knot forming apparatus |
US5217470A (en) | 1991-04-29 | 1993-06-08 | Weston Peter V | Apparatuses and methods for formation and use of a slipknot as a surgical suture knot |
US5258015A (en) | 1991-05-03 | 1993-11-02 | American Cyanamid Company | Locking filament caps |
US5234454A (en) | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
EP0536610B1 (en) | 1991-10-11 | 1997-09-03 | Angiomed GmbH & Co. Medizintechnik KG | Stenosis dilatation device |
US5151086A (en) | 1991-10-22 | 1992-09-29 | The Regents Of The University Of California | Laparoscopic tube placement method |
US5433721A (en) * | 1992-01-17 | 1995-07-18 | Ethicon, Inc. | Endoscopic instrument having a torsionally stiff drive shaft for applying fasteners to tissue |
US5259399A (en) | 1992-03-02 | 1993-11-09 | Alan Brown | Device and method of causing weight loss using removable variable volume intragastric bladder |
DK0637323T3 (en) | 1992-04-24 | 1999-05-25 | Polymer Technology Group Inc | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeation of molecules with a predetermined size |
IT1260485B (en) | 1992-05-29 | 1996-04-09 | PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT | |
US5246456A (en) | 1992-06-08 | 1993-09-21 | Wilkinson Lawrence H | Fenestrated gastric pouch |
US5292344A (en) | 1992-07-10 | 1994-03-08 | Douglas Donald D | Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port |
US5364408A (en) | 1992-09-04 | 1994-11-15 | Laurus Medical Corporation | Endoscopic suture system |
US5334200A (en) | 1993-03-02 | 1994-08-02 | Lanny L. Johnson | Suture knot making device and method for use |
US6162234A (en) | 1993-03-23 | 2000-12-19 | Freedland; Yosef | Adjustable button cinch anchor orthopedic fastener |
US5549621A (en) | 1993-05-14 | 1996-08-27 | Byron C. Sutherland | Apparatus and method for performing vertical banded gastroplasty |
US5601604A (en) | 1993-05-27 | 1997-02-11 | Inamed Development Co. | Universal gastric band |
US5716368A (en) | 1993-06-02 | 1998-02-10 | General Surgical Innovations, Inc. | Knotmaker with curved elongate member used in tying a ligature |
US5472446A (en) | 1993-06-02 | 1995-12-05 | De La Torre; Roger A. | Surgical instrument for tying a knot in a length of suture at a remote location |
US5391182A (en) | 1993-08-03 | 1995-02-21 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5354271A (en) | 1993-08-05 | 1994-10-11 | Voda Jan K | Vascular sheath |
US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5507754A (en) | 1993-08-20 | 1996-04-16 | United States Surgical Corporation | Apparatus and method for applying and adjusting an anchoring device |
US5536273A (en) | 1993-12-09 | 1996-07-16 | Lehrer; Theodor | Apparatus and method of extracorporeally applying and locking laparoscopic suture and loop ligatures |
US5406352A (en) * | 1993-12-14 | 1995-04-11 | Eastman Kodak Company | Photographic film segment flattening apparatus |
US6045496A (en) | 1994-04-15 | 2000-04-04 | Allegheny-Singer Research Institute | Occluder device and method of making |
US5545178A (en) | 1994-04-29 | 1996-08-13 | Kensey Nash Corporation | System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating |
US5499747A (en) * | 1994-05-16 | 1996-03-19 | Quennessen; Bernard R. | Retractable carrier for, and in combination with, a vial-type fluid dispenser |
US5470337A (en) | 1994-05-17 | 1995-11-28 | Moss; Gerald | Surgical fastener |
US5573540A (en) | 1994-07-18 | 1996-11-12 | Yoon; Inbae | Apparatus and method for suturing an opening in anatomical tissue |
US5545171A (en) | 1994-09-22 | 1996-08-13 | Vidamed, Inc. | Anastomosis catheter |
US5480406A (en) | 1994-10-07 | 1996-01-02 | United States Surgical Corporation | Method of employing surgical suturing apparatus to tie knots |
JP3085631B2 (en) * | 1994-10-19 | 2000-09-11 | 日本アイ・ビー・エム株式会社 | Speech synthesis method and system |
US5554162A (en) | 1994-12-02 | 1996-09-10 | Delange; Gregory S. | Method and device for surgically joining luminal structures |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5601581A (en) * | 1995-05-19 | 1997-02-11 | General Surgical Innovations, Inc. | Methods and devices for blood vessel harvesting |
US6102922A (en) | 1995-09-22 | 2000-08-15 | Kirk Promotions Limited | Surgical method and device for reducing the food intake of patient |
US5647836A (en) | 1995-09-28 | 1997-07-15 | Blake, Iii; Joseph W. | Method and means for treating female urinary incontinence |
US5626614A (en) | 1995-12-22 | 1997-05-06 | Applied Medical Resources Corporation | T-anchor suturing device and method for using same |
US5690691A (en) | 1996-05-08 | 1997-11-25 | The Center For Innovative Technology | Gastro-intestinal pacemaker having phased multi-point stimulation |
US6013053A (en) | 1996-05-17 | 2000-01-11 | Qlt Photo Therapeutics Inc. | Balloon catheter for photodynamic therapy |
US5830217A (en) * | 1996-08-09 | 1998-11-03 | Thomas J. Fogarty | Soluble fixation device and method for stent delivery catheters |
US6080160A (en) | 1996-12-04 | 2000-06-27 | Light Sciences Limited Partnership | Use of shape memory alloy for internally fixing light emitting device at treatment site |
US5961440A (en) | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5846254A (en) | 1997-04-08 | 1998-12-08 | Ethicon Endo-Surgery, Inc. | Surgical instrument for forming a knot |
US6120539A (en) | 1997-05-01 | 2000-09-19 | C. R. Bard Inc. | Prosthetic repair fabric |
US5938669A (en) | 1997-05-07 | 1999-08-17 | Klasamed S.A. | Adjustable gastric banding device for contracting a patient's stomach |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
AUPO787897A0 (en) | 1997-07-14 | 1997-08-07 | Cardiac Crc Nominees Pty Limited | Silicon-containing chain extenders |
ATE426430T1 (en) | 1997-07-16 | 2009-04-15 | Metacure N V | DEVICE FOR CONTROLLING A SMOOTH MUSCLE |
US5993473A (en) * | 1997-11-19 | 1999-11-30 | Chan; Yung C. | Expandable body device for the gastric cavity and method |
US5931788A (en) | 1997-12-05 | 1999-08-03 | Keen; Richard R. | Method and apparatus for imaging internal organs and vascular structures through the gastrointestinal wall |
AUPP268898A0 (en) | 1998-03-31 | 1998-04-23 | Cardiac Crc Nominees Pty Limited | High modulus polyurethane compositions |
US5971447A (en) | 1998-04-15 | 1999-10-26 | Steck, Iii; William F | Fisherman's knot tying device |
US6143006A (en) | 1998-04-18 | 2000-11-07 | Chan; Kwan-Ho | Apparatus and method for tying and tensioning knots |
US6113609A (en) | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US5951590A (en) | 1998-06-09 | 1999-09-14 | Goldfarb; Michael A. | Soft tissue suture anchor |
US6488691B1 (en) | 1998-06-24 | 2002-12-03 | Brendan J. Carroll | Laparascopic incision closure device |
US6067991A (en) | 1998-08-13 | 2000-05-30 | Forsell; Peter | Mechanical food intake restriction device |
US6460543B1 (en) * | 1998-08-13 | 2002-10-08 | Obtech Medical Ag | Non-injection port food intake restriction device |
DE69931800T2 (en) | 1998-10-28 | 2007-07-12 | Cellon S.A. | STRUCTURED AND POROUS SILICONE RUBBER |
US6097984A (en) | 1998-11-25 | 2000-08-01 | Medtronic, Inc. | System and method of stimulation for treating gastro-esophageal reflux disease |
DE69931018T2 (en) | 1998-12-30 | 2006-11-23 | Ethicon, Inc. | Thread belay device |
US6312405B1 (en) | 1999-02-02 | 2001-11-06 | American Medical Systems, Inc. | Self-sealing detachable balloon |
US8137364B2 (en) | 2003-09-11 | 2012-03-20 | Abbott Laboratories | Articulating suturing device and method |
US6684104B2 (en) | 1999-04-14 | 2004-01-27 | Transneuronix, Inc. | Gastric stimulator apparatus and method for installing |
AU4327599A (en) | 1999-06-02 | 2000-12-28 | Bioenterics Corporation | Pelvic displacement prosthesis for radioprotection of the small bowel |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6506196B1 (en) | 1999-06-22 | 2003-01-14 | Ndo Surgical, Inc. | Device and method for correction of a painful body defect |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US7160312B2 (en) | 1999-06-25 | 2007-01-09 | Usgi Medical, Inc. | Implantable artificial partition and methods of use |
US20040122456A1 (en) | 2002-12-11 | 2004-06-24 | Saadat Vahid C. | Methods and apparatus for gastric reduction |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7618426B2 (en) | 2002-12-11 | 2009-11-17 | Usgi Medical, Inc. | Apparatus and methods for forming gastrointestinal tissue approximations |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
CA2379441C (en) | 1999-08-12 | 2009-11-24 | Potencia Medical Ag | Stoma opening forming apparatus |
US20030208212A1 (en) | 1999-12-07 | 2003-11-06 | Valerio Cigaina | Removable gastric band |
US6600953B2 (en) | 2000-12-11 | 2003-07-29 | Impulse Dynamics N.V. | Acute and chronic electrical signal therapy for obesity |
US20010010005A1 (en) | 2000-01-24 | 2001-07-26 | Kammerer Gene W. | Meniscal repair device |
US6475136B1 (en) | 2000-02-14 | 2002-11-05 | Obtech Medical Ag | Hydraulic heartburn and reflux treatment |
MXPA00001922A (en) | 2000-02-24 | 2002-03-08 | De Hayos Garza Andres | Percutaneous intra-gastric balloon catheter for obesity treatment. |
US6869395B2 (en) | 2000-05-15 | 2005-03-22 | C. R. Bard, Inc. | Endoscopic accessory attachment mechanism |
DE10032248B4 (en) * | 2000-07-03 | 2005-02-17 | Xignal Technologies Ag | Controllable power source |
US7033373B2 (en) | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
US6934589B2 (en) * | 2000-12-29 | 2005-08-23 | Medtronic, Inc. | System and method for placing endocardial leads |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US6770076B2 (en) | 2001-02-12 | 2004-08-03 | Opus Medical, Inc. | Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device |
EP1366716B1 (en) | 2001-03-09 | 2005-04-27 | José Rafael Garza Alvarez | Intragastric balloon assembly |
US6535764B2 (en) | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
US6558400B2 (en) | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US20020188354A1 (en) | 2001-06-12 | 2002-12-12 | Peghini Paolo Lino | Device to treat obesity by obstructing gastric outlet |
US6511490B2 (en) | 2001-06-22 | 2003-01-28 | Antoine Jean Henri Robert | Gastric banding device and method |
US6627206B2 (en) | 2001-07-25 | 2003-09-30 | Greg A. Lloyd | Method and apparatus for treating obesity and for delivering time-released medicaments |
US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7104949B2 (en) | 2001-08-31 | 2006-09-12 | Ams Research Corporation | Surgical articles for placing an implant about a tubular tissue structure and methods |
US6773436B2 (en) | 2001-09-28 | 2004-08-10 | Depuy Mitek, Inc. | Absorbable bone anchor |
ITMI20012046A1 (en) | 2001-10-03 | 2003-04-03 | Sintesi S R L | ANTI-REFLUX GASTRO-ESOPHAGEAL VALVE PROSTHESIS |
US6755869B2 (en) | 2001-11-09 | 2004-06-29 | Boston Scientific Corporation | Intragastric prosthesis for the treatment of morbid obesity |
FR2834202B1 (en) | 2001-12-28 | 2004-03-19 | Cie Euro Etude Rech Paroscopie | MULTI-POCKET INTRA-GASTRIC BALLOON, SURGICAL EXPANSION DEVICE FOR SAID BALLOON AND MANUFACTURING METHOD THEREOF |
US6790213B2 (en) | 2002-01-07 | 2004-09-14 | C.R. Bard, Inc. | Implantable prosthesis |
US7402166B2 (en) | 2002-02-15 | 2008-07-22 | A&P Feigl Family Limited Partnership | Devices and methods for positioning sutures |
ES2254792T3 (en) | 2002-03-14 | 2006-06-16 | Jeffrey E. Yeung | SUTURE ANCHORAGE AND APPROXIMATION DEVICE. |
WO2003095015A1 (en) | 2002-05-09 | 2003-11-20 | Applied Medical Resources Corporation | Balloon system and methods for treating obesity |
EP1509142B8 (en) | 2002-05-17 | 2012-03-07 | Tyco Healthcare Group LP | Endoscopic organ retraction system and method of using the same |
KR100496650B1 (en) * | 2002-06-27 | 2005-06-22 | 주식회사 한화 | Flow force compensating spool valve and hydraulic valve, pneumatic valve, three-way control valve, four-way control valve using it |
US6773440B2 (en) | 2002-07-02 | 2004-08-10 | Satiety, Inc. | Method and device for use in tissue approximation and fixation |
US6746460B2 (en) | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
US7033384B2 (en) | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
US6981978B2 (en) | 2002-08-30 | 2006-01-03 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
AU2003272288A1 (en) | 2002-09-06 | 2004-03-29 | C.R. Bard, Inc. | Tissue capturing devices |
EP1572007B1 (en) | 2002-09-09 | 2011-12-28 | Brian Kelleher | Device for endoluminal therapy |
DE10243132B4 (en) | 2002-09-17 | 2006-09-14 | Biocer Entwicklungs Gmbh | Anti-infective, biocompatible titanium oxide coatings for implants and methods of making them |
US7070591B2 (en) | 2002-09-17 | 2006-07-04 | Transoma Medical, Inc. | Vascular access port with physiological sensor |
US20040068224A1 (en) | 2002-10-02 | 2004-04-08 | Couvillon Lucien Alfred | Electroactive polymer actuated medication infusion pumps |
US7220237B2 (en) | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7037344B2 (en) | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US8070743B2 (en) | 2002-11-01 | 2011-12-06 | Valentx, Inc. | Devices and methods for attaching an endolumenal gastrointestinal implant |
US7794447B2 (en) | 2002-11-01 | 2010-09-14 | Valentx, Inc. | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US9060844B2 (en) | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US6656194B1 (en) | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
US20040133147A1 (en) | 2002-11-06 | 2004-07-08 | Woo Sang Hoon | Intestinal bypass device to treat obesity |
US7016730B2 (en) | 2002-11-15 | 2006-03-21 | Cardiac Pacemakers, Inc. | Method of operating implantable medical devices to prolong battery life |
US7942898B2 (en) | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
US7444183B2 (en) | 2003-02-03 | 2008-10-28 | Enteromedics, Inc. | Intraluminal electrode apparatus and method |
US7291160B2 (en) | 2003-03-17 | 2007-11-06 | Delegge Rebecca | Intragastric catheter |
US20060058829A1 (en) | 2003-03-19 | 2006-03-16 | Sampson Douglas C | Intragastric volume-occupying device |
US7320701B2 (en) | 2003-06-02 | 2008-01-22 | Linvatec Corporation | Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor |
JP4166632B2 (en) | 2003-06-06 | 2008-10-15 | オリンパス株式会社 | Suture device |
US7553298B2 (en) | 2003-12-19 | 2009-06-30 | Ethicon Endo-Surgery, Inc. | Implantable medical device with cover and method |
US7862546B2 (en) | 2003-06-16 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Subcutaneous self attaching injection port with integral moveable retention members |
BR0302240B8 (en) | 2003-06-24 | 2013-02-19 | semi-stationary balloon in the gastric antrum with anchor rod for weight loss induction in humans. | |
US9498366B2 (en) | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
WO2005018417A2 (en) | 2003-08-13 | 2005-03-03 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
CN1882370B (en) | 2003-09-15 | 2010-05-26 | 阿勒根公司 | Implantable device fastening system |
US7144400B2 (en) | 2003-10-01 | 2006-12-05 | Ethicon Endo-Surgery, Inc. | Gastric band introduction device |
US20050247320A1 (en) | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US7282050B2 (en) | 2003-10-31 | 2007-10-16 | Medtronic, Inc. | Ablation of exterior of stomach to treat obesity |
US20050131325A1 (en) | 2003-12-16 | 2005-06-16 | How-Lun Chen | Flexible injection port |
US20050197687A1 (en) | 2004-03-02 | 2005-09-08 | Masoud Molaei | Medical devices including metallic films and methods for making same |
WO2006049725A2 (en) | 2004-03-23 | 2006-05-11 | Minimus Surgical Systems | Surgical systems and devices to enhance gastric restriction therapies |
US20070233170A1 (en) | 2004-03-23 | 2007-10-04 | Michael Gertner | Extragastric Balloon |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US8343031B2 (en) * | 2004-03-23 | 2013-01-01 | Michael Gertner | Obesity treatment systems |
US20080071306A1 (en) | 2004-03-23 | 2008-03-20 | Michael Gertner | Extragastric Balloon With Attachment Tabs |
US20060264699A1 (en) | 2004-10-27 | 2006-11-23 | Michael Gertner | Extragastric minimally invasive methods and devices to treat obesity |
US20060195139A1 (en) | 2004-03-23 | 2006-08-31 | Michael Gertner | Extragastric devices and methods for gastroplasty |
US20080147002A1 (en) | 2004-03-23 | 2008-06-19 | Michael Eric Gertner | Obesity treatment systems |
US7946976B2 (en) | 2004-03-23 | 2011-05-24 | Michael Gertner | Methods and devices for the surgical creation of satiety and biofeedback pathways |
US7841978B2 (en) | 2004-03-23 | 2010-11-30 | Michael Gertner | Methods and devices for to treatment of obesity |
US20080300618A1 (en) * | 2004-03-23 | 2008-12-04 | Michael Eric Gertner | Obesity treatment systems |
US20050228415A1 (en) | 2004-03-23 | 2005-10-13 | Michael Gertner | Methods and devices for percutaneous, non-laparoscopic treatment of obesity |
WO2005097012A2 (en) | 2004-03-26 | 2005-10-20 | Satiety, Inc. | Systems and methods for treating obesity |
US20050222638A1 (en) | 2004-03-30 | 2005-10-06 | Steve Foley | Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders |
US20060282081A1 (en) | 2004-04-16 | 2006-12-14 | Fanton Gary S | Apparatus and method for securing tissue to bone with a suture |
WO2005105003A1 (en) | 2004-04-26 | 2005-11-10 | Synecor, Llc | Restrictive and/or obstructive implant for inducing weight loss |
US20050240155A1 (en) | 2004-04-27 | 2005-10-27 | Conlon Sean P | Surgically implantable injection port having a centered catheter connection tube |
EP1744804A4 (en) | 2004-05-03 | 2009-11-04 | Fulfillium Inc | Method and system for gastric volume control |
US8012201B2 (en) | 2004-05-05 | 2011-09-06 | Direct Flow Medical, Inc. | Translumenally implantable heart valve with multiple chamber formed in place support |
US7785348B2 (en) | 2004-05-14 | 2010-08-31 | Ethicon Endo-Surgery, Inc. | Devices and methods of locking and cutting a suture in a medical procedure |
US7334822B1 (en) | 2004-05-20 | 2008-02-26 | Hines Jr Robert S | Bimini twist knot tying device |
US7112186B2 (en) | 2004-05-26 | 2006-09-26 | Shah Tilak M | Gastro-occlusive device |
US7351240B2 (en) | 2004-05-28 | 2008-04-01 | Ethicon Endo—Srugery, Inc. | Thermodynamically driven reversible infuser pump for use as a remotely controlled gastric band |
US7374565B2 (en) | 2004-05-28 | 2008-05-20 | Ethicon Endo-Surgery, Inc. | Bi-directional infuser pump with volume braking for hydraulically controlling an adjustable gastric band |
US7390294B2 (en) | 2004-05-28 | 2008-06-24 | Ethicon Endo-Surgery, Inc. | Piezo electrically driven bellows infuser for hydraulically controlling an adjustable gastric band |
US20050148956A1 (en) | 2004-06-01 | 2005-07-07 | Conlon Sean P. | Surgically implantable injection port having an improved fastener |
US20050283172A1 (en) | 2004-06-16 | 2005-12-22 | Conlon Sean P | Method of assembling an adjustable band |
US20060089646A1 (en) | 2004-10-26 | 2006-04-27 | Bonutti Peter M | Devices and methods for stabilizing tissue and implants |
US20060106288A1 (en) | 2004-11-17 | 2006-05-18 | Roth Alex T | Remote tissue retraction device |
WO2006063593A2 (en) | 2004-12-14 | 2006-06-22 | Rune Wessel Weltlesen | A system and a method for treating of obesity by use of an intragastric balloon |
US7601162B2 (en) | 2005-01-14 | 2009-10-13 | Ethicon Endo-Surgery, Inc. | Actuator for an implantable band |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
AT501281B8 (en) * | 2005-04-11 | 2007-02-15 | Wolfgang Dr Lechner | TAXABLE MAGNETIC BAND |
US7310557B2 (en) | 2005-04-29 | 2007-12-18 | Maschino Steven E | Identification of electrodes for nerve stimulation in the treatment of eating disorders |
US20060253131A1 (en) | 2005-05-03 | 2006-11-09 | Endogastric Solutions, Inc. | Tissue fixation assemblies providing single stroke deployment |
AU2006323195A1 (en) | 2005-05-10 | 2007-06-14 | Michael Gertner | Obesity treatment systems |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
DE102005027809A1 (en) * | 2005-06-15 | 2006-12-28 | Q Medial International Ag | Closing device for hollow organs |
WO2007017880A2 (en) | 2005-08-11 | 2007-02-15 | Stimplant Ltd. | Implantable device for obesity prevention |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US20070073318A1 (en) | 2005-09-26 | 2007-03-29 | Endogastric Solutions, Inc. | Apparatus for manipulating and fastening stomach tissue to treat gastroesophageal reflux disease |
US20070073323A1 (en) | 2005-09-26 | 2007-03-29 | Endogastric Solutions, Inc. | Apparatus for manipulating and fastening stomach tissue to treat gastroesophageal reflux disease |
CA2623948A1 (en) | 2005-09-27 | 2007-04-05 | Synecor, Llc | Transgastric surgical devices and procedures |
US20070255308A1 (en) | 2005-09-27 | 2007-11-01 | Williams Michael S | Procedural cannula for transgastric surgical procedures |
US7509175B2 (en) | 2006-08-03 | 2009-03-24 | Intrapace, Inc. | Method and devices for stimulation of an organ with the use of a transectionally placed guide wire |
US20070088373A1 (en) | 2005-10-18 | 2007-04-19 | Endogastric Solutions, Inc. | Invaginator for gastroesophageal flap valve restoration device |
US20070112363A1 (en) | 2005-11-15 | 2007-05-17 | Endogastric Solutions, Inc. | Apparatus including multiple invaginators for restoring a gastroesophageal flap valve and method |
US20070112385A1 (en) | 2005-11-15 | 2007-05-17 | Conlon Sean P | Expandable suture anchor |
EP2004243A4 (en) | 2005-12-01 | 2009-12-16 | Ndo Surgical Inc | Devices and methods for endoluminal gastric restriction and tissue manipulation |
US20070129738A1 (en) | 2005-12-01 | 2007-06-07 | Endogastric Solutions, Inc. | Apparatus and method for concurrently forming a gastroesophageal valve and tightening the lower esophageal sphincter |
WO2007075978A2 (en) | 2005-12-22 | 2007-07-05 | Wilson-Cook Medical Inc. | Coiled intragastric member for treating obesity |
US20070255317A1 (en) | 2006-03-22 | 2007-11-01 | Fanton Gary S | Suture passer devices and uses thereof |
ES2592316T3 (en) | 2006-03-28 | 2016-11-29 | Spatz-Fgia Inc | Floating gastrointestinal anchor |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) * | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8870916B2 (en) | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
FR2903866B1 (en) * | 2006-07-21 | 2009-03-20 | Salomon Sa | RESPIRO-SEALED SHOE |
US20080109027A1 (en) | 2006-08-01 | 2008-05-08 | Fulfillium, Inc. | Method and system for gastric volume control |
US9788825B2 (en) | 2006-08-04 | 2017-10-17 | Depuy Mitek, Llc | Suture anchor with relief mechanism |
US20080058710A1 (en) | 2006-08-15 | 2008-03-06 | Wilk Peter J | Surgical kit, closure device, and associated method |
US9326877B2 (en) | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
JP2010505543A (en) | 2006-10-03 | 2010-02-25 | アルレ メディカル,インコーポレイテッド | Minimally invasive tissue support |
US20080312729A1 (en) | 2006-10-04 | 2008-12-18 | Michael Laufer | Methods of tissue reconfiguration |
US7674275B2 (en) | 2006-10-05 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Suture anchor |
US20080086082A1 (en) | 2006-10-06 | 2008-04-10 | Brooks Jeffrey S | Radiopaque marking to detect balloon deflation |
US8702729B2 (en) | 2006-10-13 | 2014-04-22 | Boston Scientific Scimed, Inc. | Placing multiple sutures |
FR2907665B1 (en) | 2006-10-31 | 2009-04-17 | Cie Euro Etude Rech Paroscopie | IMPLANTABLE MEDICAL DEVICE WITH PRESSURE LIMITER |
US20080167519A1 (en) | 2007-01-10 | 2008-07-10 | Pascal St-Germain | Prosthetic repair patch with integrated sutures |
US20080172074A1 (en) | 2007-01-16 | 2008-07-17 | Endogastric Solutions, Inc. | Transesophageal gastric reduction method and device for practicing same |
-
2007
- 2007-03-10 US US11/716,985 patent/US8342183B2/en not_active Expired - Fee Related
- 2007-06-18 US US11/820,411 patent/US20070250088A1/en active Pending
- 2007-06-18 US US11/820,416 patent/US20070250089A1/en active Pending
- 2007-06-18 US US11/820,249 patent/US20070270892A1/en active Pending
- 2007-06-18 US US11/820,355 patent/US20070250087A1/en active Pending
- 2007-06-18 US US11/820,417 patent/US20070250090A1/en active Pending
- 2007-12-14 WO PCT/US2007/025614 patent/WO2008085291A2/en active Application Filing
- 2007-12-14 EP EP07862929A patent/EP2079407A2/en not_active Withdrawn
- 2007-12-14 EP EP12152950A patent/EP2449982A3/en not_active Withdrawn
-
2008
- 2008-06-18 US US12/214,441 patent/US20080255602A1/en not_active Abandoned
- 2008-06-18 US US12/214,515 patent/US20080262520A1/en not_active Abandoned
- 2008-06-18 US US12/214,518 patent/US8356605B2/en active Active
- 2008-06-18 US US12/214,514 patent/US20080262523A1/en not_active Abandoned
-
2012
- 2012-07-17 US US13/550,794 patent/US20120283766A1/en not_active Abandoned
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8192455B2 (en) | 2003-08-13 | 2012-06-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compressive device for percutaneous treatment of obesity |
US8356605B2 (en) | 2006-04-19 | 2013-01-22 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8342183B2 (en) | 2006-04-19 | 2013-01-01 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US7976554B2 (en) | 2006-04-19 | 2011-07-12 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8001974B2 (en) | 2006-04-19 | 2011-08-23 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8187297B2 (en) | 2006-04-19 | 2012-05-29 | Vibsynt, Inc. | Devices and methods for treatment of obesity |
US8353925B2 (en) | 2006-04-19 | 2013-01-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8585733B2 (en) | 2006-04-19 | 2013-11-19 | Vibrynt, Inc | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8460321B2 (en) | 2006-04-19 | 2013-06-11 | Vibrynt, Inc. | Devices, tools and methods for performing minimally invasive abdominal surgical procedures |
US8398668B2 (en) | 2006-04-19 | 2013-03-19 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US8556925B2 (en) | 2007-10-11 | 2013-10-15 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US9681874B2 (en) * | 2008-01-29 | 2017-06-20 | Peter Forsell | Apparatus for treating obesity |
US20110009896A1 (en) * | 2008-01-29 | 2011-01-13 | Peter Forsell | Apparatus for treating obesity |
US20110130650A1 (en) * | 2008-08-03 | 2011-06-02 | Lunguard Ltd. | Nasogastric and orogastric feeding devices, system comprising them, methods and uses thereof |
US8876762B2 (en) | 2008-08-03 | 2014-11-04 | Lunguard Ltd. | Nasogastric and orogastric feeding devices, system comprising them, methods and uses thereof |
WO2010016054A1 (en) * | 2008-08-03 | 2010-02-11 | Lunguard Ltd. | Enteral feeding device, system comprising it, methods and uses thereof |
US8382775B1 (en) | 2012-01-08 | 2013-02-26 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
US9155528B2 (en) | 2012-01-08 | 2015-10-13 | Vibrynt, Inc. | Methods, instruments and devices for extragastic reduction of stomach volume |
US9314362B2 (en) | 2012-01-08 | 2016-04-19 | Vibrynt, Inc. | Methods, instruments and devices for extragastric reduction of stomach volume |
WO2016053636A1 (en) | 2014-10-03 | 2016-04-07 | Gyrus Acmi, Inc., D.B.A. Olympus Surgical Technologies America | Hybrid introducer |
Also Published As
Publication number | Publication date |
---|---|
US20070250088A1 (en) | 2007-10-25 |
EP2449982A2 (en) | 2012-05-09 |
US20070250102A1 (en) | 2007-10-25 |
EP2079407A2 (en) | 2009-07-22 |
US20070250089A1 (en) | 2007-10-25 |
US20070250090A1 (en) | 2007-10-25 |
US20070250087A1 (en) | 2007-10-25 |
US20080262523A1 (en) | 2008-10-23 |
WO2008085291A3 (en) | 2008-10-23 |
WO2008085291A2 (en) | 2008-07-17 |
US8356605B2 (en) | 2013-01-22 |
US8342183B2 (en) | 2013-01-01 |
US20120283766A1 (en) | 2012-11-08 |
EP2449982A3 (en) | 2012-09-12 |
US20080262520A1 (en) | 2008-10-23 |
US20080255602A1 (en) | 2008-10-16 |
US20080262521A1 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8356605B2 (en) | Devices and methods for treatment of obesity | |
US8398668B2 (en) | Devices and methods for treatment of obesity | |
US8001974B2 (en) | Devices and methods for treatment of obesity | |
AU2010202356B9 (en) | Devices and methods for treatment of obesity | |
US8187297B2 (en) | Devices and methods for treatment of obesity | |
AU2012202287A1 (en) | Minimally-invasive methods for implanting obesity treatment devices | |
US20090272388A1 (en) | Minimally-invasive methods for implanting obesity treatment devices |